ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-8957275,Post-translational protein phosphorylation,5/56,108/10899,2.2249802538679763e-4,0.05579358310431215,0.05181162167581481,CP/FSTL1/P4HB/MXRA8/LAMB1,5
R-HSA-9614085,FOXO-mediated transcription,4/56,65/10899,3.353088131841659e-4,0.05579358310431215,0.05181162167581481,CAV1/SOD2/CDKN1A/SREBF1,4
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),5/56,125/10899,4.3816950081920536e-4,0.05579358310431215,0.05181162167581481,CP/FSTL1/P4HB/MXRA8/LAMB1,5
R-HSA-5663084,Diseases of carbohydrate metabolism,3/56,34/10899,6.867819652041239e-4,0.06558767767699383,0.06090671638783941,ARSB/HGSNAT/GAA,3
R-HSA-9702518,STAT5 activation downstream of FLT3 ITD mutants,2/56,10/10899,0.0011364403337085732,0.086824041495335,0.08062745104416613,STAT5A/CDKN1A,2
R-HSA-2206281,Mucopolysaccharidoses,2/56,11/10899,0.0013844066401887119,0.08814055609201465,0.08185000662168349,ARSB/HGSNAT,2
R-HSA-5668914,Diseases of metabolism,6/56,249/10899,0.0016711345040685435,0.09119619722202622,0.08468756810091715,ARSB/HGSNAT/SLC26A2/CYP1B1/GAA/TCN2,6
R-HSA-449147,Signaling by Interleukins,8/56,473/10899,0.0026912205284700614,0.12610866310525376,0.11710834793736709,IL17RA/P4HB/SOD2/PTPN18/STAT5A/MAPKAPK2/TGFB1/CDKN1A,8
R-HSA-9703648,Signaling by FLT3 ITD and TKD mutants,2/56,16/10899,0.0029711465129510046,0.12610866310525376,0.11710834793736709,STAT5A/CDKN1A,2
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,2/56,17/10899,0.0033562291941198717,0.12820795521537912,0.11905781457035756,CAV1/CDKN1A,2
R-HSA-9703465,Signaling by FLT3 fusion proteins,2/56,19/10899,0.004192278158659327,0.13642657938340902,0.12668987944945947,STAT5A/CDKN1A,2
R-HSA-5625900,RHO GTPases activate CIT,2/56,20/10899,0.0046427893507442865,0.13642657938340902,0.12668987944945947,PPP1CB/RHOB,2
R-HSA-5627117,RHO GTPases Activate ROCKs,2/56,20/10899,0.0046427893507442865,0.13642657938340902,0.12668987944945947,PPP1CB/RHOB,2
R-HSA-9013026,RHOB GTPase cycle,3/56,70/10899,0.005514220862386441,0.15045945495940147,0.1397212353852805,CAV1/CAVIN1/RHOB,3
R-HSA-163560,Triglyceride catabolism,2/56,24/10899,0.006656181157592283,0.15655161982432816,0.14537860534802588,CAV1/PPP1CB,2
R-HSA-982772,Growth hormone receptor signaling,2/56,24/10899,0.006656181157592283,0.15655161982432816,0.14537860534802588,PTPN1/STAT5A,2
R-HSA-6806834,Signaling by MET,3/56,79/10899,0.007711496999838568,0.15655161982432816,0.14537860534802588,ARF6/PTPN1/LAMB1,3
R-HSA-2173788,Downregulation of TGF-beta receptor signaling,2/56,26/10899,0.007786598891785956,0.15655161982432816,0.14537860534802588,TGFB1/PPP1CB,2
R-HSA-425410,Metal ion SLC transporters,2/56,26/10899,0.007786598891785956,0.15655161982432816,0.14537860534802588,SLC39A8/CP,2
R-HSA-9682385,FLT3 signaling in disease,2/56,28/10899,0.008997185538424126,0.17184624378390082,0.15958165928678583,STAT5A/CDKN1A,2
R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",2/56,29/10899,0.009632009332943212,0.17521083643734794,0.1627061225665094,SOD2/SREBF1,2
R-HSA-8978868,Fatty acid metabolism,4/56,177/10899,0.012813801275166119,0.22249418577788443,0.20661488180531012,CYP1B1/MAPKAPK2/ACOX2/PPT1,4
R-HSA-2129379,Molecules associated with elastic fibres,2/56,37/10899,0.015391872588687693,0.23518781315514795,0.21840257104790536,EMILIN1/TGFB1,2
R-HSA-3299685,Detoxification of Reactive Oxygen Species,2/56,37/10899,0.015391872588687693,0.23518781315514795,0.21840257104790536,P4HB/SOD2,2
R-HSA-8979227,Triglyceride metabolism,2/56,37/10899,0.015391872588687693,0.23518781315514795,0.21840257104790536,CAV1/PPP1CB,2
R-HSA-9607240,FLT3 Signaling,2/56,38/10899,0.016193964090928173,0.23792670318209852,0.22094598779930338,STAT5A/SH2B3,2
R-HSA-1474244,Extracellular matrix organization,5/56,300/10899,0.01858555855756802,0.25043574899229915,0.23256226897328414,EMILIN1/P4HB/ADAM8/LAMB1/TGFB1,5
R-HSA-9696264,RND3 GTPase cycle,2/56,42/10899,0.019576211316782156,0.25043574899229915,0.23256226897328414,CPD/CAV1,2
R-HSA-9696273,RND1 GTPase cycle,2/56,42/10899,0.019576211316782156,0.25043574899229915,0.23256226897328414,CPD/CAV1,2
R-HSA-1433557,Signaling by SCF-KIT,2/56,43/10899,0.020464279215653795,0.25043574899229915,0.23256226897328414,STAT5A/SH2B3,2
R-HSA-9696270,RND2 GTPase cycle,2/56,43/10899,0.020464279215653795,0.25043574899229915,0.23256226897328414,CAV1/PLXND1,2
R-HSA-1566948,Elastic fibre formation,2/56,44/10899,0.021368968977021854,0.25043574899229915,0.23256226897328414,EMILIN1/TGFB1,2
R-HSA-194068,Bile acid and bile salt metabolism,2/56,45/10899,0.02229009284224652,0.25043574899229915,0.23256226897328414,ABCC3/ACOX2,2
R-HSA-445355,Smooth Muscle Contraction,2/56,45/10899,0.02229009284224652,0.25043574899229915,0.23256226897328414,ACTA2/CALD1,2
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,2/56,46/10899,0.023227464482570175,0.25351118378119447,0.23541821144740296,TGFB1/PPP1CB,2
R-HSA-9020591,Interleukin-12 signaling,2/56,47/10899,0.02418089898980795,0.2547334184101668,0.23655321577356353,P4HB/SOD2,2
R-HSA-9006936,Signaling by TGFB family members,3/56,122/10899,0.02467313214967584,0.2547334184101668,0.23655321577356353,FSTL1/TGFB1/PPP1CB,3
R-HSA-1630316,Glycosaminoglycan metabolism,3/56,124/10899,0.025732453909221163,0.2586788787716443,0.24021709050990397,ARSB/HGSNAT/SLC26A2,3
R-HSA-9012999,RHO GTPase cycle,6/56,449/10899,0.026969735664641777,0.2641651031767477,0.24531176569458246,CPD/CAV1/CAVIN1/WIPF1/PLXND1/RHOB,6
R-HSA-447115,Interleukin-12 family signaling,2/56,57/10899,0.034559019289202006,0.30345303485811725,0.28179573642101274,P4HB/SOD2,2
R-HSA-2142753,Arachidonic acid metabolism,2/56,59/10899,0.036809609214530116,0.30345303485811725,0.28179573642101274,CYP1B1/MAPKAPK2,2
R-HSA-3000171,Non-integrin membrane-ECM interactions,2/56,59/10899,0.036809609214530116,0.30345303485811725,0.28179573642101274,LAMB1/TGFB1,2
R-HSA-9033241,Peroxisomal protein import,2/56,63/10899,0.041474880703078996,0.30345303485811725,0.28179573642101274,ACOX2/DDO,2
R-HSA-373755,Semaphorin interactions,2/56,65/10899,0.043886937519570395,0.30345303485811725,0.28179573642101274,PLXND1/RHOB,2
R-HSA-8957322,Metabolism of steroids,3/56,154/10899,0.04451023786124106,0.30345303485811725,0.28179573642101274,ABCC3/ACOX2/SREBF1,3
R-HSA-400253,Circadian Clock,2/56,70/10899,0.05013846160638316,0.30345303485811725,0.28179573642101274,PPP1CB/SREBF1,2
R-HSA-2562578,TRIF-mediated programmed cell death,1/56,10/10899,0.05022926053847665,0.30345303485811725,0.28179573642101274,RIPK1,1
R-HSA-442380,Zinc influx into cells by the SLC39 gene family,1/56,10/10899,0.05022926053847665,0.30345303485811725,0.28179573642101274,SLC39A8,1
R-HSA-8875656,MET receptor recycling,1/56,10/10899,0.05022926053847665,0.30345303485811725,0.28179573642101274,ARF6,1
R-HSA-8963888,Chylomicron assembly,1/56,10/10899,0.05022926053847665,0.30345303485811725,0.28179573642101274,P4HB,1
R-HSA-9020958,Interleukin-21 signaling,1/56,10/10899,0.05022926053847665,0.30345303485811725,0.28179573642101274,STAT5A,1
R-HSA-448424,Interleukin-17 signaling,2/56,72/10899,0.05272434991110929,0.30345303485811725,0.28179573642101274,IL17RA/MAPKAPK2,2
R-HSA-2586552,Signaling by Leptin,1/56,11/10899,0.0551137459283052,0.30345303485811725,0.28179573642101274,STAT5A,1
R-HSA-3371378,Regulation by c-FLIP,1/56,11/10899,0.0551137459283052,0.30345303485811725,0.28179573642101274,RIPK1,1
R-HSA-5218900,CASP8 activity is inhibited,1/56,11/10899,0.0551137459283052,0.30345303485811725,0.28179573642101274,RIPK1,1
R-HSA-5661231,Metallothioneins bind metals,1/56,11/10899,0.0551137459283052,0.30345303485811725,0.28179573642101274,MT1E,1
R-HSA-69416,Dimerization of procaspase-8,1/56,11/10899,0.0551137459283052,0.30345303485811725,0.28179573642101274,RIPK1,1
R-HSA-75072,mRNA Editing,1/56,11/10899,0.0551137459283052,0.30345303485811725,0.28179573642101274,APOBEC3C,1
R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",2/56,74/10899,0.05535713802848371,0.30345303485811725,0.28179573642101274,NPC1/P4HB,2
R-HSA-9013106,RHOC GTPase cycle,2/56,74/10899,0.05535713802848371,0.30345303485811725,0.28179573642101274,CAV1/CAVIN1,2
R-HSA-3000178,ECM proteoglycans,2/56,76/10899,0.05803563165471349,0.30345303485811725,0.28179573642101274,LAMB1/TGFB1,2
R-HSA-417957,P2Y receptors,1/56,12/10899,0.059973557668571154,0.30345303485811725,0.28179573642101274,P2RY6,1
R-HSA-9020558,Interleukin-2 signaling,1/56,12/10899,0.059973557668571154,0.30345303485811725,0.28179573642101274,STAT5A,1
R-HSA-9755779,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,1/56,12/10899,0.059973557668571154,0.30345303485811725,0.28179573642101274,CAV1,1
R-HSA-71387,Metabolism of carbohydrates,4/56,295/10899,0.06453718727113683,0.30345303485811725,0.28179573642101274,ARSB/HGSNAT/SLC26A2/GAA,4
R-HSA-1663150,The activation of arylsulfatases,1/56,13/10899,0.06480881814166362,0.30345303485811725,0.28179573642101274,ARSB,1
R-HSA-171007,p38MAPK events,1/56,13/10899,0.06480881814166362,0.30345303485811725,0.28179573642101274,MAPKAPK2,1
R-HSA-203615,eNOS activation,1/56,13/10899,0.06480881814166362,0.30345303485811725,0.28179573642101274,CAV1,1
R-HSA-5357786,TNFR1-induced proapoptotic signaling,1/56,13/10899,0.06480881814166362,0.30345303485811725,0.28179573642101274,RIPK1,1
R-HSA-75205,Dissolution of Fibrin Clot,1/56,13/10899,0.06480881814166362,0.30345303485811725,0.28179573642101274,SERPINB6,1
R-HSA-933543,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,1/56,13/10899,0.06480881814166362,0.30345303485811725,0.28179573642101274,RIPK1,1
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,2/56,84/10899,0.06918342713003515,0.30345303485811725,0.28179573642101274,TGFB1/SREBF1,2
R-HSA-198323,AKT phosphorylates targets in the cytosol,1/56,14/10899,0.0696196491341371,0.30345303485811725,0.28179573642101274,CDKN1A,1
R-HSA-2024101,CS/DS degradation,1/56,14/10899,0.0696196491341371,0.30345303485811725,0.28179573642101274,ARSB,1
R-HSA-3296469,Defects in cobalamin (B12) metabolism,1/56,14/10899,0.0696196491341371,0.30345303485811725,0.28179573642101274,TCN2,1
R-HSA-5660526,Response to metal ions,1/56,14/10899,0.0696196491341371,0.30345303485811725,0.28179573642101274,MT1E,1
R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,1/56,14/10899,0.0696196491341371,0.30345303485811725,0.28179573642101274,CDKN1A,1
R-HSA-877312,Regulation of IFNG signaling,1/56,14/10899,0.0696196491341371,0.30345303485811725,0.28179573642101274,PTPN1,1
R-HSA-8983432,Interleukin-15 signaling,1/56,14/10899,0.0696196491341371,0.30345303485811725,0.28179573642101274,STAT5A,1
R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",2/56,85/10899,0.07062337160210155,0.30345303485811725,0.28179573642101274,SLC39A8/CP,2
R-HSA-1170546,Prolactin receptor signaling,1/56,15/10899,0.07440617183955633,0.30345303485811725,0.28179573642101274,STAT5A,1
R-HSA-391903,Eicosanoid ligand-binding receptors,1/56,15/10899,0.07440617183955633,0.30345303485811725,0.28179573642101274,PTGER4,1
R-HSA-5576893,Phase 2 - plateau phase,1/56,15/10899,0.07440617183955633,0.30345303485811725,0.28179573642101274,KCNE4,1
R-HSA-9706369,Negative regulation of FLT3,1/56,15/10899,0.07440617183955633,0.30345303485811725,0.28179573642101274,SH2B3,1
R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,1/56,15/10899,0.07440617183955633,0.30345303485811725,0.28179573642101274,CAV1,1
R-HSA-1433559,Regulation of KIT signaling,1/56,16/10899,0.07916850686132992,0.30345303485811725,0.28179573642101274,SH2B3,1
R-HSA-2173791,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),1/56,16/10899,0.07916850686132992,0.30345303485811725,0.28179573642101274,TGFB1,1
R-HSA-3229121,Glycogen storage diseases,1/56,16/10899,0.07916850686132992,0.30345303485811725,0.28179573642101274,GAA,1
R-HSA-418038,Nucleotide-like (purinergic) receptors,1/56,16/10899,0.07916850686132992,0.30345303485811725,0.28179573642101274,P2RY6,1
R-HSA-70221,Glycogen breakdown (glycogenolysis),1/56,16/10899,0.07916850686132992,0.30345303485811725,0.28179573642101274,GAA,1
R-HSA-877300,Interferon gamma signaling,2/56,92/10899,0.080971745215147925,0.30345303485811725,0.28179573642101274,CIITA/PTPN1,2
R-HSA-170834,Signaling by TGF-beta Receptor Complex,2/56,93/10899,0.08248689611799633,0.30345303485811725,0.28179573642101274,TGFB1/PPP1CB,2
R-HSA-140534,Caspase activation via Death Receptors in the presence of ligand,1/56,17/10899,0.08390677421553083,0.30345303485811725,0.28179573642101274,RIPK1,1
R-HSA-1810476,RIP-mediated NFkB activation via ZBP1,1/56,17/10899,0.08390677421553083,0.30345303485811725,0.28179573642101274,RIPK1,1
R-HSA-202131,Metabolism of nitric oxide: NOS3 activation and regulation,1/56,17/10899,0.08390677421553083,0.30345303485811725,0.28179573642101274,CAV1,1
R-HSA-435354,Zinc transporters,1/56,17/10899,0.08390677421553083,0.30345303485811725,0.28179573642101274,SLC39A8,1
R-HSA-450385,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,1/56,17/10899,0.08390677421553083,0.30345303485811725,0.28179573642101274,MAPKAPK2,1
R-HSA-450513,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",1/56,17/10899,0.08390677421553083,0.30345303485811725,0.28179573642101274,MAPKAPK2,1
R-HSA-9022699,MECP2 regulates neuronal receptors and channels,1/56,17/10899,0.08390677421553083,0.30345303485811725,0.28179573642101274,PTPN1,1
R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,1/56,17/10899,0.08390677421553083,0.30345303485811725,0.28179573642101274,CDKN1A,1
R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",1/56,17/10899,0.08390677421553083,0.30345303485811725,0.28179573642101274,CDKN1A,1
R-HSA-5625740,RHO GTPases activate PKNs,2/56,95/10899,0.08554351682373286,0.30345303485811725,0.28179573642101274,PPP1CB/RHOB,2
R-HSA-9692914,SARS-CoV-1-host interactions,2/56,95/10899,0.08554351682373286,0.30345303485811725,0.28179573642101274,CAV1/RIPK1,2
R-HSA-8878159,Transcriptional regulation by RUNX3,2/56,96/10899,0.0870847343490791,0.30345303485811725,0.28179573642101274,TGFB1/CDKN1A,2
R-HSA-397014,Muscle contraction,3/56,205/10899,0.08813113959522394,0.30345303485811725,0.28179573642101274,ACTA2/CALD1/KCNE4,3
R-HSA-1368082,RORA activates gene expression,1/56,18/10899,0.08862109333370072,0.30345303485811725,0.28179573642101274,SREBF1,1
R-HSA-159418,Recycling of bile acids and salts,1/56,18/10899,0.08862109333370072,0.30345303485811725,0.28179573642101274,ABCC3,1
R-HSA-1839117,Signaling by cytosolic FGFR1 fusion mutants,1/56,18/10899,0.08862109333370072,0.30345303485811725,0.28179573642101274,STAT5A,1
R-HSA-5676594,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,1/56,18/10899,0.08862109333370072,0.30345303485811725,0.28179573642101274,TNFRSF11A,1
R-HSA-5619102,SLC transporter disorders,2/56,98/10899,0.09019236070822237,0.30345303485811725,0.28179573642101274,SLC26A2/CP,2
R-HSA-4420097,VEGFA-VEGFR2 Pathway,2/56,99/10899,0.09175852336158877,0.30345303485811725,0.28179573642101274,CAV1/MAPKAPK2,2
R-HSA-416700,Other semaphorin interactions,1/56,19/10899,0.09331158306564791,0.30345303485811725,0.28179573642101274,PLXND1,1
R-HSA-8963898,Plasma lipoprotein assembly,1/56,19/10899,0.09331158306564791,0.30345303485811725,0.28179573642101274,P4HB,1
R-HSA-8964038,LDL clearance,1/56,19/10899,0.09331158306564791,0.30345303485811725,0.28179573642101274,NPC1,1
R-HSA-9725371,Nuclear events stimulated by ALK signaling in cancer,1/56,19/10899,0.09331158306564791,0.30345303485811725,0.28179573642101274,STAT5A,1
R-HSA-167044,Signalling to RAS,1/56,20/10899,0.09797836168222152,0.30345303485811725,0.28179573642101274,MAPKAPK2,1
R-HSA-168927,"TICAM1, RIP1-mediated IKK complex recruitment",1/56,20/10899,0.09797836168222152,0.30345303485811725,0.28179573642101274,RIPK1,1
R-HSA-9013695,NOTCH4 Intracellular Domain Regulates Transcription,1/56,20/10899,0.09797836168222152,0.30345303485811725,0.28179573642101274,ACTA2,1
R-HSA-9669938,Signaling by KIT in disease,1/56,20/10899,0.09797836168222152,0.30345303485811725,0.28179573642101274,STAT5A,1
R-HSA-9670439,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",1/56,20/10899,0.09797836168222152,0.30345303485811725,0.28179573642101274,STAT5A,1
R-HSA-6798695,Neutrophil degranulation,5/56,482/10899,0.10059985610107079,0.30345303485811725,0.28179573642101274,ARSB/HGSNAT/ADAM8/GAA/SERPINB6,5
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,2/56,105/10899,0.10132079397002997,0.30345303485811725,0.28179573642101274,RIPK1/MAPKAPK2,2
R-HSA-9645723,Diseases of programmed cell death,2/56,105/10899,0.10132079397002997,0.30345303485811725,0.28179573642101274,RIPK1/SOD2,2
R-HSA-1606322,ZBP1(DAI) mediated induction of type I IFNs,1/56,21/10899,0.10262154687808489,0.30345303485811725,0.28179573642101274,RIPK1,1
R-HSA-2142691,Synthesis of Leukotrienes (LT) and Eoxins (EX),1/56,21/10899,0.10262154687808489,0.30345303485811725,0.28179573642101274,MAPKAPK2,1
R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,1/56,21/10899,0.10262154687808489,0.30345303485811725,0.28179573642101274,RHOB,1
R-HSA-6807004,Negative regulation of MET activity,1/56,21/10899,0.10262154687808489,0.30345303485811725,0.28179573642101274,PTPN1,1
R-HSA-9008059,Interleukin-37 signaling,1/56,21/10899,0.10262154687808489,0.30345303485811725,0.28179573642101274,PTPN18,1
R-HSA-194138,Signaling by VEGF,2/56,108/10899,0.10620289505218562,0.30345303485811725,0.28179573642101274,CAV1/MAPKAPK2,2
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,2/56,108/10899,0.10620289505218562,0.30345303485811725,0.28179573642101274,TGFB1/CDKN1A,2
R-HSA-196741,"Cobalamin (Cbl, vitamin B12) transport and metabolism",1/56,22/10899,0.10724125577446553,0.30345303485811725,0.28179573642101274,TCN2,1
R-HSA-2024096,HS-GAG degradation,1/56,22/10899,0.10724125577446553,0.30345303485811725,0.28179573642101274,HGSNAT,1
R-HSA-3296482,Defects in vitamin and cofactor metabolism,1/56,22/10899,0.10724125577446553,0.30345303485811725,0.28179573642101274,TCN2,1
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/56,22/10899,0.10724125577446553,0.30345303485811725,0.28179573642101274,SOD2,1
R-HSA-8863678,Neurodegenerative Diseases,1/56,22/10899,0.10724125577446553,0.30345303485811725,0.28179573642101274,SOD2,1
R-HSA-166166,MyD88-independent TLR4 cascade ,2/56,110/10899,0.10949291935152503,0.30530142476118655,0.2835122076178558,RIPK1/MAPKAPK2,2
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,2/56,110/10899,0.10949291935152503,0.30530142476118655,0.2835122076178558,RIPK1/MAPKAPK2,2
R-HSA-156584,Cytosolic sulfonation of small molecules,1/56,24/10899,0.11641071030295591,0.3060065070328086,0.2841669685038757,SLC26A2,1
R-HSA-193368,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,1/56,24/10899,0.11641071030295591,0.3060065070328086,0.2841669685038757,ACOX2,1
R-HSA-429947,Deadenylation of mRNA,1/56,24/10899,0.11641071030295591,0.3060065070328086,0.2841669685038757,TUT7,1
R-HSA-450302,activated TAK1 mediates p38 MAPK activation,1/56,24/10899,0.11641071030295591,0.3060065070328086,0.2841669685038757,MAPKAPK2,1
R-HSA-5627123,RHO GTPases activate PAKs,1/56,24/10899,0.11641071030295591,0.3060065070328086,0.2841669685038757,PPP1CB,1
R-HSA-210991,Basigin interactions,1/56,25/10899,0.12096068733495835,0.3060065070328086,0.2841669685038757,CAV1,1
R-HSA-400685,Sema4D in semaphorin signaling,1/56,25/10899,0.12096068733495835,0.3060065070328086,0.2841669685038757,RHOB,1
R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,1/56,25/10899,0.12096068733495835,0.3060065070328086,0.2841669685038757,CDKN1A,1
R-HSA-8854691,Interleukin-20 family signaling,1/56,25/10899,0.12096068733495835,0.3060065070328086,0.2841669685038757,STAT5A,1
R-HSA-9006335,Signaling by Erythropoietin,1/56,25/10899,0.12096068733495835,0.3060065070328086,0.2841669685038757,STAT5A,1
R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,1/56,25/10899,0.12096068733495835,0.3060065070328086,0.2841669685038757,PLXND1,1
R-HSA-937041,IKK complex recruitment mediated by RIP1,1/56,25/10899,0.12096068733495835,0.3060065070328086,0.2841669685038757,RIPK1,1
R-HSA-9705462,Inactivation of CSF3 (G-CSF) signaling,1/56,25/10899,0.12096068733495835,0.3060065070328086,0.2841669685038757,STAT5A,1
R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,1/56,25/10899,0.12096068733495835,0.3060065070328086,0.2841669685038757,SOD2,1
R-HSA-912694,Regulation of IFNA/IFNB signaling,1/56,26/10899,0.12548765087268532,0.3140347423794839,0.2916222325210418,PTPN1,1
R-HSA-191273,Cholesterol biosynthesis,1/56,27/10899,0.12999171521105857,0.3140347423794839,0.2916222325210418,SREBF1,1
R-HSA-211976,Endogenous sterols,1/56,27/10899,0.12999171521105857,0.3140347423794839,0.2916222325210418,CYP1B1,1
R-HSA-3000170,Syndecan interactions,1/56,27/10899,0.12999171521105857,0.3140347423794839,0.2916222325210418,TGFB1,1
R-HSA-354192,Integrin signaling,1/56,27/10899,0.12999171521105857,0.3140347423794839,0.2916222325210418,PTPN1,1
R-HSA-5357769,Caspase activation via extrinsic apoptotic signalling pathway,1/56,27/10899,0.12999171521105857,0.3140347423794839,0.2916222325210418,RIPK1,1
R-HSA-8982491,Glycogen metabolism,1/56,27/10899,0.12999171521105857,0.3140347423794839,0.2916222325210418,GAA,1
R-HSA-201451,Signaling by BMP,1/56,28/10899,0.13447299408782265,0.3140347423794839,0.2916222325210418,FSTL1,1
R-HSA-3295583,TRP channels,1/56,28/10899,0.13447299408782265,0.3140347423794839,0.2916222325210418,RIPK1,1
R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,1/56,28/10899,0.13447299408782265,0.3140347423794839,0.2916222325210418,LAMB1,1
R-HSA-425407,SLC-mediated transmembrane transport,3/56,250/10899,0.13698215846227313,0.3140347423794839,0.2916222325210418,SLC39A8/SLC26A2/CP,3
R-HSA-186763,Downstream signal transduction,1/56,29/10899,0.13893160068621146,0.3140347423794839,0.2916222325210418,STAT5A,1
R-HSA-390918,Peroxisomal lipid metabolism,1/56,29/10899,0.13893160068621146,0.3140347423794839,0.2916222325210418,ACOX2,1
R-HSA-5213460,RIPK1-mediated regulated necrosis,1/56,29/10899,0.13893160068621146,0.3140347423794839,0.2916222325210418,RIPK1,1
R-HSA-5218920,VEGFR2 mediated vascular permeability,1/56,29/10899,0.13893160068621146,0.3140347423794839,0.2916222325210418,CAV1,1
R-HSA-5675482,Regulation of necroptotic cell death,1/56,29/10899,0.13893160068621146,0.3140347423794839,0.2916222325210418,RIPK1,1
R-HSA-8863795,Downregulation of ERBB2 signaling,1/56,29/10899,0.13893160068621146,0.3140347423794839,0.2916222325210418,PTPN18,1
R-HSA-9753281,Paracetamol ADME,1/56,29/10899,0.13893160068621146,0.3140347423794839,0.2916222325210418,ABCC3,1
R-HSA-3000157,Laminin interactions,1/56,30/10899,0.1433676476375979,0.3165690254194359,0.29397564498856404,LAMB1,1
R-HSA-5357956,TNFR1-induced NFkappaB signaling pathway,1/56,30/10899,0.1433676476375979,0.3165690254194359,0.29397564498856404,RIPK1,1
R-HSA-8874081,MET activates PTK2 signaling,1/56,30/10899,0.1433676476375979,0.3165690254194359,0.29397564498856404,LAMB1,1
R-HSA-9674555,Signaling by CSF3 (G-CSF),1/56,30/10899,0.1433676476375979,0.3165690254194359,0.29397564498856404,STAT5A,1
R-HSA-1839124,FGFR1 mutant receptor activation,1/56,31/10899,0.14778124702413697,0.318940318436273,0.2961776999532213,STAT5A,1
R-HSA-389661,Glyoxylate metabolism and glycine degradation,1/56,31/10899,0.14778124702413697,0.318940318436273,0.2961776999532213,DDO,1
R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,1/56,31/10899,0.14778124702413697,0.318940318436273,0.2961776999532213,MAPKAPK2,1
R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,1/56,31/10899,0.14778124702413697,0.318940318436273,0.2961776999532213,CAV1,1
R-HSA-1251985,Nuclear signaling by ERBB4,1/56,32/10899,0.15217251038139223,0.3237495894310737,0.30064373556977636,STAT5A,1
R-HSA-73863,RNA Polymerase I Transcription Termination,1/56,32/10899,0.15217251038139223,0.3237495894310737,0.30064373556977636,CAVIN1,1
R-HSA-76002,"Platelet activation, signaling and aggregation",3/56,263/10899,0.15255216255914467,0.3237495894310737,0.30064373556977636,PTPN1/TGFB1/RHOB,3
R-HSA-202733,Cell surface interactions at the vascular wall,2/56,137/10899,0.15622822747599716,0.32856522859210513,0.3051156848595741,CAV1/TGFB1,2
R-HSA-8963899,Plasma lipoprotein remodeling,1/56,33/10899,0.1565415487009506,0.32856522859210513,0.3051156848595741,P4HB,1
R-HSA-187687,Signalling to ERKs,1/56,34/10899,0.16088847243302717,0.3319710868747139,0.308278468660178,MAPKAPK2,1
R-HSA-192105,Synthesis of bile acids and bile salts,1/56,34/10899,0.16088847243302717,0.3319710868747139,0.308278468660178,ACOX2,1
R-HSA-5579029,Metabolic disorders of biological oxidation enzymes,1/56,34/10899,0.16088847243302717,0.3319710868747139,0.308278468660178,CYP1B1,1
R-HSA-1474228,Degradation of the extracellular matrix,2/56,140/10899,0.1616403721431853,0.3319710868747139,0.308278468660178,ADAM8/LAMB1,2
R-HSA-9678108,SARS-CoV-1 Infection,2/56,141/10899,0.16345227029605222,0.3338971510860532,0.31006707058693833,CAV1/RIPK1,2
R-HSA-114604,GPVI-mediated activation cascade,1/56,35/10899,0.1652133914890559,0.33392336269216594,0.3100914114832182,RHOB,1
R-HSA-1296065,Inwardly rectifying K+ channels,1/56,35/10899,0.1652133914890559,0.33392336269216594,0.3100914114832182,KCNJ8,1
R-HSA-1266695,Interleukin-7 signaling,1/56,36/10899,0.1695164152442673,0.3355195369083425,0.3115736675065071,STAT5A,1
R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,1/56,36/10899,0.1695164152442673,0.3355195369083425,0.3115736675065071,WIPF1,1
R-HSA-5673000,RAF activation,1/56,36/10899,0.1695164152442673,0.3355195369083425,0.3115736675065071,PPP1CB,1
R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,1/56,36/10899,0.1695164152442673,0.3355195369083425,0.3115736675065071,CDKN1A,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,2/56,146/10899,0.1725668171981678,0.33672205378533754,0.31269036132724926,RIPK1/MAPKAPK2,2
R-HSA-8964043,Plasma lipoprotein clearance,1/56,37/10899,0.17379765254025548,0.33672205378533754,0.31269036132724926,NPC1,1
R-HSA-8980692,RHOA GTPase cycle,2/56,147/10899,0.17440015675616619,0.33672205378533754,0.31269036132724926,CAV1/CAVIN1,2
R-HSA-5655302,Signaling by FGFR1 in disease,1/56,38/10899,0.17805721168753452,0.33672205378533754,0.31269036132724926,STAT5A,1
R-HSA-75105,Fatty acyl-CoA biosynthesis,1/56,38/10899,0.17805721168753452,0.33672205378533754,0.31269036132724926,PPT1,1
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,1/56,38/10899,0.17805721168753452,0.33672205378533754,0.31269036132724926,CDKN1A,1
R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,1/56,38/10899,0.17805721168753452,0.33672205378533754,0.31269036132724926,SOD2,1
R-HSA-9013407,RHOH GTPase cycle,1/56,38/10899,0.17805721168753452,0.33672205378533754,0.31269036132724926,CAV1,1
R-HSA-9675126,Diseases of mitotic cell cycle,1/56,38/10899,0.17805721168753452,0.33672205378533754,0.31269036132724926,CDKN1A,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,4/56,433/10899,0.18194304178562848,0.3396915442868605,0.31544792070728017,STAT5A/TGFB1/PPP1CB/CDKN1A,4
R-HSA-5689896,Ovarian tumor domain proteases,1/56,39/10899,0.18229520046807957,0.3396915442868605,0.31544792070728017,RIPK1,1
R-HSA-76009,Platelet Aggregation (Plug Formation),1/56,39/10899,0.18229520046807957,0.3396915442868605,0.31544792070728017,PTPN1,1
R-HSA-5357905,Regulation of TNFR1 signaling,1/56,40/10899,0.18651172613785738,0.34586155041097827,0.32117757643565625,RIPK1,1
R-HSA-9013148,CDC42 GTPase cycle,2/56,155/10899,0.18917854354953256,0.3485647562392836,0.32368785575265524,CAV1/WIPF1,2
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,1/56,41/10899,0.19070689542934627,0.3485647562392836,0.32368785575265524,SLC26A2,1
R-HSA-8875878,MET promotes cell motility,1/56,41/10899,0.19070689542934627,0.3485647562392836,0.32368785575265524,LAMB1,1
R-HSA-163841,"Gamma carboxylation, hypusine formation and arylsulfatase activation",1/56,42/10899,0.19488081455404282,0.34950455943495,0.3245605856422656,ARSB,1
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,1/56,42/10899,0.19488081455404282,0.34950455943495,0.3245605856422656,STAB1,1
R-HSA-2426168,Activation of gene expression by SREBF (SREBP),1/56,42/10899,0.19488081455404282,0.34950455943495,0.3245605856422656,SREBF1,1
R-HSA-9035034,RHOF GTPase cycle,1/56,42/10899,0.19488081455404282,0.34950455943495,0.3245605856422656,CAV1,1
R-HSA-451927,Interleukin-2 family signaling,1/56,44/10899,0.20316532455909508,0.35930163880358484,0.33365845212677897,STAT5A,1
R-HSA-9749641,Aspirin ADME,1/56,44/10899,0.20316532455909508,0.35930163880358484,0.33365845212677897,ABCC3,1
R-HSA-975634,Retinoid metabolism and transport,1/56,44/10899,0.20316532455909508,0.35930163880358484,0.33365845212677897,RETSAT,1
R-HSA-9609507,Protein localization,2/56,163/10899,0.2041277203993499,0.3593400423619892,0.3336941148415276,ACOX2/DDO,2
R-HSA-1660662,Glycosphingolipid metabolism,1/56,46/10899,0.21136609551987384,0.3686842396739352,0.3423714212458423,ARSB,1
R-HSA-8854214,TBC/RABGAPs,1/56,46/10899,0.21136609551987384,0.3686842396739352,0.3423714212458423,ARF6,1
R-HSA-168898,Toll-like Receptor Cascades,2/56,168/10899,0.2135411267975995,0.3690417016523401,0.34270337133325607,RIPK1/MAPKAPK2,2
R-HSA-69231,Cyclin D associated events in G1,1/56,47/10899,0.21543533892270117,0.3690417016523401,0.34270337133325607,CDKN1A,1
R-HSA-69236,G1 Phase,1/56,47/10899,0.21543533892270117,0.3690417016523401,0.34270337133325607,CDKN1A,1
R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,1/56,47/10899,0.21543533892270117,0.3690417016523401,0.34270337133325607,SREBF1,1
R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",1/56,48/10899,0.2194839586260121,0.3709861601554718,0.3445090547599724,STAT5A,1
R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,1/56,48/10899,0.2194839586260121,0.3709861601554718,0.3445090547599724,CDKN1A,1
R-HSA-6806667,Metabolism of fat-soluble vitamins,1/56,48/10899,0.2194839586260121,0.3709861601554718,0.3445090547599724,RETSAT,1
R-HSA-75893,TNF signaling,1/56,49/10899,0.22351205726364443,0.3744807275206674,0.34775421651822797,RIPK1,1
R-HSA-9012852,Signaling by NOTCH3,1/56,49/10899,0.22351205726364443,0.3744807275206674,0.34775421651822797,PLXND1,1
R-HSA-1227986,Signaling by ERBB2,1/56,50/10899,0.22751973696808958,0.37788060661656614,0.35091144786382694,PTPN18,1
R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,1/56,50/10899,0.22751973696808958,0.37788060661656614,0.35091144786382694,ARSB,1
R-HSA-5619115,Disorders of transmembrane transporters,2/56,176/10899,0.2286900544556891,0.3781800900522651,0.35118955730948836,SLC26A2/CP,2
R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,1/56,51/10899,0.23150709937290026,0.38118841362262024,0.3539831782607414,GALNT2,1
R-HSA-195258,RHO GTPase Effectors,3/56,327/10899,0.2359912667305386,0.3869041368715268,0.35929097306614644,WIPF1/PPP1CB/RHOB,3
R-HSA-8848021,Signaling by PTK6,1/56,54/10899,0.24334829169104255,0.38709655529059955,0.3594696586743787,PTPN1,1
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,1/56,54/10899,0.24334829169104255,0.38709655529059955,0.3594696586743787,PTPN1,1
R-HSA-9013405,RHOD GTPase cycle,1/56,54/10899,0.24334829169104255,0.38709655529059955,0.3594696586743787,CAV1,1
R-HSA-9013149,RAC1 GTPase cycle,2/56,185/10899,0.24582563945673042,0.38709655529059955,0.3594696586743787,CAV1/WIPF1,2
R-HSA-1638091,Heparan sulfate/heparin (HS-GAG) metabolism,1/56,55/10899,0.247255391337451,0.38709655529059955,0.3594696586743787,HGSNAT,1
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),1/56,55/10899,0.247255391337451,0.38709655529059955,0.3594696586743787,SREBF1,1
R-HSA-429914,Deadenylation-dependent mRNA decay,1/56,55/10899,0.247255391337451,0.38709655529059955,0.3594696586743787,TUT7,1
R-HSA-8941858,Regulation of RUNX3 expression and activity,1/56,55/10899,0.247255391337451,0.38709655529059955,0.3594696586743787,TGFB1,1
R-HSA-9013409,RHOJ GTPase cycle,1/56,55/10899,0.247255391337451,0.38709655529059955,0.3594696586743787,CAV1,1
R-HSA-9700206,Signaling by ALK in cancer,1/56,55/10899,0.247255391337451,0.38709655529059955,0.3594696586743787,STAT5A,1
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,1/56,55/10899,0.247255391337451,0.38709655529059955,0.3594696586743787,STAT5A,1
R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,1/56,56/10899,0.25114267445116345,0.38998577902579035,0.3621526798889263,SOD2,1
R-HSA-432722,Golgi Associated Vesicle Biogenesis,1/56,56/10899,0.25114267445116345,0.38998577902579035,0.3621526798889263,CPD,1
R-HSA-5218859,Regulated Necrosis,1/56,57/10899,0.25501023972191295,0.39247256483704845,0.36446198498232385,RIPK1,1
R-HSA-196854,Metabolism of vitamins and cofactors,2/56,190/10899,0.2553726701810441,0.39247256483704845,0.36446198498232385,RETSAT/TCN2,2
R-HSA-1236394,Signaling by ERBB4,1/56,58/10899,0.25885818535699656,0.39247256483704845,0.36446198498232385,STAT5A,1
R-HSA-186797,Signaling by PDGF,1/56,58/10899,0.25885818535699656,0.39247256483704845,0.36446198498232385,STAT5A,1
R-HSA-917937,Iron uptake and transport,1/56,58/10899,0.25885818535699656,0.39247256483704845,0.36446198498232385,CP,1
R-HSA-9013406,RHOQ GTPase cycle,1/56,59/10899,0.26268660908359065,0.39247256483704845,0.36446198498232385,CAV1,1
R-HSA-9664407,Parasite infection,1/56,59/10899,0.26268660908359065,0.39247256483704845,0.36446198498232385,WIPF1,1
R-HSA-9664417,Leishmania phagocytosis,1/56,59/10899,0.26268660908359065,0.39247256483704845,0.36446198498232385,WIPF1,1
R-HSA-9664422,FCGR3A-mediated phagocytosis,1/56,59/10899,0.26268660908359065,0.39247256483704845,0.36446198498232385,WIPF1,1
R-HSA-9711123,Cellular response to chemical stress,2/56,194/10899,0.26301826334629425,0.39247256483704845,0.36446198498232385,P4HB/SOD2,2
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,1/56,60/10899,0.26649560815105555,0.3946369933602301,0.3664719392736223,CDKN1A,1
R-HSA-69275,G2/M Transition,2/56,196/10899,0.2668425419754592,0.3946369933602301,0.3664719392736223,PPP1CB/CDKN1A,2
R-HSA-2559583,Cellular Senescence,2/56,197/10899,0.2687548704270971,0.3946369933602301,0.3664719392736223,MAPKAPK2/CDKN1A,2
R-HSA-198725,Nuclear Events (kinase and transcription factor activation),1/56,61/10899,0.2702852793332253,0.3946369933602301,0.3664719392736223,MAPKAPK2,1
R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,1/56,61/10899,0.2702852793332253,0.3946369933602301,0.3664719392736223,WIPF1,1
R-HSA-453274,Mitotic G2-G2/M phases,2/56,198/10899,0.2706672572261264,0.3946369933602301,0.3664719392736223,PPP1CB/CDKN1A,2
R-HSA-8986944,Transcriptional Regulation by MECP2,1/56,62/10899,0.2740557189306919,0.3971816142075208,0.3688349517441017,PTPN1,1
R-HSA-913531,Interferon Signaling,2/56,200/10899,0.2744920056303285,0.3971816142075208,0.3688349517441017,CIITA/PTPN1,2
R-HSA-1226099,Signaling by FGFR in disease,1/56,63/10899,0.2778070227730728,0.39819049292415704,0.3697718272676796,STAT5A,1
R-HSA-913709,O-linked glycosylation of mucins,1/56,63/10899,0.2778070227730728,0.39819049292415704,0.3697718272676796,GALNT2,1
R-HSA-9705683,SARS-CoV-2-host interactions,2/56,202/10899,0.27831639165117783,0.39819049292415704,0.3697718272676796,IL17RA/CAV1,2
R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,1/56,64/10899,0.281539286221274,0.39980671872314744,0.3712727038018757,RIPK1,1
R-HSA-450294,MAP kinase activation,1/56,64/10899,0.281539286221274,0.39980671872314744,0.3712727038018757,MAPKAPK2,1
R-HSA-5358346,Hedgehog ligand biogenesis,1/56,65/10899,0.2852526041697381,0.40357961034385165,0.3747763259462056,P4HB,1
R-HSA-211897,Cytochrome P450 - arranged by substrate type,1/56,66/10899,0.2889470710486831,0.4043142166322232,0.3754585037339742,CYP1B1,1
R-HSA-69563,p53-Dependent G1 DNA Damage Response,1/56,66/10899,0.2889470710486831,0.4043142166322232,0.3754585037339742,CDKN1A,1
R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,1/56,66/10899,0.2889470710486831,0.4043142166322232,0.3754585037339742,CDKN1A,1
R-HSA-1650814,Collagen biosynthesis and modifying enzymes,1/56,67/10899,0.2926227808263323,0.40796314699145597,0.3788470116729696,P4HB,1
R-HSA-69615,G1/S DNA Damage Checkpoints,1/56,68/10899,0.29627982701112987,0.4115596142481877,0.3821868007760795,CDKN1A,1
R-HSA-3371453,Regulation of HSF1-mediated heat shock response,1/56,69/10899,0.29991830265394914,0.4151043174413354,0.3854785201921467,MAPKAPK2,1
R-HSA-199992,trans-Golgi Network Vesicle Budding,1/56,72/10899,0.3107232300217827,0.42696501391482367,0.39649272441249817,CPD,1
R-HSA-909733,Interferon alpha/beta signaling,1/56,72/10899,0.3107232300217827,0.42696501391482367,0.39649272441249817,PTPN1,1
R-HSA-211859,Biological oxidations,2/56,222/10899,0.31645874715411726,0.43328760363036845,0.40236407391412005,SLC26A2/CYP1B1,2
R-HSA-9013408,RHOG GTPase cycle,1/56,74/10899,0.3178353477649706,0.4336182244507813,0.4026710984841921,CAV1,1
R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,1/56,77/10899,0.3283685851223537,0.4448113458040394,0.41306537210240085,CDKN1A,1
R-HSA-9009391,Extra-nuclear estrogen signaling,1/56,77/10899,0.3283685851223537,0.4448113458040394,0.41306537210240085,CAV1,1
R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,1/56,80/10899,0.3387420400222664,0.4556318989031893,0.42311366748518825,CDKN1A,1
R-HSA-416482,G alpha (12/13) signalling events,1/56,80/10899,0.3387420400222664,0.4556318989031893,0.42311366748518825,RHOB,1
R-HSA-157118,Signaling by NOTCH,2/56,236/10899,0.34292839403170294,0.45964437375477374,0.42683977391942346,ACTA2/PLXND1,2
R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,1/56,82/10899,0.34557008552761737,0.45995739606811786,0.42713045597948673,RIPK1,1
R-HSA-9013694,Signaling by NOTCH4,1/56,82/10899,0.34557008552761737,0.45995739606811786,0.42713045597948673,ACTA2,1
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/56,83/10899,0.3489580928503918,0.4628541370446169,0.4298204579334139,CDKN1A,1
R-HSA-6802957,Oncogenic MAPK signaling,1/56,84/10899,0.3523288719554565,0.4657080591245134,0.4324706969549767,PPP1CB,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/56,85/10899,0.355682508864425,0.4685197185731391,0.43508168960911514,CDKN1A,1
R-HSA-9679506,SARS-CoV Infections,3/56,413/10899,0.35698297079514885,0.46861682076888955,0.43517186166744504,IL17RA/CAV1/RIPK1,3
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,1/56,86/10899,0.35901908917731506,0.4696756577593642,0.4361551299666733,WIPF1,1
R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,1/56,88/10899,0.3656414203191015,0.47347465275219247,0.43968299249790266,PPP1CB,1
R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,1/56,88/10899,0.3656414203191015,0.47347465275219247,0.43968299249790266,MAPKAPK2,1
R-HSA-9013404,RAC2 GTPase cycle,1/56,88/10899,0.3656414203191015,0.47347465275219247,0.43968299249790266,CAV1,1
R-HSA-3371556,Cellular response to heat stress,1/56,89/10899,0.3689273402582498,0.47551531430590915,0.4415780130093452,MAPKAPK2,1
R-HSA-1474290,Collagen formation,1/56,90/10899,0.3721965418258294,0.47551531430590915,0.4415780130093452,P4HB,1
R-HSA-428157,Sphingolipid metabolism,1/56,90/10899,0.3721965418258294,0.47551531430590915,0.4415780130093452,ARSB,1
R-HSA-9616222,Transcriptional regulation of granulopoiesis,1/56,90/10899,0.3721965418258294,0.47551531430590915,0.4415780130093452,CDKN1A,1
R-HSA-381119,Unfolded Protein Response (UPR),1/56,94/10899,0.38510782869378535,0.48874149688048507,0.4538602492386979,CREB3L2,1
R-HSA-9013423,RAC3 GTPase cycle,1/56,94/10899,0.38510782869378535,0.48874149688048507,0.4538602492386979,CAV1,1
R-HSA-1592230,Mitochondrial biogenesis,1/56,95/10899,0.3882946830753815,0.49115420177084684,0.45610076053120796,SOD2,1
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,1/56,97/10899,0.3946198029056437,0.4942451301965767,0.45897109086868654,MAPKAPK2,1
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,1/56,97/10899,0.3946198029056437,0.4942451301965767,0.45897109086868654,MAPKAPK2,1
R-HSA-975871,MyD88 cascade initiated on plasma membrane,1/56,97/10899,0.3946198029056437,0.4942451301965767,0.45897109086868654,MAPKAPK2,1
R-HSA-9679191,Potential therapeutics for SARS,1/56,99/10899,0.40088067613237577,0.5004458113809397,0.46472923239288144,RIPK1,1
R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,1/56,102/10899,0.41015292368935985,0.5075468669184073,0.4713234889818223,TNFRSF11A,1
R-HSA-5689603,UCH proteinases,1/56,102/10899,0.41015292368935985,0.5075468669184073,0.4713234889818223,TGFB1,1
R-HSA-1296071,Potassium Channels,1/56,103/10899,0.4132122398210071,0.5075468669184073,0.4713234889818223,KCNJ8,1
R-HSA-382556,ABC-family proteins mediated transport,1/56,103/10899,0.4132122398210071,0.5075468669184073,0.4713234889818223,ABCC3,1
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,1/56,103/10899,0.4132122398210071,0.5075468669184073,0.4713234889818223,MAPKAPK2,1
R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/56,104/10899,0.4162559703295312,0.5080184685810892,0.4717614326586582,CDKN1A,1
R-HSA-975155,MyD88 dependent cascade initiated on endosome,1/56,104/10899,0.4162559703295312,0.5080184685810892,0.4717614326586582,MAPKAPK2,1
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,1/56,105/10899,0.41928419317914156,0.5084652755378796,0.47217635121594226,MAPKAPK2,1
R-HSA-2187338,Visual phototransduction,1/56,105/10899,0.41928419317914156,0.5084652755378796,0.47217635121594226,RETSAT,1
R-HSA-211945,Phase I - Functionalization of compounds,1/56,106/10899,0.4222969859512342,0.510498255168897,0.4740642380598465,CYP1B1,1
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,1/56,108/10899,0.42827658968543025,0.512857859748697,0.4762554387856459,MAPKAPK2,1
R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,1/56,108/10899,0.42827658968543025,0.512857859748697,0.4762554387856459,SLC26A2,1
R-HSA-9748784,Drug ADME,1/56,108/10899,0.42827658968543025,0.512857859748697,0.4762554387856459,ABCC3,1
R-HSA-156580,Phase II - Conjugation of compounds,1/56,109/10899,0.43124355391280667,0.5131932635348665,0.4765669049634886,SLC26A2,1
R-HSA-2672351,Stimuli-sensing channels,1/56,109/10899,0.43124355391280667,0.5131932635348665,0.4765669049634886,RIPK1,1
R-HSA-5173105,O-linked glycosylation,1/56,111/10899,0.43713218743238913,0.5185853900595423,0.48157419798860784,GALNT2,1
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),1/56,112/10899,0.44005400774234305,0.5188291078937501,0.4818005217971722,CDKN1A,1
R-HSA-73864,RNA Polymerase I Transcription,1/56,112/10899,0.44005400774234305,0.5188291078937501,0.4818005217971722,CAVIN1,1
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,1/56,113/10899,0.44296093047956664,0.5190523786601057,0.4820078578353696,MAPKAPK2,1
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,1/56,113/10899,0.44296093047956664,0.5190523786601057,0.4820078578353696,MAPKAPK2,1
R-HSA-187037,Signaling by NTRK1 (TRKA),1/56,115/10899,0.4487303812074842,0.5240056033695476,0.4866075732585768,MAPKAPK2,1
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,1/56,116/10899,0.4515930572694635,0.5240056033695476,0.4866075732585768,MAPKAPK2,1
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,1/56,116/10899,0.4515930572694635,0.5240056033695476,0.4866075732585768,MAPKAPK2,1
R-HSA-1989781,PPARA activates gene expression,1/56,117/10899,0.45444113190480695,0.5240056033695476,0.4866075732585768,SREBF1,1
R-HSA-5688426,Deubiquitination,2/56,298/10899,0.4554184825096591,0.5240056033695476,0.4866075732585768,RIPK1/TGFB1,2
R-HSA-9694516,SARS-CoV-2 Infection,2/56,298/10899,0.4554184825096591,0.5240056033695476,0.4866075732585768,IL17RA/CAV1,2
R-HSA-9006931,Signaling by Nuclear Receptors,2/56,299/10899,0.4571497796461017,0.5244180655399725,0.4869905982005256,CAV1/SREBF1,2
R-HSA-373760,L1CAM interactions,1/56,119/10899,0.4600937690521415,0.524644238143039,0.48720062897273114,LAMB1,1
R-HSA-400206,Regulation of lipid metabolism by PPARalpha,1/56,119/10899,0.4600937690521415,0.524644238143039,0.48720062897273114,SREBF1,1
R-HSA-8878166,Transcriptional regulation by RUNX2,1/56,121/10899,0.4656888733779273,0.5294438977094292,0.4916577391239396,CDKN1A,1
R-HSA-2132295,MHC class II antigen presentation,1/56,123/10899,0.4712270199138,0.5340956237360764,0.4959774736816141,CTSF,1
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/56,124/10899,0.4739749121636909,0.5340956237360764,0.4959774736816141,TCN2,1
R-HSA-9007101,Rab regulation of trafficking,1/56,124/10899,0.4739749121636909,0.5340956237360764,0.4959774736816141,ARF6,1
R-HSA-2559580,Oxidative Stress Induced Senescence,1/56,125/10899,0.47670877804942957,0.5355963329849474,0.49737107802680425,MAPKAPK2,1
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,1/56,126/10899,0.4794286878720796,0.5370726063552328,0.4987419904704147,IL17RA,1
R-HSA-114608,Platelet degranulation ,1/56,129/10899,0.4875053787942396,0.5445235517526302,0.5056611654467799,TGFB1,1
R-HSA-6809371,Formation of the cornified envelope,1/56,130/10899,0.4901701604829606,0.5459037938906441,0.5069429003613862,DSC2,1
R-HSA-69206,G1/S Transition,1/56,131/10899,0.4928213324592774,0.5472608982541975,0.5082031488334654,CDKN1A,1
R-HSA-5576891,Cardiac conduction,1/56,132/10899,0.4954589629739765,0.5485951416117653,0.5094421678786578,KCNE4,1
R-HSA-8856688,Golgi-to-ER retrograde transport,1/56,133/10899,0.4980831199418838,0.5496122376448614,0.5103866742527371,GALNT2,1
R-HSA-166520,Signaling by NTRKs,1/56,134/10899,0.5006938709434864,0.5496122376448614,0.5103866742527371,MAPKAPK2,1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,1/56,134/10899,0.5006938709434864,0.5496122376448614,0.5103866742527371,TGFB1,1
R-HSA-5663220,RHO GTPases Activate Formins,1/56,140/10899,0.5160805944467566,0.564651883355121,0.5243529476182853,RHOB,1
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),2/56,335/10899,0.5173512020269433,0.564651883355121,0.5243529476182853,PTGER4/P2RY6,2
R-HSA-3781865,Diseases of glycosylation,1/56,143/10899,0.5235983488226252,0.5698420776360195,0.5291727202076014,SLC26A2,1
R-HSA-73887,Death Receptor Signalling,1/56,146/10899,0.5310013675101197,0.5746247093169001,0.5336140177453715,RIPK1,1
R-HSA-8856828,Clathrin-mediated endocytosis,1/56,146/10899,0.5310013675101197,0.5746247093169001,0.5336140177453715,ARF6,1
R-HSA-453279,Mitotic G1 phase and G1/S transition,1/56,149/10899,0.5382913702407948,0.5792318406534749,0.5378923403147452,CDKN1A,1
R-HSA-5358351,Signaling by Hedgehog,1/56,149/10899,0.5382913702407948,0.5792318406534749,0.5378923403147452,P4HB,1
R-HSA-446652,Interleukin-1 family signaling,1/56,153/10899,0.5478384963195233,0.5878491730170167,0.5458946577755155,PTPN18,1
R-HSA-168255,Influenza Infection,1/56,156/10899,0.5548713415278572,0.5937278780494158,0.5513538024322214,TGFB1,1
R-HSA-418555,G alpha (s) signalling events,1/56,157/10899,0.5571916621900972,0.5945452931749081,0.5521128790298817,PTGER4,1
R-HSA-69242,S Phase,1/56,163/10899,0.5708661811088624,0.6074397804556697,0.5640870929004153,CDKN1A,1
R-HSA-9658195,Leishmania infection,1/56,164/10899,0.5731045840389952,0.6081276419524894,0.564725862050121,WIPF1,1
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,1/56,168/10899,0.5819440883136414,0.615796791511942,0.5718476680615168,SH2B3,1
R-HSA-109581,Apoptosis,1/56,180/10899,0.6073979049876798,0.6409558002908665,0.595211090377575,RIPK1,1
R-HSA-983712,Ion channel transport,1/56,186/10899,0.619547668746787,0.6519757836398695,0.605444582768355,RIPK1,1
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,1/56,202/10899,0.650170494668481,0.6823217828663729,0.6336248024964665,GALNT2,1
R-HSA-5357801,Programmed Cell Death,1/56,210/10899,0.6645606331022982,0.6955127721782955,0.6458743571895443,RIPK1,1
R-HSA-6805567,Keratinization,1/56,214/10899,0.6715360639914839,0.7008928318162483,0.6508704445358933,DSC2,1
R-HSA-416476,G alpha (q) signalling events,1/56,216/10899,0.6749701557783654,0.702557491845601,0.6524162985725201,P2RY6,1
R-HSA-5689880,Ub-specific processing proteases,1/56,220/10899,0.681732888353448,0.7076683786712423,0.6571624238418535,RIPK1,1
R-HSA-8939211,ESR-mediated signaling,1/56,223/10899,0.6867140600725791,0.7109072383407188,0.6601701276407336,CAV1,1
R-HSA-500792,GPCR ligand binding,2/56,467/10899,0.6988789037738627,0.7215452465989609,0.670048906320887,PTGER4/P2RY6,2
R-HSA-201681,TCF dependent signaling in response to WNT,1/56,233/10899,0.7027712861409683,0.7236081706357139,0.6719646004525645,CAV1,1
R-HSA-1257604,PIP3 activates AKT signaling,1/56,267/10899,0.7515498294382578,0.771752781842512,0.7166731537088082,CDKN1A,1
R-HSA-5673001,RAF/MAP kinase cascade,1/56,280/10899,0.7680434823719637,0.7865753626436733,0.7304378539843426,PPP1CB,1
R-HSA-5684996,MAPK1/MAPK3 signaling,1/56,286/10899,0.7752885094289378,0.7918722208605729,0.7353566779553956,PPP1CB,1
R-HSA-69620,Cell Cycle Checkpoints,1/56,293/10899,0.7834604541772792,0.7980850493219217,0.7411260998112087,CDKN1A,1
R-HSA-1852241,Organelle biogenesis and maintenance,1/56,296/10899,0.7868727015691384,0.799429180849497,0.7423743013124289,SOD2,1
R-HSA-9006925,Intracellular signaling by second messengers,1/56,309/10899,0.8010589054105595,0.8116830288244925,0.7537535979990466,CDKN1A,1
R-HSA-5683057,MAPK family signaling cascades,1/56,325/10899,0.8172505921013846,0.8258987465151559,0.766954746694978,PPP1CB,1
R-HSA-195721,Signaling by WNT,1/56,332/10899,0.8239206577117117,0.8304424571131237,0.7711741748336255,CAV1,1
R-HSA-3700989,Transcriptional Regulation by TP53,1/56,362/10899,0.8498992580634316,0.8543724120532391,0.7933962602974417,CDKN1A,1
R-HSA-71291,Metabolism of amino acids and derivatives,1/56,374/10899,0.8592017732785517,0.8614568960430624,0.7999751280421935,DDO,1
R-HSA-112316,Neuronal System,1/56,410/10899,0.8838419676189708,0.8838419676189708,0.8207625877310366,KCNJ8,1
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,6/37,161/4383,0.0020203514267338662,0.06943470108240542,0.0563830655405999,CAV1/SOD2/RHOB/PPT1/CDKN1A/RETSAT,6
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,6/37,200/4383,0.005951545807063322,0.06943470108240542,0.0563830655405999,ACTA2/CALD1/FSTL1/WIPF1/TGFB1/RHOB,6
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,6/37,200/4383,0.005951545807063322,0.06943470108240542,0.0563830655405999,CP/CAV1/CAVIN1/GAA/MT1E/CDKN1A,6
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,5/37,200/4383,0.024974181871680056,0.14568272758480033,0.11829875623427397,CIITA/PTPN1/RIPK1/SOD2/CDKN1A,5
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,5/37,200/4383,0.024974181871680056,0.14568272758480033,0.11829875623427397,TGFB1/CDKN1A/RETSAT/TCN2/CTSF,5
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,5/37,200/4383,0.024974181871680056,0.14568272758480033,0.11829875623427397,PTGER4/SOD2/STAT5A/RHOB/CDKN1A,5
HALLMARK_IL6_JAK_STAT3_SIGNALING,HALLMARK_IL6_JAK_STAT3_SIGNALING,3/37,87/4383,0.03613052755588947,0.15965835141607568,0.12964738310478327,IL17RA/PTPN1/TGFB1,3
HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,2/37,36/4383,0.036493337466531585,0.15965835141607568,0.12964738310478327,FSTL1/KCNJ8,2
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,4/37,199/4383,0.08479460785972864,0.301054015079625,0.24446491450074812,SLC39A8/MAPKAPK2/RHOB/SERPINB6,4
HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,4/37,200/4383,0.08601543287989286,0.301054015079625,0.24446491450074812,ABCC3/NPC1/ACOX2/RETSAT,4
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,3/37,158/4383,0.14710809805386268,0.46807122108047217,0.38008790884730076,SOD2/RHOB/PPT1,3
HALLMARK_PEROXISOME,HALLMARK_PEROXISOME,2/37,104/4383,0.2186666138345506,0.47401655064007925,0.3849156952566058,SOD2/RETSAT,2
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,2/37,105/4383,0.22179290525280426,0.47401655064007925,0.3849156952566058,RIPK1/CDKN1A,2
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,3/37,200/4383,0.23729712394234928,0.47401655064007925,0.3849156952566058,CAVIN1/STAT5A/RETSAT,3
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,3/37,200/4383,0.23729712394234928,0.47401655064007925,0.3849156952566058,SLC26A2/CAV1/ACOX2,3
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,3/37,200/4383,0.23729712394234928,0.47401655064007925,0.3849156952566058,PTGER4/STAB1/CDKN1A,3
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,3/37,200/4383,0.23729712394234928,0.47401655064007925,0.3849156952566058,GAA/TGFB1/CDKN1A,3
HALLMARK_BILE_ACID_METABOLISM,HALLMARK_BILE_ACID_METABOLISM,2/37,112/4383,0.24377994032918363,0.47401655064007925,0.3849156952566058,NPC1/RETSAT,2
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,1/37,49/4383,0.3414407454939632,0.602996760602597,0.4896515048502292,SOD2,1
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,2/37,144/4383,0.3445695774871983,0.602996760602597,0.4896515048502292,CAV1/MT1E,2
HALLMARK_TGF_BETA_SIGNALING,HALLMARK_TGF_BETA_SIGNALING,1/37,54/4383,0.36908848174335296,0.615147469572255,0.4995182459684477,TGFB1,1
HALLMARK_FATTY_ACID_METABOLISM,HALLMARK_FATTY_ACID_METABOLISM,2/37,158/4383,0.3876931685058699,0.6167845862593384,0.5008476339549516,HSDL2/RETSAT,2
HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,2/37,200/4383,0.5090147586688127,0.7423131897253519,0.6027806352656994,STAB1/TGFB1,2
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,2/37,200/4383,0.5090147586688127,0.7423131897253519,0.6027806352656994,CP/SH2B3,2
HALLMARK_PROTEIN_SECRETION,HALLMARK_PROTEIN_SECRETION,1/37,96/4383,0.5608141251697583,0.7750967247999074,0.6294018517172181,PPT1,1
HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,1/37,100/4383,0.5757861384227884,0.7750967247999074,0.6294018517172181,SLC26A2,1
HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/37,138/4383,0.6953699077319759,0.82366711736378,0.6688424712427687,ACOX2,1
HALLMARK_MITOTIC_SPINDLE,HALLMARK_MITOTIC_SPINDLE,1/37,199/4383,0.8220938555703051,0.82366711736378,0.6688424712427687,ARF6,1
HALLMARK_E2F_TARGETS,HALLMARK_E2F_TARGETS,1/37,200/4383,0.82366711736378,0.82366711736378,0.6688424712427687,CDKN1A,1
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,1/37,200/4383,0.82366711736378,0.82366711736378,0.6688424712427687,SLC26A2,1
HALLMARK_G2M_CHECKPOINT,HALLMARK_G2M_CHECKPOINT,1/37,200/4383,0.82366711736378,0.82366711736378,0.6688424712427687,TGFB1,1
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,1/37,200/4383,0.82366711736378,0.82366711736378,0.6688424712427687,DSC2,1
HALLMARK_KRAS_SIGNALING_UP,HALLMARK_KRAS_SIGNALING_UP,1/37,200/4383,0.82366711736378,0.82366711736378,0.6688424712427687,ADAM8,1
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,1/37,200/4383,0.82366711736378,0.82366711736378,0.6688424712427687,CDKN1A,1
HALLMARK_OXIDATIVE_PHOSPHORYLATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION,1/37,200/4383,0.82366711736378,0.82366711736378,0.6688424712427687,RETSAT,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,9/65,210/21728,1.2404408787121138e-8,2.4808817574242275e-5,1.757508866048953e-5,ABCC3/ACTA2/CP/CALD1/EMILIN1/CAVIN1/CYP1B1/FSTL1/LAMB1,9
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,9/65,251/21728,5.775797190451896e-8,5.7757971904518965e-5,4.091696325446449e-5,CALD1/CPD/CAV1/PTPN1/FSTL1/GAA/TGFB1/CDKN1A/TCN2,9
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,8/65,216/21728,2.599705674471603e-7,1.733137116314402e-4,1.227790820294308e-4,PTGER4/DSC2/TNFRSF11A/CAVIN1/WIPF1/STAB1/SH2B3/LAMB1,8
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,9/65,316/21728,4.0637164027515645e-7,2.0318582013757823e-4,1.4394111258167385e-4,ACTA2/CALD1/CAV1/CAVIN1/CYP1B1/FILIP1L/TSPAN9/RHOB/CDKN1A,9
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,10/65,466/21728,1.1654622428649809e-6,4.6618489714599234e-4,3.302551955571083e-4,ACTA2/CALD1/GALNT2/CAV1/CAVIN1/FSTL1/WIPF1/SH2B3/LAMB1/TGFB1,10
KEGG_LYSOSOME,KEGG_LYSOSOME,6/65,121/21728,1.662825472718488e-6,5.3932800708699e-4,3.820713144942572e-4,ARSB/HGSNAT/NPC1/GAA/PPT1/CTSF,6
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,7/65,195/21728,1.887648024804465e-6,5.3932800708699e-4,3.820713144942572e-4,ABCC3/CP/GALNT2/CPD/CAVIN1/SOD2/SH2B3,7
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,5/65,82/21728,4.67958238643775e-6,0.0011698955966094376,8.28778670019107e-4,CIITA/CAV1/WIPF1/RHOB/DEXI,5
LEI_MYB_TARGETS,LEI_MYB_TARGETS,8/65,323/21728,5.285854751182496e-6,0.0011746343891516659,8.321357304200749e-4,ACTA2/CREB3L2/NPC1/CAV1/CYP1B1/SH2B3/LAMB1/CDKN1A,8
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,6/65,168/21728,1.1064910947548455e-5,0.002212982189509691,0.0015677231721473919,ACTA2/CP/CALD1/GALNT2/CPD/CDKN1A,6
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,9/65,491/21728,1.4848304648935843e-5,0.0026996917543519712,0.0019125184743988182,ABCC3/ACTA2/CALD1/CAV1/CAVIN1/CD248/LAMB1/ACOX2/KCNJ8,9
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,6/65,182/21728,1.7434982057457642e-5,0.002905830342909607,0.002058551390292806,ACTA2/CALD1/CAV1/CAVIN1/FSTL1/MXRA8,6
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,7/65,286/21728,2.306388262994402e-5,0.0035482896353760027,0.00251368307853479,GALNT2/PTPN18/MAPKAPK2/GAA/RHOB/CDKN1A/CTSF,7
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,3/65,21/21728,3.270027619015169e-5,0.004227626868074001,0.0029949398760145294,CALD1/CYP1B1/SERPINB6,3
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,5/65,124/21728,3.506181585516391e-5,0.004227626868074001,0.0029949398760145294,CP/FSTL1/P4HB/MXRA8/LAMB1,5
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,8/65,423/21728,3.6937430856168033e-5,0.004227626868074001,0.0029949398760145294,ACTA2/CP/CAV1/CAVIN1/STAB1/LAMB1/PPP1CB/RHOB,8
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,4/65,63/21728,3.804864181266601e-5,0.004227626868074001,0.0029949398760145294,TMEM127/SOD2/RHOB/CDKN1A,4
WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,4/65,63/21728,3.804864181266601e-5,0.004227626868074001,0.0029949398760145294,HLX/CREB3L2/STAT5A/SH2B3,4
REACTOME_FOXO_MEDIATED_TRANSCRIPTION,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,4/65,66/21728,4.572815604642933e-5,0.004813490110150456,0.0034099777306644814,CAV1/SOD2/CDKN1A/SREBF1,4
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,5/65,134/21728,5.081060942374437e-5,0.005081060942374437,0.0035995305412821013,CPD/EMILIN1/PTPN1/FSTL1/WIPF1,5
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,6/65,224/21728,5.5833691585790845e-5,0.005103706890995708,0.0036155734080422232,DSC2/CREB3L2/P2RY6/SOD2/PPP1CB/TCN2,6
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,7/65,329/21728,5.614077580095279e-5,0.005103706890995708,0.0036155734080422232,DSC2/CPD/SOD2/PPP1CB/RHOB/SREBF1/RETSAT,7
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,8/65,463/21728,6.969108072522347e-5,0.006060093976106389,0.004293098153599579,IL17RA/P4HB/SOD2/PTPN18/STAT5A/MAPKAPK2/TGFB1/CDKN1A,8
FRIDMAN_SENESCENCE_UP,FRIDMAN_SENESCENCE_UP,4/65,77/21728,8.377243183135768e-5,0.006981035985946473,0.004945512861623134,CYP1B1/FILIP1L/RHOB/CDKN1A,4
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,7/65,353/21728,8.726821832036887e-5,0.00698145746562951,0.004945811446703853,CALD1/CAVIN1/FSTL1/MXRA8/WIPF1/LAMB1/OLFML2B,7
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,6/65,246/21728,9.363773804492212e-5,0.00720290292653247,0.005102688073217215,ARSB/HGSNAT/SLC26A2/CYP1B1/GAA/TCN2,6
HUANG_DASATINIB_SENSITIVITY_UP,HUANG_DASATINIB_SENSITIVITY_UP,4/65,80/21728,9.724979936710378e-5,0.007203688842007687,0.005103244832285447,CALD1/CAV1/CAVIN1/FSTL1,4
GHANDHI_BYSTANDER_IRRADIATION_UP,GHANDHI_BYSTANDER_IRRADIATION_UP,4/65,84/21728,1.1758538937173737e-4,0.00771109996750612,0.005462705555928021,SLC39A8/TUT7/SOD2/MT1E,4
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,5/65,162/21728,1.2468684959901738e-4,0.00771109996750612,0.005462705555928021,ACTA2/MT1E/RHOB/CDKN1A/TCN2,5
FRIDMAN_IMMORTALIZATION_DN,FRIDMAN_IMMORTALIZATION_DN,3/65,33/21728,1.3074817665985737e-4,0.00771109996750612,0.005462705555928021,CYP1B1/FILIP1L/CDKN1A,3
LIEN_BREAST_CARCINOMA_METAPLASTIC,LIEN_BREAST_CARCINOMA_METAPLASTIC,3/65,33/21728,1.3074817665985737e-4,0.00771109996750612,0.005462705555928021,P4HB/MXRA8/KCNE4,3
ROZANOV_MMP14_TARGETS_SUBSET,ROZANOV_MMP14_TARGETS_SUBSET,3/65,33/21728,1.3074817665985737e-4,0.00771109996750612,0.005462705555928021,CALD1/LAMB1/PLXND1,3
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,3/65,33/21728,1.3074817665985737e-4,0.00771109996750612,0.005462705555928021,CAV1/TNFRSF11A/PTPN1,3
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,4/65,87/21728,1.3474006425324208e-4,0.00771109996750612,0.005462705555928021,IL17RA/ADAM8/SOD2/CDKN1A,4
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,6/65,263/21728,1.349442494313571e-4,0.00771109996750612,0.005462705555928021,CREB3L2/CALD1/NPC1/CAV1/CYP1B1/MT1E,6
REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,3/65,34/21728,1.430952814398862e-4,0.007758790404386885,0.005496490465423552,ARSB/HGSNAT/GAA,3
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,6/65,266/21728,1.4353762248115736e-4,0.007758790404386885,0.005496490465423552,CP/SOD2/RHOB/ACOX2/KCNJ8/SREBF1,6
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,7/65,389/21728,1.5919510852530373e-4,0.008293221810805025,0.005875092924917665,ACTA2/CAV1/CAVIN1/FILIP1L/SH2B3/MT1E/SREBF1,7
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,6/65,274/21728,1.6859017707896554e-4,0.008293221810805025,0.005875092924917665,ACTA2/EMILIN1/CYP1B1/ADAM8/MXRA8/KCNE4,6
BIOCARTA_P38MAPK_PATHWAY,BIOCARTA_P38MAPK_PATHWAY,3/65,36/21728,1.70011047121503e-4,0.008293221810805025,0.005875092924917665,RIPK1/MAPKAPK2/TGFB1,3
HOUSTIS_ROS,HOUSTIS_ROS,3/65,36/21728,1.70011047121503e-4,0.008293221810805025,0.005875092924917665,CP/CYP1B1/SOD2,3
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,4/65,94/21728,1.8172650912234113e-4,0.008653643291540053,0.0061304230896910075,HLX/PTGER4/ADAM8/SOD2,4
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,5/65,179/21728,1.9868890948079857e-4,0.009126649597400087,0.006465510714789746,PTGER4/GALNT2/EMILIN1/TSPAN9/CD248,5
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,6/65,283/21728,2.0078629114280192e-4,0.009126649597400087,0.006465510714789746,PTGER4/CIITA/TNFRSF11A/CYP1B1/OLFML2B/CDKN1A,6
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,7/65,407/21728,2.099950227501042e-4,0.009331636767006851,0.006610727941258538,CREB3L2/CAV1/CAVIN1/FSTL1/P4HB/CD248/TGFB1,7
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,5/65,182/21728,2.1462764564115757e-4,0.009331636767006851,0.006610727941258538,PTGER4/GALNT2/PTPN18/RHOB/SERPINB6,5
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,4/65,102/21728,2.4875064406521035e-4,0.010463806011710342,0.007412780469348485,CALD1/LAMB1/MT1E/CDKN1A,4
XU_CREBBP_TARGETS_DN,XU_CREBBP_TARGETS_DN,3/65,41/21728,2.511313442810482e-4,0.010463806011710342,0.007412780469348485,CIITA/ARF6/TGFB1,3
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,4/65,103/21728,2.5822314449392374e-4,0.01046805432784231,0.007415790065934607,ADAM8/STAT5A/MAPKAPK2/SH2B3,4
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,7/65,422/21728,2.6170135819605776e-4,0.01046805432784231,0.007415790065934607,ABCC3/NPC1/CPD/EMILIN1/CYP1B1/FILIP1L/SOD2,7
MACAEVA_PBMC_RESPONSE_TO_IR,MACAEVA_PBMC_RESPONSE_TO_IR,4/65,106/21728,2.881968629623148e-4,0.011301837763228031,0.008006459804897333,ACTA2/APOBEC3C/CDKN1A/RETSAT,4
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,7/65,433/21728,3.057861392770629e-4,0.011761005356810112,0.008331743794877059,ABCC3/CALD1/CPD/P4HB/GAA/RHOB/RETSAT,7
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,5/65,199/21728,3.2415144342302574e-4,0.012052775982371871,0.008538440248564495,CP/GALNT2/CAVIN1/SOD2/SH2B3,5
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,7/65,438/21728,3.2770773341873026e-4,0.012052775982371871,0.008538440248564495,HLX/CAV1/ARF6/PTPN1/P4HB/SOD2/MAPKAPK2,7
KERLEY_RESPONSE_TO_CISPLATIN_UP,KERLEY_RESPONSE_TO_CISPLATIN_UP,3/65,45/21728,3.3145133951522645e-4,0.012052775982371871,0.008538440248564495,ACTA2/CAV1/CDKN1A,3
WELCSH_BRCA1_TARGETS_UP,WELCSH_BRCA1_TARGETS_UP,5/65,201/21728,3.393858329707233e-4,0.012120922606097262,0.008586716751477324,ACTA2/ARF6/PTPN1/FSTL1/CDKN1A,5
KHETCHOUMIAN_TRIM24_TARGETS_UP,KHETCHOUMIAN_TRIM24_TARGETS_UP,3/65,46/21728,3.538203657459855e-4,0.01220070226710295,0.008643234342905563,CP/TGFB1/CDKN1A,3
NAKAJIMA_MAST_CELL,NAKAJIMA_MAST_CELL,3/65,46/21728,3.538203657459855e-4,0.01220070226710295,0.008643234342905563,CAVIN1/CYP1B1/MT1E,3
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,7/65,445/21728,3.6050442138437503e-4,0.01222048886048729,0.008657251582218892,ABCC3/DSC2/CPD/CYP1B1/MXRA8/PLXND1/CDKN1A,7
REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,2/65,10/21728,3.904525029207948e-4,0.012917656114269057,0.00915113954200324,STAT5A/CDKN1A,2
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,6/65,321/21728,3.939885114852063e-4,0.012917656114269057,0.00915113954200324,ABCC3/SLC39A8/SLC26A2/CYP1B1/TGFB1/SREBF1,6
BIOCARTA_EPONFKB_PATHWAY,BIOCARTA_EPONFKB_PATHWAY,2/65,11/21728,4.762987157988596e-4,0.015120594152344749,0.010711747225818967,SOD2/CDKN1A,2
REACTOME_MUCOPOLYSACCHARIDOSES,REACTOME_MUCOPOLYSACCHARIDOSES,2/65,11/21728,4.762987157988596e-4,0.015120594152344749,0.010711747225818967,ARSB/HGSNAT,2
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,5/65,219/21728,5.021523221948384e-4,0.015411097944031508,0.010917546227719165,HLX/CYP1B1/FILIP1L/CD248/CDKN1A,5
MARKEY_RB1_CHRONIC_LOF_DN,MARKEY_RB1_CHRONIC_LOF_DN,4/65,123/21728,5.070597141948138e-4,0.015411097944031508,0.010917546227719165,CP/ADAM8/STAB1/RHOB,4
PID_PTP1B_PATHWAY,PID_PTP1B_PATHWAY,3/65,52/21728,5.085662321530397e-4,0.015411097944031508,0.010917546227719165,CAV1/PTPN1/STAT5A,3
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,5/65,222/21728,5.341573483013169e-4,0.01571107511070063,0.011130056367896343,PTGER4/GALNT2/CYP1B1/SOD2/CDKN1A,5
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,4/65,125/21728,5.388707965707792e-4,0.01571107511070063,0.011130056367896343,ACTA2/DSC2/MAPKAPK2/CDKN1A,4
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,6/65,341/21728,5.420320913191718e-4,0.01571107511070063,0.011130056367896343,NPC1/EMILIN1/CYP1B1/FILIP1L/ADAM8/CDKN1A,6
INGRAM_SHH_TARGETS_UP,INGRAM_SHH_TARGETS_UP,4/65,126/21728,5.552974568692024e-4,0.015865641624834354,0.01123955454054055,CP/CYP1B1/FILIP1L/OLFML2B,4
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,7/65,484/21728,5.948100809580049e-4,0.016755213548112817,0.011869746018820975,ACTA2/PTGER4/CIITA/EMILIN1/CAV1/CYP1B1/WIPF1,7
WP_ADIPOGENESIS,WP_ADIPOGENESIS,4/65,131/21728,6.428138019938132e-4,0.01785593894427259,0.012649523062626792,STAT5A/TGFB1/CDKN1A/SREBF1,4
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,2/65,13/21728,6.728742331745583e-4,0.01838953757588921,0.013027535566919407,CAV1/CDKN1A,2
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,4/65,133/21728,6.804128903079007e-4,0.01838953757588921,0.013027535566919407,ACTA2/CP/P4HB/SERPINB6,4
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,5/65,235/21728,6.909091428572927e-4,0.018424243809527806,0.013052122193486542,ACTA2/CYP1B1/ADAM8/LAMB1/PPP1CB,5
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,3/65,58/21728,7.010399598661318e-4,0.01844841999647715,0.013069249113293815,PTGER4/CALD1/RHOB,3
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,5/65,238/21728,7.315126639254096e-4,0.01900032893312752,0.013460233023152447,ABCC3/SLC26A2/CALD1/CAV1/FSTL1,5
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,3/65,60/21728,7.741645512537659e-4,0.019599102563386477,0.013884416868588528,TGFB1/CDKN1A/SREBF1,3
ZHENG_GLIOBLASTOMA_PLASTICITY_DN,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,3/65,60/21728,7.741645512537659e-4,0.019599102563386477,0.013884416868588528,SLC26A2/EMILIN1/CAV1,3
DASU_IL6_SIGNALING_UP,DASU_IL6_SIGNALING_UP,3/65,61/21728,8.124756281230178e-4,0.020311890703075444,0.01438937099281029,SOD2/TGFB1/SREBF1,3
HOLLERN_EMT_BREAST_TUMOR_UP,HOLLERN_EMT_BREAST_TUMOR_UP,4/65,140/21728,8.243123887155345e-4,0.020353392313963815,0.014418771607681737,HLX/MXRA8/LAMB1/PLXND1,4
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,5/65,247/21728,8.640831234910113e-4,0.021075198133927105,0.014930114046455731,ACTA2/SLC26A2/CYP1B1/ADAM8/MXRA8,5
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,5/65,250/21728,9.120217463262061e-4,0.021798741543418074,0.015442687430231965,PTGER4/CIITA/CAV1/CAVIN1/PLXND1,5
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,4/65,144/21728,9.155471448235591e-4,0.021798741543418074,0.015442687430231965,P2RY6/ADAM8/SOD2/STAT5A,4
BROWNE_HCMV_INFECTION_24HR_DN,BROWNE_HCMV_INFECTION_24HR_DN,4/65,145/21728,9.394228210141205e-4,0.022104066376802838,0.015658985970092958,ACTA2/CALD1/CAV1/CDKN1A,4
GUO_HEX_TARGETS_DN,GUO_HEX_TARGETS_DN,3/65,65/21728,9.77716721863206e-4,0.022737598182865252,0.016107793239019282,SLC39A8/CAVIN1/STAB1,3
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,5/65,256/21728,0.0010138172262735231,0.02330614313272467,0.016510562450867062,SLC39A8/ACTA2/CREB3L2/TGFB1/CTSF,5
REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,2/65,16/21728,0.0010292140847165663,0.02339122919810378,0.016570839210867206,STAT5A/CDKN1A,2
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,6/65,388/21728,0.0010604385056012982,0.023830078777557263,0.016881729491890568,NPC1/CYP1B1/MXRA8/GAA/WIPF1/TGFB1,6
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP,2/65,17/21728,0.001164194281605066,0.024987765985586722,0.017701859482420913,PTGER4/ARF6,2
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,2/65,17/21728,0.001164194281605066,0.024987765985586722,0.017701859482420913,CREB3L2/GAA,2
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,2/65,17/21728,0.001164194281605066,0.024987765985586722,0.017701859482420913,CAV1/CDKN1A,2
WP_GLYCOSAMINOGLYCAN_DEGRADATION,WP_GLYCOSAMINOGLYCAN_DEGRADATION,2/65,17/21728,0.001164194281605066,0.024987765985586722,0.017701859482420913,ARSB/HGSNAT,2
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,4/65,154/21728,0.001174425001322576,0.024987765985586722,0.017701859482420913,CREB3L2/STAT5A/TGFB1/CDKN1A,4
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,6/65,398/21728,0.0012082382079251707,0.02525653164225101,0.017892258731826247,FSTL1/ADAM8/MAPKAPK2/GAA/SERPINB6/TCN2,6
REACTOME_RHOB_GTPASE_CYCLE,REACTOME_RHOB_GTPASE_CYCLE,3/65,70/21728,0.0012123135188280487,0.02525653164225101,0.017892258731826247,CAV1/CAVIN1/RHOB,3
GU_PDEF_TARGETS_UP,GU_PDEF_TARGETS_UP,3/65,71/21728,0.001263108465921282,0.026043473524150148,0.018449744928161104,MAPKAPK2/WIPF1/TGFB1,3
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,2/65,18/21728,0.0013071945813900802,0.026677440436532248,0.018898860435564428,CYP1B1/ADAM8,2
KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_CHRONIC_MYELOID_LEUKEMIA,3/65,73/21728,0.0013686793336411397,0.027650087548305852,0.01958790412632615,STAT5A/TGFB1/CDKN1A,3
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,6/65,412/21728,0.0014411483948257452,0.028041678510209,0.01986531540775859,ABCC3/NPC1/CPD/EMILIN1/CYP1B1/SOD2,6
REACTOME_RHO_GTPASES_ACTIVATE_CIT,REACTOME_RHO_GTPASES_ACTIVATE_CIT,2/65,19/21728,0.001458167282530868,0.028041678510209,0.01986531540775859,PPP1CB/RHOB,2
REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,2/65,19/21728,0.001458167282530868,0.028041678510209,0.01986531540775859,PPP1CB/RHOB,2
REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,2/65,19/21728,0.001458167282530868,0.028041678510209,0.01986531540775859,STAT5A/CDKN1A,2
WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY_CGL,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY_CGL,2/65,19/21728,0.001458167282530868,0.028041678510209,0.01986531540775859,CAV1/CAVIN1,2
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,6/65,414/21728,0.0014770391582363924,0.028134079204502713,0.01993077400487403,CP/CAV1/TUT7/FILIP1L/STAT5A/CDKN1A,6
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,3/65,77/21728,0.0015961015533155034,0.02995520669956022,0.02122089906189898,RIPK1/SOD2/RHOB,3
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,6/65,421/21728,0.0016080641845807406,0.02995520669956022,0.02122089906189898,ABCC3/CIITA/CYP1B1/ADAM8/SOD2/CDKN1A,6
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,4/65,168/21728,0.0016175811617762518,0.02995520669956022,0.02122089906189898,ACTA2/APOBEC3C/CDKN1A/RETSAT,4
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,6/65,423/21728,0.0016470799933745064,0.029980506082993755,0.021238821677741895,IL17RA/P4HB/MAPKAPK2/GAA/PPT1/DEXI,6
KEGG_PEROXISOME,KEGG_PEROXISOME,3/65,78/21728,0.0016564214893992357,0.029980506082993755,0.021238821677741895,SOD2/ACOX2/DDO,3
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,6/65,425/21728,0.0016868137873513544,0.029980506082993755,0.021238821677741895,CALD1/NPC1/CPD/FSTL1/LAMB1/RHOB,6
REACTOME_SIGNALING_BY_MET,REACTOME_SIGNALING_BY_MET,3/65,79/21728,0.0017181515057197042,0.029980506082993755,0.021238821677741895,ARF6/PTPN1/LAMB1,3
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,5/65,289/21728,0.0017316768952594594,0.029980506082993755,0.021238821677741895,ARF6/PTPN1/RIPK1/FILIP1L/RHOB,5
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,4/65,172/21728,0.0017629540171727703,0.029980506082993755,0.021238821677741895,DSC2/CAV1/CAVIN1/CYP1B1,4
BURTON_ADIPOGENESIS_8,BURTON_ADIPOGENESIS_8,3/65,80/21728,0.0017813035202529214,0.029980506082993755,0.021238821677741895,ACTA2/MAPKAPK2/SERPINB6,3
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,2/65,21/21728,0.0017838401119381283,0.029980506082993755,0.021238821677741895,ARSB/HGSNAT,2
MOOTHA_GLYCOGEN_METABOLISM,MOOTHA_GLYCOGEN_METABOLISM,2/65,21/21728,0.0017838401119381283,0.029980506082993755,0.021238821677741895,GAA/PPP1CB,2
MURAKAMI_UV_RESPONSE_6HR_DN,MURAKAMI_UV_RESPONSE_6HR_DN,2/65,21/21728,0.0017838401119381283,0.029980506082993755,0.021238821677741895,DSC2/TGFB1,2
WP_FOXA2_PATHWAY,WP_FOXA2_PATHWAY,2/65,21/21728,0.0017838401119381283,0.029980506082993755,0.021238821677741895,ABCC3/SREBF1,2
BIOCARTA_MAPK_PATHWAY,BIOCARTA_MAPK_PATHWAY,3/65,81/21728,0.0018458893118326028,0.030260480521845944,0.021437161464423503,RIPK1/MAPKAPK2/TGFB1,3
FALVELLA_SMOKERS_WITH_LUNG_CANCER,FALVELLA_SMOKERS_WITH_LUNG_CANCER,3/65,81/21728,0.0018458893118326028,0.030260480521845944,0.021437161464423503,SOD2/MAPKAPK2/RHOB,3
HARRIS_HYPOXIA,HARRIS_HYPOXIA,3/65,81/21728,0.0018458893118326028,0.030260480521845944,0.021437161464423503,CP/TGFB1/CDKN1A,3
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,6/65,434/21728,0.0018747333233349863,0.0304834686721136,0.021595130964560477,SLC39A8/PTGER4/SLC26A2/SH2B3/TGFB1/KCNE4,6
REACTOME_FATTY_ACID_METABOLISM,REACTOME_FATTY_ACID_METABOLISM,4/65,177/21728,0.0019571365104314622,0.0308416671499588,0.021848886307286604,CYP1B1/MAPKAPK2/ACOX2/PPT1,4
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,4/65,177/21728,0.0019571365104314622,0.0308416671499588,0.021848886307286604,CALD1/CYP1B1/FSTL1/SOD2,4
KIM_LIVER_CANCER_POOR_SURVIVAL_UP,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,2/65,22/21728,0.0019584458640223837,0.0308416671499588,0.021848886307286604,LAMB1/PPT1,2
MURATA_VIRULENCE_OF_H_PILORI,MURATA_VIRULENCE_OF_H_PILORI,2/65,22/21728,0.0019584458640223837,0.0308416671499588,0.021848886307286604,SOD2/CDKN1A,2
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,5/65,300/21728,0.002038150885169203,0.03103583436319825,0.021986438448876235,SLC39A8/ADAM8/CD248/PLXND1/SERPINB6,5
BROWNE_HCMV_INFECTION_16HR_DN,BROWNE_HCMV_INFECTION_16HR_DN,3/65,84/21728,0.0020483650679710844,0.03103583436319825,0.021986438448876235,APOBEC3C/FILIP1L/SERPINB6,3
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,3/65,84/21728,0.0020483650679710844,0.03103583436319825,0.021986438448876235,SOD2/STAT5A/CDKN1A,3
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,3/65,84/21728,0.0020483650679710844,0.03103583436319825,0.021986438448876235,MAPKAPK2/TGFB1/CDKN1A,3
ZHU_CMV_24_HR_DN,ZHU_CMV_24_HR_DN,3/65,84/21728,0.0020483650679710844,0.03103583436319825,0.021986438448876235,ACTA2/CYP1B1/SERPINB6,3
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,5/65,301/21728,0.0020678548724583023,0.03109556199185417,0.022028750758439852,EMILIN1/P4HB/ADAM8/LAMB1/TGFB1,5
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,2/65,23/21728,0.0021408352635562153,0.03195276512770471,0.022636011506258175,GALNT2/RHOB,2
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,6/65,450/21728,0.002247628786775361,0.033298204248523866,0.023589148904480592,CPD/CAV1/CAVIN1/WIPF1/PLXND1/RHOB,6
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,5/65,309/21728,0.0023170221653095336,0.03329945187532612,0.023590032749573137,ACTA2/TNFRSF11A/TMEM127/SOD2/TCN2,5
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,6/65,453/21728,0.0023233743486860458,0.03329945187532612,0.023590032749573137,SLC39A8/PTGER4/DSC2/APOBEC3C/STAB1/OLFML2B,6
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,2/65,24/21728,0.002330961631272828,0.03329945187532612,0.023590032749573137,PTPN1/STAT5A,2
REACTOME_TRIGLYCERIDE_CATABOLISM,REACTOME_TRIGLYCERIDE_CATABOLISM,2/65,24/21728,0.002330961631272828,0.03329945187532612,0.023590032749573137,CAV1/PPP1CB,2
WENG_POR_TARGETS_GLOBAL_DN,WENG_POR_TARGETS_GLOBAL_DN,2/65,24/21728,0.002330961631272828,0.03329945187532612,0.023590032749573137,HSDL2/RETSAT,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,6/65,456/21728,0.0024010347241009947,0.03405723012909212,0.024126858817767372,CALD1/GALNT2/CAV1/CAVIN1/FSTL1/RETSAT,6
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,6/65,461/21728,0.0025348074735610567,0.03568861911116059,0.025282569117695875,PTGER4/TMEM127/CYP1B1/MT1E/RHOB/CDKN1A,6
LU_IL4_SIGNALING,LU_IL4_SIGNALING,3/65,91/21728,0.0025730985204961863,0.03568861911116059,0.025282569117695875,HLX/SLC39A8/TNFRSF11A,3
WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,3/65,91/21728,0.0025730985204961863,0.03568861911116059,0.025282569117695875,CAV1/RHOB/CDKN1A,3
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,5/65,317/21728,0.002587424885559143,0.03568861911116059,0.025282569117695875,PTGER4/CPD/MAPKAPK2/MT1E/CDKN1A,5
KASLER_HDAC7_TARGETS_1_UP,KASLER_HDAC7_TARGETS_1_UP,4/65,192/21728,0.0026279004798250806,0.035741693649449485,0.02532016823797843,PTGER4/FILIP1L/STAT5A/TGFB1,4
ELVIDGE_HIF1A_TARGETS_DN,ELVIDGE_HIF1A_TARGETS_DN,3/65,92/21728,0.0026541943151975785,0.035741693649449485,0.02532016823797843,DSC2/CAV1/CAVIN1,3
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,2/65,26/21728,0.0027342395641828856,0.035741693649449485,0.02532016823797843,CAV1/GAA,2
PID_ALK1_PATHWAY,PID_ALK1_PATHWAY,2/65,26/21728,0.0027342395641828856,0.035741693649449485,0.02532016823797843,CAV1/TGFB1,2
PID_IL27_PATHWAY,PID_IL27_PATHWAY,2/65,26/21728,0.0027342395641828856,0.035741693649449485,0.02532016823797843,STAT5A/TGFB1,2
PID_RXR_VDR_PATHWAY,PID_RXR_VDR_PATHWAY,2/65,26/21728,0.0027342395641828856,0.035741693649449485,0.02532016823797843,TGFB1/SREBF1,2
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,2/65,26/21728,0.0027342395641828856,0.035741693649449485,0.02532016823797843,TGFB1/PPP1CB,2
REACTOME_METAL_ION_SLC_TRANSPORTERS,REACTOME_METAL_ION_SLC_TRANSPORTERS,2/65,26/21728,0.0027342395641828856,0.035741693649449485,0.02532016823797843,SLC39A8/CP,2
GROSS_ELK3_TARGETS_UP,GROSS_ELK3_TARGETS_UP,2/65,27/21728,0.002947298778556374,0.03827660751371914,0.027115954586034722,CPD/CAV1,2
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,4/65,200/21728,0.0030433506551923568,0.03918484409282242,0.02775936849944157,CPD/CAV1/P4HB/SOD2,4
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,6/65,480/21728,0.0030949712208892147,0.03918484409282242,0.02775936849944157,ACTA2/CALD1/CAV1/WIPF1/LAMB1/CDKN1A,6
BIOCARTA_G1_PATHWAY,BIOCARTA_G1_PATHWAY,2/65,28/21728,0.0031679102579574734,0.03918484409282242,0.02775936849944157,TGFB1/CDKN1A,2
CHEN_LUNG_CANCER_SURVIVAL,CHEN_LUNG_CANCER_SURVIVAL,2/65,28/21728,0.0031679102579574734,0.03918484409282242,0.02775936849944157,P4HB/SOD2,2
REACTOME_FLT3_SIGNALING_IN_DISEASE,REACTOME_FLT3_SIGNALING_IN_DISEASE,2/65,28/21728,0.0031679102579574734,0.03918484409282242,0.02775936849944157,STAT5A/CDKN1A,2
WP_7OXOC_AND_7BETAHC_PATHWAYS,WP_7OXOC_AND_7BETAHC_PATHWAYS,2/65,28/21728,0.0031679102579574734,0.03918484409282242,0.02775936849944157,NPC1/ACOX2,2
WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,2/65,28/21728,0.0031679102579574734,0.03918484409282242,0.02775936849944157,ACTA2/TGFB1,2
QI_PLASMACYTOMA_DN,QI_PLASMACYTOMA_DN,3/65,98/21728,0.003173972371518616,0.03918484409282242,0.02775936849944157,FSTL1/P4HB/LAMB1,3
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,2/65,29/21728,0.0033960283262872985,0.041669059218249066,0.0295192387935596,PTGER4/WIPF1,2
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,3/65,102/21728,0.003552819906506493,0.04332707203056699,0.030693809975338517,CALD1/CAV1/CAVIN1,3
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,2/65,30/21728,0.003631607505816871,0.04401948491899237,0.031184329842612497,SOD2/SREBF1,2
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,6/65,497/21728,0.003670612757939079,0.044131878314170994,0.031263951689933775,ABCC3/SLC39A8/CALD1/FSTL1/TSPAN9/ACOX2,6
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,4/65,211/21728,0.0036850118392332777,0.044131878314170994,0.031263951689933775,CP/NPC1/FSTL1/PPP1CB,4
REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,3/65,104/21728,0.0037521639136584993,0.04466861801974404,0.031644189397144994,FSTL1/TGFB1/PPP1CB,3
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,3/65,105/21728,0.003854346905938585,0.04479309267559125,0.031732369863866225,DSC2/CAV1/CAVIN1,3
GHANDHI_DIRECT_IRRADIATION_UP,GHANDHI_DIRECT_IRRADIATION_UP,3/65,105/21728,0.003854346905938585,0.04479309267559125,0.031732369863866225,SOD2/MT1E/CDKN1A,3
DANG_MYC_TARGETS_DN,DANG_MYC_TARGETS_DN,2/65,31/21728,0.0038746025164386427,0.04479309267559125,0.031732369863866225,PTPN1/TGFB1,2
SIMBULAN_PARP1_TARGETS_UP,SIMBULAN_PARP1_TARGETS_UP,2/65,31/21728,0.0038746025164386427,0.04479309267559125,0.031732369863866225,CAV1/CDKN1A,2
WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE,2/65,31/21728,0.0038746025164386427,0.04479309267559125,0.031732369863866225,PTGER4/CDKN1A,2
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,4/65,217/21728,0.004071077636492848,0.046793995821756876,0.033149851776886716,CALD1/SOD2/LAMB1/PPP1CB,4
POS_HISTAMINE_RESPONSE_NETWORK,POS_HISTAMINE_RESPONSE_NETWORK,2/65,32/21728,0.00412496827492067,0.04687463948773489,0.03320698144762693,EMILIN1/TGFB1,2
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,2/65,32/21728,0.00412496827492067,0.04687463948773489,0.03320698144762693,TGFB1/PPP1CB,2
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,4/65,221/21728,0.00434314849478621,0.04738010696392756,0.033565065249182374,CPD/CYP1B1/MAPKAPK2/ACOX2,4
CUI_TCF21_TARGETS_DN,CUI_TCF21_TARGETS_DN,2/65,33/21728,0.0043826598941632995,0.04738010696392756,0.033565065249182374,PTGER4/SERPINB6,2
KASLER_HDAC7_TARGETS_2_DN,KASLER_HDAC7_TARGETS_2_DN,2/65,33/21728,0.0043826598941632995,0.04738010696392756,0.033565065249182374,ACOX2/CDKN1A,2
PID_EPO_PATHWAY,PID_EPO_PATHWAY,2/65,33/21728,0.0043826598941632995,0.04738010696392756,0.033565065249182374,STAT5A/SH2B3,2
WP_PROSTAGLANDIN_SIGNALING,WP_PROSTAGLANDIN_SIGNALING,2/65,33/21728,0.0043826598941632995,0.04738010696392756,0.033565065249182374,PTGER4/TGFB1,2
WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,2/65,33/21728,0.0043826598941632995,0.04738010696392756,0.033565065249182374,ACTA2/TGFB1,2
WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,2/65,33/21728,0.0043826598941632995,0.04738010696392756,0.033565065249182374,TNFRSF11A/P4HB,2
WP_WHITE_FAT_CELL_DIFFERENTIATION,WP_WHITE_FAT_CELL_DIFFERENTIATION,2/65,33/21728,0.0043826598941632995,0.04738010696392756,0.033565065249182374,STAT5A/SREBF1,2
ZHAN_LATE_DIFFERENTIATION_GENES_UP,ZHAN_LATE_DIFFERENTIATION_GENES_UP,2/65,33/21728,0.0043826598941632995,0.04738010696392756,0.033565065249182374,CAV1/PPT1,2
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,4/65,223/21728,0.00448368442809469,0.04816182950964025,0.03411885395788199,ABCC3/CAVIN1/P4HB/STAB1,4
DOANE_BREAST_CANCER_ESR1_UP,DOANE_BREAST_CANCER_ESR1_UP,3/65,111/21728,0.004503131059151363,0.04816182950964025,0.03411885395788199,RHOB/ACOX2/KCNE4,3
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,3/65,112/21728,0.004617285592194797,0.04892244928903699,0.034657693022654625,SLC39A8/CYP1B1/STAT5A,3
PETRETTO_CARDIAC_HYPERTROPHY,PETRETTO_CARDIAC_HYPERTROPHY,2/65,34/21728,0.004647632682458514,0.04892244928903699,0.034657693022654625,ACTA2/FSTL1,2
WP_P38_MAPK_SIGNALING_PATHWAY,WP_P38_MAPK_SIGNALING_PATHWAY,2/65,34/21728,0.004647632682458514,0.04892244928903699,0.034657693022654625,RIPK1/MAPKAPK2,2
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,3/65,114/21728,0.004850828782709347,0.050794018667113576,0.03598355217154468,SOD2/TGFB1/CDKN1A,3
WANG_METHYLATED_IN_BREAST_CANCER,WANG_METHYLATED_IN_BREAST_CANCER,2/65,35/21728,0.004919842142751784,0.05123951147812695,0.03629914865766257,CAV1/CAVIN1,2
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,3/65,115/21728,0.004970232613378314,0.05123951147812695,0.03629914865766257,ACTA2/CALD1/PPP1CB,3
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,3/65,115/21728,0.004970232613378314,0.05123951147812695,0.03629914865766257,MAPKAPK2/TGFB1/RHOB,3
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,4/65,230/21728,0.004999704875428151,0.051279024363365656,0.03632714041741588,ADAM8/TBC1D22A/SOD2/STAB1,4
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,5/65,371/21728,0.0050469797864814946,0.051499793739607086,0.036483538091321654,CIITA/GALNT2/CAV1/PLXND1/CTSF,5
SEMENZA_HIF1_TARGETS,SEMENZA_HIF1_TARGETS,2/65,36/21728,0.005199243971906503,0.05240544563497615,0.03712512096035679,CP/CDKN1A,2
WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,2/65,36/21728,0.005199243971906503,0.05240544563497615,0.03712512096035679,TGFB1/CDKN1A,2
HOELZEL_NF1_TARGETS_DN,HOELZEL_NF1_TARGETS_DN,3/65,117/21728,0.005214341840680126,0.05240544563497615,0.03712512096035679,SLC39A8/CP/FSTL1,3
FOROUTAN_INTEGRATED_TGFB_EMT_UP,FOROUTAN_INTEGRATED_TGFB_EMT_UP,3/65,118/21728,0.005339061743253616,0.05312499247018523,0.037634863086773336,SLC26A2/CALD1/TGFB1,3
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,3/65,118/21728,0.005339061743253616,0.05312499247018523,0.037634863086773336,CAV1/RHOB/CDKN1A,3
ZHU_CMV_ALL_DN,ZHU_CMV_ALL_DN,3/65,119/21728,0.0054655679928974155,0.05351994204849789,0.037914653682777986,ACTA2/CYP1B1/SERPINB6,3
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,2/65,37/21728,0.005485794059971034,0.05351994204849789,0.037914653682777986,GALNT2/RHOB,2
REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,2/65,37/21728,0.005485794059971034,0.05351994204849789,0.037914653682777986,P4HB/SOD2,2
WP_ZINC_HOMEOSTASIS,WP_ZINC_HOMEOSTASIS,2/65,37/21728,0.005485794059971034,0.05351994204849789,0.037914653682777986,SLC39A8/MT1E,2
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,4/65,238/21728,0.005636695703329956,0.05446082805149716,0.03858119713542905,ACTA2/FILIP1L/TSPAN9/CDKN1A,4
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,4/65,238/21728,0.005636695703329956,0.05446082805149716,0.03858119713542905,CAV1/CAVIN1/STAT5A/RHOB,4
HUANG_FOXA2_TARGETS_DN,HUANG_FOXA2_TARGETS_DN,2/65,38/21728,0.005779448489448178,0.054523098957058286,0.03862531115589497,ACOX2/CDKN1A,2
REACTOME_FLT3_SIGNALING,REACTOME_FLT3_SIGNALING,2/65,38/21728,0.005779448489448178,0.054523098957058286,0.03862531115589497,STAT5A/SH2B3,2
REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,2/65,38/21728,0.005779448489448178,0.054523098957058286,0.03862531115589497,EMILIN1/TGFB1,2
REACTOME_SMOOTH_MUSCLE_CONTRACTION,REACTOME_SMOOTH_MUSCLE_CONTRACTION,2/65,38/21728,0.005779448489448178,0.054523098957058286,0.03862531115589497,ACTA2/CALD1,2
REACTOME_TRIGLYCERIDE_METABOLISM,REACTOME_TRIGLYCERIDE_METABOLISM,2/65,38/21728,0.005779448489448178,0.054523098957058286,0.03862531115589497,CAV1/PPP1CB,2
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,5/65,385/21728,0.005889318713583859,0.05529876726369821,0.039174810914177786,SLC39A8/PTGER4/CAV1/CYP1B1/SOD2,5
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,4/65,242/21728,0.005974645772324927,0.05583781095630773,0.03955668081431064,SLC39A8/GALNT2/NPC1/SOD2,4
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,4/65,243/21728,0.006061198460855712,0.056038373590482554,0.03969876360673134,CP/CALD1/TGFB1/CDKN1A,4
AMIT_EGF_RESPONSE_60_MCF10A,AMIT_EGF_RESPONSE_60_MCF10A,2/65,39/21728,0.006080163534567358,0.056038373590482554,0.03969876360673134,PTGER4/CALD1,2
ONGUSAHA_TP53_TARGETS,ONGUSAHA_TP53_TARGETS,2/65,39/21728,0.006080163534567358,0.056038373590482554,0.03969876360673134,CDKN1A/CTSF,2
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,3/65,124/21728,0.006125134974129042,0.05619389884522057,0.03980894097140363,ARSB/HGSNAT/SLC26A2,3
WP_ATM_SIGNALING_PATHWAY,WP_ATM_SIGNALING_PATHWAY,2/65,40/21728,0.006387895660559135,0.05833694667177293,0.04132712116852967,RIPK1/CDKN1A,2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,5/65,399/21728,0.006826587519726875,0.06090095715500315,0.04314352017401802,DSC2/GALNT2/CAVIN1/PLXND1/CDKN1A,5
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,3/65,129/21728,0.006830362222417534,0.06090095715500315,0.04314352017401802,ACTA2/PTPN1/STAT5A,3
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,5/65,400/21728,0.006897308808531347,0.06090095715500315,0.04314352017401802,CALD1/NPC1/FSTL1/SH2B3/LAMB1,5
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,5/65,401/21728,0.006968543490795373,0.06090095715500315,0.04314352017401802,APOBEC3C/SLC26A2/CYP1B1/P4HB/TGFB1,5
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,3/65,130/21728,0.006976955540147379,0.06090095715500315,0.04314352017401802,CAV1/RHOB/CDKN1A,3
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,3/65,130/21728,0.006976955540147379,0.06090095715500315,0.04314352017401802,SOD2/MAPKAPK2/STAB1,3
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,2/65,42/21728,0.007024237966753902,0.06090095715500315,0.04314352017401802,PTGER4/KCNJ8,2
ONO_FOXP3_TARGETS_DN,ONO_FOXP3_TARGETS_DN,2/65,42/21728,0.007024237966753902,0.06090095715500315,0.04314352017401802,IL17RA/CDKN1A,2
PID_TCPTP_PATHWAY,PID_TCPTP_PATHWAY,2/65,42/21728,0.007024237966753902,0.06090095715500315,0.04314352017401802,PTPN1/STAT5A,2
REACTOME_RND1_GTPASE_CYCLE,REACTOME_RND1_GTPASE_CYCLE,2/65,42/21728,0.007024237966753902,0.06090095715500315,0.04314352017401802,CPD/CAV1,2
REACTOME_RND3_GTPASE_CYCLE,REACTOME_RND3_GTPASE_CYCLE,2/65,42/21728,0.007024237966753902,0.06090095715500315,0.04314352017401802,CPD/CAV1,2
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,4/65,254/21728,0.007069021991197154,0.06090095715500315,0.04314352017401802,CIITA/PTPN1/PTPN18/TGFB1,4
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,3/65,131/21728,0.007125411987135368,0.06090095715500315,0.04314352017401802,CALD1/CPD/CAVIN1,3
WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,3/65,131/21728,0.007125411987135368,0.06090095715500315,0.04314352017401802,ACTA2/PPP1CB/SREBF1,3
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,3/65,131/21728,0.007125411987135368,0.06090095715500315,0.04314352017401802,NPC1/CAV1/RHOB,3
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,3/65,132/21728,0.007275737292778619,0.061606500258382976,0.04364334176199132,P4HB/HSDL2/KCNJ8,3
FUJII_YBX1_TARGETS_UP,FUJII_YBX1_TARGETS_UP,2/65,43/21728,0.0073527620259307095,0.061606500258382976,0.04364334176199132,ACTA2/CDKN1A,2
REACTOME_RND2_GTPASE_CYCLE,REACTOME_RND2_GTPASE_CYCLE,2/65,43/21728,0.0073527620259307095,0.061606500258382976,0.04364334176199132,CAV1/PLXND1,2
REACTOME_SIGNALING_BY_SCF_KIT,REACTOME_SIGNALING_BY_SCF_KIT,2/65,43/21728,0.0073527620259307095,0.061606500258382976,0.04364334176199132,STAT5A/SH2B3,2
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,4/65,257/21728,0.007361976780876766,0.061606500258382976,0.04364334176199132,ACTA2/PTGER4/CYP1B1/WIPF1,4
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,3/65,133/21728,0.007427937086681773,0.061899475722348114,0.04385089174856872,CAV1/TGFB1/CDKN1A,3
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,3/65,134/21728,0.007582016899319198,0.062921302069039,0.04457477504469816,STAB1/TGFB1/RHOB,3
PID_INSULIN_PATHWAY,PID_INSULIN_PATHWAY,2/65,44/21728,0.007688130922494483,0.06327679771600397,0.044826615645127035,CAV1/PTPN1,2
VARELA_ZMPSTE24_TARGETS_UP,VARELA_ZMPSTE24_TARGETS_UP,2/65,44/21728,0.007688130922494483,0.06327679771600397,0.044826615645127035,MAPKAPK2/CDKN1A,2
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,5/65,412/21728,0.00778655285541792,0.06382420373293377,0.045214409591857296,HLX/DSC2/P4HB/SOD2/PLXND1,5
BURTON_ADIPOGENESIS_4,BURTON_ADIPOGENESIS_4,2/65,45/21728,0.008030302065888879,0.0644447222499147,0.045653997972834315,PLXND1/SREBF1,2
CHENG_RESPONSE_TO_NICKEL_ACETATE,CHENG_RESPONSE_TO_NICKEL_ACETATE,2/65,45/21728,0.008030302065888879,0.0644447222499147,0.045653997972834315,ABCC3/CP,2
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,2/65,45/21728,0.008030302065888879,0.0644447222499147,0.045653997972834315,ABCC3/ACOX2,2
REACTOME_ELASTIC_FIBRE_FORMATION,REACTOME_ELASTIC_FIBRE_FORMATION,2/65,45/21728,0.008030302065888879,0.0644447222499147,0.045653997972834315,EMILIN1/TGFB1,2
SAGIV_CD24_TARGETS_DN,SAGIV_CD24_TARGETS_DN,2/65,45/21728,0.008030302065888879,0.0644447222499147,0.045653997972834315,CAV1/CDKN1A,2
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,3/65,137/21728,0.008055590281239337,0.0644447222499147,0.045653997972834315,PTPN1/PPP1CB/SREBF1,3
CHUNG_BLISTER_CYTOTOXICITY_UP,CHUNG_BLISTER_CYTOTOXICITY_UP,3/65,138/21728,0.00821724351394323,0.06521621836462882,0.04620054206252126,GALNT2/MT1E/CDKN1A,3
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,3/65,138/21728,0.00821724351394323,0.06521621836462882,0.04620054206252126,ABCC3/TMEM127/RHOB,3
HOLLERN_MICROACINAR_BREAST_TUMOR_UP,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,2/65,46/21728,0.008379233052259008,0.06571947491967849,0.046557059600993295,CPD/DDO,2
MARCHINI_TRABECTEDIN_RESISTANCE_DN,MARCHINI_TRABECTEDIN_RESISTANCE_DN,2/65,46/21728,0.008379233052259008,0.06571947491967849,0.046557059600993295,ACTA2/FSTL1,2
PID_TNF_PATHWAY,PID_TNF_PATHWAY,2/65,46/21728,0.008379233052259008,0.06571947491967849,0.046557059600993295,CAV1/RIPK1,2
MOOTHA_PGC,MOOTHA_PGC,5/65,421/21728,0.008503966285969783,0.06643723660913893,0.04706553709257948,MXRA8/SOD2/MAPKAPK2/TCN2/CTSF,5
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,3/65,140/21728,0.008546273550059559,0.0665079653701133,0.04711564283588027,ABCC3/DSC2/CPD,3
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,3/65,141/21728,0.008713660157715079,0.066678485982776,0.04723644322779816,TGFB1/MT1E/RHOB,3
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,2/65,47/21728,0.008734881663743655,0.066678485982776,0.04723644322779816,SOD2/RHOB,2
DOANE_BREAST_CANCER_ESR1_DN,DOANE_BREAST_CANCER_ESR1_DN,2/65,47/21728,0.008734881663743655,0.066678485982776,0.04723644322779816,DSC2/SOD2,2
REACTOME_INTERLEUKIN_12_SIGNALING,REACTOME_INTERLEUKIN_12_SIGNALING,2/65,47/21728,0.008734881663743655,0.066678485982776,0.04723644322779816,P4HB/SOD2,2
YANG_BREAST_CANCER_ESR1_LASER_DN,YANG_BREAST_CANCER_ESR1_LASER_DN,2/65,47/21728,0.008734881663743655,0.066678485982776,0.04723644322779816,DSC2/PPP1CB,2
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,5/65,428/21728,0.009092839577555887,0.06763721834773037,0.0479156294189711,CALD1/NPC1/EMILIN1/GAA/PPT1,5
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,2/65,48/21728,0.009097205867769735,0.06763721834773037,0.0479156294189711,ACTA2/PPP1CB,2
DAUER_STAT3_TARGETS_UP,DAUER_STAT3_TARGETS_UP,2/65,48/21728,0.009097205867769735,0.06763721834773037,0.0479156294189711,NPC1/SOD2,2
LEE_CALORIE_RESTRICTION_MUSCLE_DN,LEE_CALORIE_RESTRICTION_MUSCLE_DN,2/65,48/21728,0.009097205867769735,0.06763721834773037,0.0479156294189711,CYP1B1/MAPKAPK2,2
PID_AJDISS_2PATHWAY,PID_AJDISS_2PATHWAY,2/65,48/21728,0.009097205867769735,0.06763721834773037,0.0479156294189711,ARF6/PTPN1,2
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,2/65,48/21728,0.009097205867769735,0.06763721834773037,0.0479156294189711,CYP1B1/CDKN1A,2
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,2/65,48/21728,0.009097205867769735,0.06763721834773037,0.0479156294189711,CYP1B1/TGFB1,2
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,3/65,145/21728,0.009402460523322297,0.06884482775526835,0.048771125346626955,ACTA2/RHOB/SERPINB6,3
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,3/65,145/21728,0.009402460523322297,0.06884482775526835,0.048771125346626955,DSC2/CALD1/TUT7,3
WP_NRF2_PATHWAY,WP_NRF2_PATHWAY,3/65,145/21728,0.009402460523322297,0.06884482775526835,0.048771125346626955,ABCC3/SLC39A8/TGFB1,3
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,2/65,49/21728,0.009466163816349397,0.06884482775526835,0.048771125346626955,IL17RA/PPP1CB,2
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,2/65,49/21728,0.009466163816349397,0.06884482775526835,0.048771125346626955,STAT5A/CDKN1A,2
WP_IL3_SIGNALING_PATHWAY,WP_IL3_SIGNALING_PATHWAY,2/65,49/21728,0.009466163816349397,0.06884482775526835,0.048771125346626955,STAT5A/TGFB1,2
BROWNE_HCMV_INFECTION_4HR_UP,BROWNE_HCMV_INFECTION_4HR_UP,2/65,50/21728,0.009841713845379423,0.07080369672934836,0.05015882936721207,RIPK1/SOD2,2
ROY_WOUND_BLOOD_VESSEL_UP,ROY_WOUND_BLOOD_VESSEL_UP,2/65,50/21728,0.009841713845379423,0.07080369672934836,0.05015882936721207,GALNT2/KCNJ8,2
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,2/65,50/21728,0.009841713845379423,0.07080369672934836,0.05015882936721207,TGFB1/CDKN1A,2
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,5/65,437/21728,0.009890763942830512,0.0709015336403621,0.05022813909469863,PTGER4/CREB3L2/CALD1/CYP1B1/MXRA8,5
GOZGIT_ESR1_TARGETS_UP,GOZGIT_ESR1_TARGETS_UP,3/65,149/21728,0.010122281294008832,0.07230200924292023,0.051220265495247705,PTGER4/DSC2/LAMB1,3
PID_CASPASE_PATHWAY,PID_CASPASE_PATHWAY,2/65,51/21728,0.010223814473943119,0.07250932251023488,0.05136713057830325,RIPK1/SREBF1,2
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,2/65,51/21728,0.010223814473943119,0.07250932251023488,0.05136713057830325,PTPN1/SERPINB6,2
SMID_BREAST_CANCER_ERBB2_UP,SMID_BREAST_CANCER_ERBB2_UP,3/65,151/21728,0.01049390855502092,0.07412459607923304,0.05251142438034088,ABCC3/CPD/P4HB,3
PID_KIT_PATHWAY,PID_KIT_PATHWAY,2/65,52/21728,0.010612424403614722,0.07412459607923304,0.05251142438034088,STAT5A/SH2B3,2
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,4/65,286/21728,0.01061508125983928,0.07412459607923304,0.05251142438034088,PTGER4/FSTL1/SOD2/SH2B3,4
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,5/65,445/21728,0.010639535675725637,0.07412459607923304,0.05251142438034088,HGSNAT/TUT7/ARF6/RHOB/KCNE4,5
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,3/65,152/21728,0.01068266528483911,0.07412459607923304,0.05251142438034088,ACTA2/FSTL1/LAMB1,3
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,5/65,446/21728,0.010735793899121611,0.07412459607923304,0.05251142438034088,ACTA2/MAPKAPK2/LAMB1/TGFB1/CDKN1A,5
REACTOME_METABOLISM_OF_STEROIDS,REACTOME_METABOLISM_OF_STEROIDS,3/65,153/21728,0.010873389134600231,0.07412459607923304,0.05251142438034088,ABCC3/ACOX2/SREBF1,3
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,4/65,289/21728,0.010996877014838414,0.07412459607923304,0.05251142438034088,CIITA/CAV1/SOD2/RHOB,4
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,2/65,53/21728,0.011007502517766105,0.07412459607923304,0.05251142438034088,SLC26A2/NPC1,2
GENTILE_RESPONSE_CLUSTER_D3,GENTILE_RESPONSE_CLUSTER_D3,2/65,53/21728,0.011007502517766105,0.07412459607923304,0.05251142438034088,RIPK1/RHOB,2
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,2/65,53/21728,0.011007502517766105,0.07412459607923304,0.05251142438034088,GALNT2/RHOB,2
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,2/65,53/21728,0.011007502517766105,0.07412459607923304,0.05251142438034088,SLC39A8/SOD2,2
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SMIRNOV_RESPONSE_TO_IR_2HR_UP,2/65,53/21728,0.011007502517766105,0.07412459607923304,0.05251142438034088,PTGER4/CDKN1A,2
WP_VITAMIN_B12_METABOLISM,WP_VITAMIN_B12_METABOLISM,2/65,53/21728,0.011007502517766105,0.07412459607923304,0.05251142438034088,SOD2/TCN2,2
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,2/65,53/21728,0.011007502517766105,0.07412459607923304,0.05251142438034088,CDKN1A/TCN2,2
GENTILE_UV_RESPONSE_CLUSTER_D4,GENTILE_UV_RESPONSE_CLUSTER_D4,2/65,54/21728,0.01140900788087593,0.07606005253917288,0.053882542483014044,ARF6/FILIP1L,2
PID_TGFBR_PATHWAY,PID_TGFBR_PATHWAY,2/65,54/21728,0.01140900788087593,0.07606005253917288,0.053882542483014044,CAV1/TGFB1,2
SUNG_METASTASIS_STROMA_DN,SUNG_METASTASIS_STROMA_DN,2/65,54/21728,0.01140900788087593,0.07606005253917288,0.053882542483014044,ARF6/MT1E,2
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,4/65,293/21728,0.011519620803124951,0.07654233091777377,0.05422419863964395,ARSB/HGSNAT/SLC26A2/GAA,4
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,4/65,295/21728,0.011786905093625481,0.07774276143316652,0.05507460888896957,ACTA2/CALD1/TGFB1/PLXND1,4
LAU_APOPTOSIS_CDKN2A_UP,LAU_APOPTOSIS_CDKN2A_UP,2/65,55/21728,0.011816899737841313,0.07774276143316652,0.05507460888896957,RHOB/CDKN1A,2
PID_IL2_1PATHWAY,PID_IL2_1PATHWAY,2/65,55/21728,0.011816899737841313,0.07774276143316652,0.05507460888896957,STAT5A/MAPKAPK2,2
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,3/65,159/21728,0.012059241956759616,0.07907699643776797,0.05601980905538721,CYP1B1/TGFB1/CDKN1A,3
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,2/65,56/21728,0.012231137513291761,0.07994207525027294,0.05663264909835127,CYP1B1/ADAM8,2
REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,2/65,57/21728,0.01265168081090549,0.08242137336094782,0.058389036075703046,P4HB/SOD2,2
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,3/65,163/21728,0.012889587172245797,0.08369861800159609,0.05929386306849913,CAV1/ARF6/STAT5A,3
KANNAN_TP53_TARGETS_UP,KANNAN_TP53_TARGETS_UP,2/65,58/21728,0.01307848941272832,0.08465041691086292,0.05996813745369553,ACTA2/CDKN1A,2
BROWN_MYELOID_CELL_DEVELOPMENT_UP,BROWN_MYELOID_CELL_DEVELOPMENT_UP,3/65,165/21728,0.013316766044122018,0.08497813382701082,0.0602002990163982,HLX/NPC1/CPD,3
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,4/65,307/21728,0.013474690005806906,0.08497813382701082,0.0602002990163982,ACTA2/PTPN1/SOD2/CDKN1A,4
AMIT_EGF_RESPONSE_240_HELA,AMIT_EGF_RESPONSE_240_HELA,2/65,59/21728,0.01351152327849472,0.08497813382701082,0.0602002990163982,ARF6/SH2B3,2
BARIS_THYROID_CANCER_DN,BARIS_THYROID_CANCER_DN,2/65,59/21728,0.01351152327849472,0.08497813382701082,0.0602002990163982,ABCC3/TGFB1,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,2/65,59/21728,0.01351152327849472,0.08497813382701082,0.0602002990163982,GALNT2/CAVIN1,2
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,2/65,59/21728,0.01351152327849472,0.08497813382701082,0.0602002990163982,CYP1B1/SOD2,2
MIKKELSEN_NPC_LCP_WITH_H3K4ME3,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,2/65,59/21728,0.01351152327849472,0.08497813382701082,0.0602002990163982,CP/EMILIN1,2
REACTOME_ARACHIDONIC_ACID_METABOLISM,REACTOME_ARACHIDONIC_ACID_METABOLISM,2/65,59/21728,0.01351152327849472,0.08497813382701082,0.0602002990163982,CYP1B1/MAPKAPK2,2
REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2/65,59/21728,0.01351152327849472,0.08497813382701082,0.0602002990163982,LAMB1/TGFB1,2
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,3/65,167/21728,0.01375197862671359,0.08606367049466944,0.060969316045171085,GALNT2/P4HB/LAMB1,3
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,4/65,309/21728,0.01377018727914711,0.08606367049466944,0.060969316045171085,CREB3L2/LAMB1/CDKN1A/SREBF1,4
CHANG_IMMORTALIZED_BY_HPV31_DN,CHANG_IMMORTALIZED_BY_HPV31_DN,2/65,60/21728,0.0139507425449513,0.08665057481336211,0.061385091420413374,DSC2/CDKN1A,2
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,2/65,60/21728,0.0139507425449513,0.08665057481336211,0.061385091420413374,FSTL1/GAA,2
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,4/65,311/21728,0.014069793180511577,0.086821073306003,0.061505876142042136,CALD1/MAPKAPK2/TGFB1/PPT1,4
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,4/65,311/21728,0.014069793180511577,0.086821073306003,0.061505876142042136,ACTA2/APOBEC3C/CDKN1A/RETSAT,4
DARWICHE_PAPILLOMA_RISK_LOW_DN,DARWICHE_PAPILLOMA_RISK_LOW_DN,3/65,169/21728,0.01419524548553149,0.086821073306003,0.061505876142042136,ACTA2/CP/CD248,3
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,3/65,169/21728,0.01419524548553149,0.086821073306003,0.061505876142042136,ABCC3/CYP1B1/PLXND1,3
SMID_BREAST_CANCER_LUMINAL_B_UP,SMID_BREAST_CANCER_LUMINAL_B_UP,3/65,169/21728,0.01419524548553149,0.086821073306003,0.061505876142042136,ACOX2/SREBF1/KCNE4,3
REACTOME_NEUTROPHIL_DEGRANULATION,REACTOME_NEUTROPHIL_DEGRANULATION,5/65,479/21728,0.014257444621690915,0.08693563793713972,0.06158703613862636,ARSB/HGSNAT/ADAM8/GAA/SERPINB6,5
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,2/65,61/21728,0.014396107525182765,0.08724913651625918,0.06180912513204467,PTGER4/SOD2,2
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,2/65,61/21728,0.014396107525182765,0.08724913651625918,0.06180912513204467,CYP1B1/RETSAT,2
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,4/65,315/21728,0.014681405227911858,0.08837844469011955,0.06260915081731627,ARSB/ARF6/CDKN1A/SERPINB6,4
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,2/65,62/21728,0.014847578707940083,0.08837844469011955,0.06260915081731627,LAMB1/PPP1CB,2
NAKAMURA_ADIPOGENESIS_EARLY_UP,NAKAMURA_ADIPOGENESIS_EARLY_UP,2/65,62/21728,0.014847578707940083,0.08837844469011955,0.06260915081731627,SOD2/MT1E,2
PID_IL12_2PATHWAY,PID_IL12_2PATHWAY,2/65,62/21728,0.014847578707940083,0.08837844469011955,0.06260915081731627,HLX/STAT5A,2
TENEDINI_MEGAKARYOCYTE_MARKERS,TENEDINI_MEGAKARYOCYTE_MARKERS,2/65,62/21728,0.014847578707940083,0.08837844469011955,0.06260915081731627,STAT5A/TGFB1,2
WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,2/65,62/21728,0.014847578707940083,0.08837844469011955,0.06260915081731627,CIITA/STAT5A,2
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,5/65,485/21728,0.01497226570083848,0.08885617626610373,0.06294758592325034,CIITA/CPD/FSTL1/WIPF1/KCNJ8,5
LINDSTEDT_DENDRITIC_CELL_MATURATION_C,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,2/65,63/21728,0.015305116756971035,0.08976608068604713,0.06359218137022075,TNFRSF11A/STAT5A,2
LINDSTEDT_DENDRITIC_CELL_MATURATION_D,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,2/65,63/21728,0.015305116756971035,0.08976608068604713,0.06359218137022075,CIITA/P2RY6,2
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,2/65,63/21728,0.015305116756971035,0.08976608068604713,0.06359218137022075,ABCC3/SOD2,2
REACTOME_PEROXISOMAL_PROTEIN_IMPORT,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,2/65,63/21728,0.015305116756971035,0.08976608068604713,0.06359218137022075,ACOX2/DDO,2
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,2/65,64/21728,0.015768682510353176,0.09165434656362172,0.06492986867086045,ACTA2/OLFML2B,2
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,2/65,64/21728,0.015768682510353176,0.09165434656362172,0.06492986867086045,HLX/SOD2,2
REACTOME_SEMAPHORIN_INTERACTIONS,REACTOME_SEMAPHORIN_INTERACTIONS,2/65,64/21728,0.015768682510353176,0.09165434656362172,0.06492986867086045,PLXND1/RHOB,2
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,3/65,176/21728,0.015810374782224745,0.09165434656362172,0.06492986867086045,CYP1B1/SOD2/PPP1CB,3
MEISSNER_NPC_HCP_WITH_H3K4ME2,MEISSNER_NPC_HCP_WITH_H3K4ME2,5/65,493/21728,0.015962399287585423,0.09226820397448221,0.06536473818402794,IL17RA/CD248/OLFML2B/KCNJ8/CTSF,5
WP_FERROPTOSIS,WP_FERROPTOSIS,2/65,65/21728,0.016238236979829047,0.09358394502315785,0.06629683684272132,SLC39A8/CP,2
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,4/65,325/21728,0.016283606434029468,0.09358394502315785,0.06629683684272132,STAT5A/LAMB1/TGFB1/CDKN1A,4
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,4/65,329/21728,0.016954116051432662,0.09715825817439921,0.06882895552775861,RHOB/ACOX2/SREBF1/RETSAT,4
BROWNE_HCMV_INFECTION_18HR_DN,BROWNE_HCMV_INFECTION_18HR_DN,3/65,182/21728,0.017274021978037523,0.09842747565833346,0.06972809591374572,CAVIN1/PLXND1/ACOX2,3
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,3/65,182/21728,0.017274021978037523,0.09842747565833346,0.06972809591374572,P4HB/CDKN1A/TCN2,3
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,2/65,68/21728,0.01768244539332416,0.09933958086137169,0.0703742504417928,CYP1B1/CDKN1A,2
WP_AMPACTIVATED_PROTEIN_KINASE_AMPK_SIGNALING,WP_AMPACTIVATED_PROTEIN_KINASE_AMPK_SIGNALING,2/65,68/21728,0.01768244539332416,0.09933958086137169,0.0703742504417928,CDKN1A/SREBF1,2
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,2/65,68/21728,0.01768244539332416,0.09933958086137169,0.0703742504417928,STAT5A/CDKN1A,2
WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,2/65,68/21728,0.01768244539332416,0.09933958086137169,0.0703742504417928,RIPK1/TGFB1,2
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,2/65,68/21728,0.01768244539332416,0.09933958086137169,0.0703742504417928,CP/SERPINB6,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,3/65,184/21728,0.017778228425241002,0.09959791834868909,0.0705572621564924,HLX/GALNT2/CAV1,3
FOROUTAN_PRODRANK_TGFB_EMT_UP,FOROUTAN_PRODRANK_TGFB_EMT_UP,3/65,185/21728,0.01803339871696156,0.10049788658217935,0.07119481859979654,SLC26A2/CALD1/TGFB1,3
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,4/65,336/21728,0.018168795121017593,0.10049788658217935,0.07119481859979654,FSTL1/MXRA8/TBC1D22A/RHOB,4
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,2/65,69/21728,0.018175568294763213,0.10049788658217935,0.07119481859979654,CYP1B1/LAMB1,2
PID_VEGFR1_2_PATHWAY,PID_VEGFR1_2_PATHWAY,2/65,69/21728,0.018175568294763213,0.10049788658217935,0.07119481859979654,CAV1/MAPKAPK2,2
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,3/65,186/21728,0.018290615357956643,0.10049788658217935,0.07119481859979654,CIITA/PLXND1/SERPINB6,3
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,3/65,186/21728,0.018290615357956643,0.10049788658217935,0.07119481859979654,PTGER4/TGFB1/CDKN1A,3
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,3/65,186/21728,0.018290615357956643,0.10049788658217935,0.07119481859979654,CAVIN1/SH2B3/CDKN1A,3
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,2/65,70/21728,0.01867448755287894,0.1014917801786899,0.07189891374764032,ACTA2/CYP1B1,2
REACTOME_CIRCADIAN_CLOCK,REACTOME_CIRCADIAN_CLOCK,2/65,70/21728,0.01867448755287894,0.1014917801786899,0.07189891374764032,PPP1CB/SREBF1,2
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,2/65,70/21728,0.01867448755287894,0.1014917801786899,0.07189891374764032,WIPF1/LAMB1,2
WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,2/65,70/21728,0.01867448755287894,0.1014917801786899,0.07189891374764032,STAT5A/TGFB1,2
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,3/65,188/21728,0.018811192188822327,0.10195768124022941,0.07222896786807831,ABCC3/PTGER4/CYP1B1,3
DOANE_BREAST_CANCER_CLASSES_UP,DOANE_BREAST_CANCER_CLASSES_UP,2/65,71/21728,0.019179165207573335,0.10283734695749777,0.07285214158146948,CPD/RHOB,2
REACTOME_INTERLEUKIN_17_SIGNALING,REACTOME_INTERLEUKIN_17_SIGNALING,2/65,71/21728,0.019179165207573335,0.10283734695749777,0.07285214158146948,IL17RA/MAPKAPK2,2
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,2/65,71/21728,0.019179165207573335,0.10283734695749777,0.07285214158146948,NPC1/P4HB,2
SATOH_COLORECTAL_CANCER_MYC_DN,SATOH_COLORECTAL_CANCER_MYC_DN,2/65,71/21728,0.019179165207573335,0.10283734695749777,0.07285214158146948,SLC26A2/RETSAT,2
KUMAR_AUTOPHAGY_NETWORK,KUMAR_AUTOPHAGY_NETWORK,2/65,72/21728,0.01968956346782473,0.1044539176011922,0.0739973542585288,GALNT2/LAMB1,2
LANDIS_BREAST_CANCER_PROGRESSION_DN,LANDIS_BREAST_CANCER_PROGRESSION_DN,2/65,72/21728,0.01968956346782473,0.1044539176011922,0.0739973542585288,FSTL1/LAMB1,2
WP_NONSMALL_CELL_LUNG_CANCER,WP_NONSMALL_CELL_LUNG_CANCER,2/65,72/21728,0.01968956346782473,0.1044539176011922,0.0739973542585288,STAT5A/CDKN1A,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,2/65,72/21728,0.01968956346782473,0.1044539176011922,0.0739973542585288,CPD/CTSF,2
FOROUTAN_TGFB_EMT_UP,FOROUTAN_TGFB_EMT_UP,3/65,192/21728,0.01987694777790267,0.10516903586191888,0.07450395908954886,SLC26A2/CALD1/TGFB1,3
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,3/65,193/21728,0.02014851707803089,0.10606637643591159,0.0751396540435458,IL17RA/CYP1B1/STAB1,3
GAURNIER_PSMD4_TARGETS,GAURNIER_PSMD4_TARGETS,2/65,73/21728,0.02020564471104116,0.10606637643591159,0.0751396540435458,IL17RA/TGFB1,2
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,2/65,73/21728,0.02020564471104116,0.10606637643591159,0.0751396540435458,FILIP1L/WIPF1,2
REACTOME_MUSCLE_CONTRACTION,REACTOME_MUSCLE_CONTRACTION,3/65,195/21728,0.020697817131008017,0.10711819887553785,0.07588478720340734,ACTA2/CALD1/KCNE4,3
REACTOME_RHOC_GTPASE_CYCLE,REACTOME_RHOC_GTPASE_CYCLE,2/65,74/21728,0.020727371482416573,0.10711819887553785,0.07588478720340734,CAV1/CAVIN1,2
SESTO_RESPONSE_TO_UV_C1,SESTO_RESPONSE_TO_UV_C1,2/65,74/21728,0.020727371482416573,0.10711819887553785,0.07588478720340734,SOD2/CDKN1A,2
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,2/65,74/21728,0.020727371482416573,0.10711819887553785,0.07588478720340734,WIPF1/LAMB1,2
WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,2/65,74/21728,0.020727371482416573,0.10711819887553785,0.07588478720340734,TGFB1/CDKN1A,2
WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,2/65,74/21728,0.020727371482416573,0.10711819887553785,0.07588478720340734,TGFB1/CDKN1A,2
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,2/65,75/21728,0.021254706494288626,0.1092786966287333,0.07741532929593423,DSC2/CAVIN1,2
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,2/65,75/21728,0.021254706494288626,0.1092786966287333,0.07741532929593423,TGFB1/PPP1CB,2
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,2/65,76/21728,0.021787612625499345,0.11076689327637741,0.07846959913158107,NPC1/TCN2,2
REACTOME_ECM_PROTEOGLYCANS,REACTOME_ECM_PROTEOGLYCANS,2/65,76/21728,0.021787612625499345,0.11076689327637741,0.07846959913158107,LAMB1/TGFB1,2
WP_PROLACTIN_SIGNALING_PATHWAY,WP_PROLACTIN_SIGNALING_PATHWAY,2/65,76/21728,0.021787612625499345,0.11076689327637741,0.07846959913158107,PTPN1/STAT5A,2
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,3/65,199/21728,0.02182107797544635,0.11076689327637741,0.07846959913158107,CAV1/LAMB1/PPP1CB,3
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,3/65,199/21728,0.02182107797544635,0.11076689327637741,0.07846959913158107,CALD1/CAV1/SOD2,3
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,3/65,200/21728,0.022107033213825854,0.11193434538646004,0.07929664678430275,ACTA2/CAVIN1/ADAM8,3
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,2/65,77/21728,0.02232605292075759,0.11247381824059238,0.07967882071149336,PTGER4/SERPINB6,2
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,2/65,77/21728,0.02232605292075759,0.11247381824059238,0.07967882071149336,DSC2/RHOB,2
KIM_MYC_AMPLIFICATION_TARGETS_UP,KIM_MYC_AMPLIFICATION_TARGETS_UP,3/65,202/21728,0.02268511359207056,0.11370984256676972,0.08055444636572213,ABCC3/LAMB1/RHOB,3
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,3/65,202/21728,0.02268511359207056,0.11370984256676972,0.08055444636572213,CAV1/LAMB1/PPP1CB,3
ROSS_AML_WITH_AML1_ETO_FUSION,ROSS_AML_WITH_AML1_ETO_FUSION,2/65,78/21728,0.022869990590003844,0.11406479097258776,0.08080589928900166,CIITA/CAV1,2
WONG_ENDMETRIUM_CANCER_DN,WONG_ENDMETRIUM_CANCER_DN,2/65,78/21728,0.022869990590003844,0.11406479097258776,0.08080589928900166,EMILIN1/CD248,2
PID_MET_PATHWAY,PID_MET_PATHWAY,2/65,79/21728,0.023419389007777465,0.1165143731730222,0.08254123488994101,ARF6/PTPN1,2
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,4/65,364/21728,0.02356446085175965,0.1166715872675966,0.08265260866430793,HLX/CALD1/CAV1/TBC1D22A,4
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,3/65,205/21728,0.023567660628054515,0.1166715872675966,0.08265260866430793,CREB3L2/FILIP1L/LAMB1,3
ROSS_AML_WITH_PML_RARA_FUSION,ROSS_AML_WITH_PML_RARA_FUSION,2/65,80/21728,0.023974211712585784,0.1183911689510409,0.08387079653057952,P4HB/STAB1,2
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,3/65,207/21728,0.024166309566225893,0.11860033888702776,0.08401897691681019,PPP1CB/CDKN1A/SERPINB6,3
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,3/65,207/21728,0.024166309566225893,0.11860033888702776,0.08401897691681019,TNFRSF11A/PPP1CB/SREBF1,3
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,4/65,367/21728,0.02419446913295366,0.11860033888702776,0.08401897691681019,CP/TMEM127/FSTL1/TSPAN9,4
GAVIN_FOXP3_TARGETS_CLUSTER_P2,GAVIN_FOXP3_TARGETS_CLUSTER_P2,2/65,81/21728,0.02453442240627576,0.11909913789454252,0.0843723366347654,ARSB/GAA,2
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,2/65,81/21728,0.02453442240627576,0.11909913789454252,0.0843723366347654,ARF6/SOD2,2
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,2/65,81/21728,0.02453442240627576,0.11909913789454252,0.0843723366347654,CAV1/P4HB,2
ZAMORA_NOS2_TARGETS_DN,ZAMORA_NOS2_TARGETS_DN,2/65,81/21728,0.02453442240627576,0.11909913789454252,0.0843723366347654,CP/RIPK1,2
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,3/65,210/21728,0.02507970628652562,0.12096378290798804,0.08569329041797469,PTGER4/TGFB1/CDKN1A,3
BHAT_ESR1_TARGETS_VIA_AKT1_DN,BHAT_ESR1_TARGETS_VIA_AKT1_DN,2/65,82/21728,0.025099984953407515,0.12096378290798804,0.08569329041797469,CREB3L2/LAMB1,2
PID_REG_GR_PATHWAY,PID_REG_GR_PATHWAY,2/65,82/21728,0.025099984953407515,0.12096378290798804,0.08569329041797469,STAT5A/CDKN1A,2
NELSON_RESPONSE_TO_ANDROGEN_UP,NELSON_RESPONSE_TO_ANDROGEN_UP,2/65,83/21728,0.025670863380630477,0.12266785761652617,0.08690049281676013,SLC26A2/CPD,2
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,2/65,83/21728,0.025670863380630477,0.12266785761652617,0.08690049281676013,SOD2/RHOB,2
SWEET_KRAS_TARGETS_UP,SWEET_KRAS_TARGETS_UP,2/65,83/21728,0.025670863380630477,0.12266785761652617,0.08690049281676013,CALD1/WIPF1,2
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,3/65,212/21728,0.025698916170662233,0.12266785761652617,0.08690049281676013,ABCC3/SLC39A8/CD248,3
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,3/65,213/21728,0.02601160350001896,0.12386477857151887,0.08774841681961285,SLC26A2/CREB3L2/CPD,3
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,2/65,84/21728,0.026247021876061198,0.12439346860692511,0.08812295197101117,TGFB1/SREBF1,2
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,2/65,84/21728,0.026247021876061198,0.12439346860692511,0.08812295197101117,SLC26A2/CP,2
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,4/65,378/21728,0.02659192996680344,0.12543363191888415,0.08885982555937795,NPC1/SOD2/STAT5A/WIPF1,4
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,4/65,378/21728,0.02659192996680344,0.12543363191888415,0.08885982555937795,CREB3L2/TNFRSF11A/FILIP1L/P4HB,4
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,2/65,85/21728,0.02682842478866378,0.1262514107701825,0.08943915731403457,ACTA2/PTPN1,2
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,3/65,216/21728,0.026961988592284606,0.12658210606706388,0.08967342882435159,CALD1/NPC1/SH2B3,3
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,2/65,86/21728,0.027415036627632366,0.12721594722799243,0.09012245524677781,CP/HSDL2,2
COATES_MACROPHAGE_M1_VS_M2_UP,COATES_MACROPHAGE_M1_VS_M2_UP,2/65,86/21728,0.027415036627632366,0.12721594722799243,0.09012245524677781,ARSB/FILIP1L,2
DELASERNA_MYOD_TARGETS_UP,DELASERNA_MYOD_TARGETS_UP,2/65,86/21728,0.027415036627632366,0.12721594722799243,0.09012245524677781,RHOB/CDKN1A,2
REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,2/65,86/21728,0.027415036627632366,0.12721594722799243,0.09012245524677781,SLC39A8/CP,2
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,2/65,86/21728,0.027415036627632366,0.12721594722799243,0.09012245524677781,ACTA2/PTPN1,2
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,3/65,219/21728,0.027930844470128703,0.1284716608338331,0.09101202920123123,CP/FSTL1/SOD2,3
KEGG_ERBB_SIGNALING_PATHWAY,KEGG_ERBB_SIGNALING_PATHWAY,2/65,87/21728,0.028006822061775613,0.1284716608338331,0.09101202920123123,STAT5A/CDKN1A,2
MARTIN_VIRAL_GPCR_SIGNALING_UP,MARTIN_VIRAL_GPCR_SIGNALING_UP,2/65,87/21728,0.028006822061775613,0.1284716608338331,0.09101202920123123,ACTA2/CP,2
WP_ACUTE_VIRAL_MYOCARDITIS,WP_ACUTE_VIRAL_MYOCARDITIS,2/65,87/21728,0.028006822061775613,0.1284716608338331,0.09101202920123123,CAV1/TGFB1,2
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,2/65,87/21728,0.028006822061775613,0.1284716608338331,0.09101202920123123,CAV1/SH2B3,2
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,2/65,88/21728,0.028603745918903516,0.1286354174477617,0.09112803783404595,CREB3L2/LAMB1,2
KANG_IMMORTALIZED_BY_TERT_UP,KANG_IMMORTALIZED_BY_TERT_UP,2/65,88/21728,0.028603745918903516,0.1286354174477617,0.09112803783404595,LAMB1/TGFB1,2
IVANOVSKA_MIR106B_TARGETS,IVANOVSKA_MIR106B_TARGETS,2/65,89/21728,0.0292057731852164,0.1286354174477617,0.09112803783404595,TMEM127/CDKN1A,2
KEGG_PROSTATE_CANCER,KEGG_PROSTATE_CANCER,2/65,89/21728,0.0292057731852164,0.1286354174477617,0.09112803783404595,CREB3L2/CDKN1A,2
SEIDEN_ONCOGENESIS_BY_MET,SEIDEN_ONCOGENESIS_BY_MET,2/65,89/21728,0.0292057731852164,0.1286354174477617,0.09112803783404595,LAMB1/PPP1CB,2
WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,2/65,89/21728,0.0292057731852164,0.1286354174477617,0.09112803783404595,DSC2/TGFB1,2
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,2/65,89/21728,0.0292057731852164,0.1286354174477617,0.09112803783404595,TGFB1/CDKN1A,2
BIOCARTA_SODD_PATHWAY,BIOCARTA_SODD_PATHWAY,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,RIPK1,1
KRISHNAN_FURIN_TARGETS_DN,KRISHNAN_FURIN_TARGETS_DN,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,TSPAN9,1
MAINA_VHL_TARGETS_UP,MAINA_VHL_TARGETS_UP,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,FILIP1L,1
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,CDKN1A,1
PYEON_HPV_POSITIVE_TUMORS_DN,PYEON_HPV_POSITIVE_TUMORS_DN,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,CAV1,1
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,TGFB1,1
REACTOME_CHYLOMICRON_ASSEMBLY,REACTOME_CHYLOMICRON_ASSEMBLY,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,P4HB,1
REACTOME_INTERLEUKIN_21_SIGNALING,REACTOME_INTERLEUKIN_21_SIGNALING,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,STAT5A,1
REACTOME_MET_RECEPTOR_RECYCLING,REACTOME_MET_RECEPTOR_RECYCLING,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,ARF6,1
REACTOME_MRNA_EDITING,REACTOME_MRNA_EDITING,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,APOBEC3C,1
REACTOME_RUNX3_REGULATES_P14_ARF,REACTOME_RUNX3_REGULATES_P14_ARF,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,TGFB1,1
REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY,REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,SLC39A8,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,CYP1B1,1
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,MAPKAPK2,1
WP_LIVER_X_RECEPTOR_PATHWAY,WP_LIVER_X_RECEPTOR_PATHWAY,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,SREBF1,1
XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,1/65,10/21728,0.02952182830426131,0.1286354174477617,0.09112803783404595,SOD2,1
BOYLAN_MULTIPLE_MYELOMA_D_UP,BOYLAN_MULTIPLE_MYELOMA_D_UP,2/65,90/21728,0.029812869004695878,0.12962116958563424,0.09182636540119143,FSTL1/MXRA8,2
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,2/65,91/21728,0.030424998678498093,0.13142548025269155,0.09310457706322255,PTGER4/CP,2
WP_ERBB_SIGNALING_PATHWAY,WP_ERBB_SIGNALING_PATHWAY,2/65,91/21728,0.030424998678498093,0.13142548025269155,0.09310457706322255,STAT5A/CDKN1A,2
WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,2/65,91/21728,0.030424998678498093,0.13142548025269155,0.09310457706322255,SH2B3/TGFB1,2
REACTOME_RHO_GTPASES_ACTIVATE_PKNS,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,2/65,92/21728,0.031042127664349193,0.13380227441529827,0.09478834808578498,PPP1CB/RHOB,2
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,3/65,230/21728,0.031640951289878844,0.13567523541049295,0.0961151930855387,ARSB/TGFB1/CTSF,3
REACTOME_INTERFERON_GAMMA_SIGNALING,REACTOME_INTERFERON_GAMMA_SIGNALING,2/65,93/21728,0.03166422157594268,0.13567523541049295,0.0961151930855387,CIITA/PTPN1,2
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,4/65,400/21728,0.03180375640405639,0.13567523541049295,0.0961151930855387,IL17RA/CAV1/CYP1B1/GAA,4
BIOCARTA_VITCB_PATHWAY,BIOCARTA_VITCB_PATHWAY,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,P4HB,1
ONGUSAHA_BRCA1_TARGETS_DN,ONGUSAHA_BRCA1_TARGETS_DN,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,MAPKAPK2,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,PTGER4,1
PID_INTEGRIN4_PATHWAY,PID_INTEGRIN4_PATHWAY,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,LAMB1,1
REACTOME_ENOS_ACTIVATION,REACTOME_ENOS_ACTIVATION,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,CAV1,1
REACTOME_METALLOTHIONEINS_BIND_METALS,REACTOME_METALLOTHIONEINS_BIND_METALS,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,MT1E,1
REACTOME_REGULATION_BY_C_FLIP,REACTOME_REGULATION_BY_C_FLIP,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,RIPK1,1
REACTOME_SIGNALING_BY_LEPTIN,REACTOME_SIGNALING_BY_LEPTIN,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,STAT5A,1
VERRECCHIA_RESPONSE_TO_TGFB1_C4,VERRECCHIA_RESPONSE_TO_TGFB1_C4,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,LAMB1,1
WHITESIDE_CISPLATIN_RESISTANCE_UP,WHITESIDE_CISPLATIN_RESISTANCE_UP,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,CDKN1A,1
WP_NUCLEOTIDE_GPCRS,WP_NUCLEOTIDE_GPCRS,1/65,11/21728,0.03242638126310782,0.13567523541049295,0.0961151930855387,P2RY6,1
LIM_MAMMARY_LUMINAL_MATURE_DN,LIM_MAMMARY_LUMINAL_MATURE_DN,2/65,95/21728,0.03292316740736692,0.1374662522228264,0.09738398710101281,CALD1/FSTL1,2
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2/65,96/21728,0.03355995132902826,0.13954241716851667,0.09885478605727552,TGFB1/CDKN1A,2
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,2/65,96/21728,0.03355995132902826,0.13954241716851667,0.09885478605727552,ACTA2/HSDL2,2
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,2/65,97/21728,0.03420156417890276,0.1407265916503998,0.09969368019023063,ACTA2/LAMB1,2
HOEBEKE_LYMPHOID_STEM_CELL_UP,HOEBEKE_LYMPHOID_STEM_CELL_UP,2/65,97/21728,0.03420156417890276,0.1407265916503998,0.09969368019023063,HLX/PLXND1,2
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,2/65,97/21728,0.03420156417890276,0.1407265916503998,0.09969368019023063,RIPK1/MAPKAPK2,2
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,4/65,410/21728,0.034358546658817754,0.1407265916503998,0.09969368019023063,SLC39A8/PPP1CB/RHOB/PPT1,4
NABA_ECM_REGULATORS,NABA_ECM_REGULATORS,3/65,238/21728,0.03449411982176508,0.1407265916503998,0.09969368019023063,ADAM8/SERPINB6/CTSF,3
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,3/65,238/21728,0.03449411982176508,0.1407265916503998,0.09969368019023063,CD248/RHOB/SREBF1,3
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,2/65,98/21728,0.03484797234155661,0.1407265916503998,0.09969368019023063,CP/SERPINB6,2
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,2/65,98/21728,0.03484797234155661,0.1407265916503998,0.09969368019023063,LAMB1/CDKN1A,2
BIOCARTA_PRION_PATHWAY,BIOCARTA_PRION_PATHWAY,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,LAMB1,1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,SLC26A2,1
CLAUS_PGR_POSITIVE_MENINGIOMA_DN,CLAUS_PGR_POSITIVE_MENINGIOMA_DN,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,FSTL1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,LAMB1,1
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,KCNJ8,1
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,ADAM8,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,RHOB,1
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,CDKN1A,1
REACTOME_INTERLEUKIN_2_SIGNALING,REACTOME_INTERLEUKIN_2_SIGNALING,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,STAT5A,1
REACTOME_P2Y_RECEPTORS,REACTOME_P2Y_RECEPTORS,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,P2RY6,1
WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,CDKN1A,1
WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,RIPK1,1
WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,1/65,12/21728,0.03532237450425035,0.1407265916503998,0.09969368019023063,TGFB1,1
REACTOME_SLC_TRANSPORTER_DISORDERS,REACTOME_SLC_TRANSPORTER_DISORDERS,2/65,99/21728,0.03549914235395232,0.14114967138748438,0.09999339878292317,SLC26A2/CP,2
PID_CXCR4_PATHWAY,PID_CXCR4_PATHWAY,2/65,100/21728,0.0361550409048611,0.1419021528373976,0.10052647248375644,STAT5A/RHOB,2
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,3/65,244/21728,0.036719058644060436,0.1419021528373976,0.10052647248375644,MAPKAPK2/RHOB/CDKN1A,3
REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,2/65,101/21728,0.03681563483427668,0.1419021528373976,0.10052647248375644,RIPK1/SOD2,2
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,2/65,101/21728,0.03681563483427668,0.1419021528373976,0.10052647248375644,CAV1/GAA,2
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,3/65,245/21728,0.0370969378014153,0.1419021528373976,0.10052647248375644,NPC1/P4HB/CDKN1A,3
KOBAYASHI_EGFR_SIGNALING_24HR_UP,KOBAYASHI_EGFR_SIGNALING_24HR_UP,2/65,102/21728,0.037480891132832116,0.1419021528373976,0.10052647248375644,CPD/CYP1B1,2
HUMMERICH_SKIN_CANCER_PROGRESSION_DN,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,2/65,103/21728,0.03815077694121756,0.1419021528373976,0.10052647248375644,GAA/PPP1CB,2
WIELAND_UP_BY_HBV_INFECTION,WIELAND_UP_BY_HBV_INFECTION,2/65,103/21728,0.03815077694121756,0.1419021528373976,0.10052647248375644,SOD2/PPT1,2
ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,ACTA2,1
BIOCARTA_IL10_PATHWAY,BIOCARTA_IL10_PATHWAY,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,STAT5A,1
COLLIS_PRKDC_REGULATORS,COLLIS_PRKDC_REGULATORS,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,PTPN1,1
CONRAD_GERMLINE_STEM_CELL,CONRAD_GERMLINE_STEM_CELL,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,FSTL1,1
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,CYP1B1,1
HO_LIVER_CANCER_VASCULAR_INVASION,HO_LIVER_CANCER_VASCULAR_INVASION,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,SERPINB6,1
INAMURA_LUNG_CANCER_SCC_DN,INAMURA_LUNG_CANCER_SCC_DN,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,CAV1,1
MARTINELLI_IMMATURE_NEUTROPHIL_DN,MARTINELLI_IMMATURE_NEUTROPHIL_DN,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,SOD2,1
NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,MAPKAPK2,1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,CDKN1A,1
REACTOME_DISSOLUTION_OF_FIBRIN_CLOT,REACTOME_DISSOLUTION_OF_FIBRIN_CLOT,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,SERPINB6,1
REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10,REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,RIPK1,1
REACTOME_P38MAPK_EVENTS,REACTOME_P38MAPK_EVENTS,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,MAPKAPK2,1
REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,ARSB,1
REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING,REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,RIPK1,1
RUAN_RESPONSE_TO_TNF_UP,RUAN_RESPONSE_TO_TNF_UP,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,CP,1
TSAI_DNAJB4_TARGETS_UP,TSAI_DNAJB4_TARGETS_UP,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,CDKN1A,1
WACKER_HYPOXIA_TARGETS_OF_VHL,WACKER_HYPOXIA_TARGETS_OF_VHL,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,CP,1
WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,TNFRSF11A,1
WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,TGFB1,1
WP_ESTROGEN_RECEPTOR_PATHWAY,WP_ESTROGEN_RECEPTOR_PATHWAY,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,CYP1B1,1
WP_IRINOTECAN_PATHWAY,WP_IRINOTECAN_PATHWAY,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,NPC1,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,STAT5A,1
WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,SREBF1,1
WP_VITAMIN_B12_DISORDERS,WP_VITAMIN_B12_DISORDERS,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,TCN2,1
WU_HBX_TARGETS_3_DN,WU_HBX_TARGETS_3_DN,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,TGFB1,1
YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,1/65,13/21728,0.03820983286017354,0.1419021528373976,0.10052647248375644,CALD1,1
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,3/65,248/21728,0.038242630189678654,0.1419021528373976,0.10052647248375644,CP/MXRA8/SERPINB6,3
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,3/65,249/21728,0.038628538714474754,0.14306866190546205,0.10135285206565893,SLC39A8/SLC26A2/CP,3
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,3/65,250/21728,0.03901644904436745,0.14423825894405712,0.10218141923089522,FILIP1L/ADAM8/CDKN1A,3
LEIN_CHOROID_PLEXUS_MARKERS,LEIN_CHOROID_PLEXUS_MARKERS,2/65,105/21728,0.039504306397050826,0.14523642057739272,0.10288853794587931,MXRA8/TCN2,2
STEIN_ESRRA_TARGETS_DN,STEIN_ESRRA_TARGETS_DN,2/65,105/21728,0.039504306397050826,0.14523642057739272,0.10288853794587931,CYP1B1/LAMB1,2
WOO_LIVER_CANCER_RECURRENCE_UP,WOO_LIVER_CANCER_RECURRENCE_UP,2/65,105/21728,0.039504306397050826,0.14523642057739272,0.10288853794587931,TGFB1/PPT1,2
BROWNE_HCMV_INFECTION_8HR_UP,BROWNE_HCMV_INFECTION_8HR_UP,2/65,106/21728,0.04018788507095965,0.14544701271667002,0.10303772585086204,SOD2/RHOB,2
REACTOME_SIGNALING_BY_VEGF,REACTOME_SIGNALING_BY_VEGF,2/65,106/21728,0.04018788507095965,0.14544701271667002,0.10303772585086204,CAV1/MAPKAPK2,2
WANG_HCP_PROSTATE_CANCER,WANG_HCP_PROSTATE_CANCER,2/65,106/21728,0.04018788507095965,0.14544701271667002,0.10303772585086204,SLC39A8/CYP1B1,2
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,4/65,432/21728,0.04039156903866655,0.14544701271667002,0.10303772585086204,STAT5A/TGFB1/PPP1CB/CDKN1A,4
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,2/65,107/21728,0.04087596330647148,0.14544701271667002,0.10303772585086204,LAMB1/KCNE4,2
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,2/65,107/21728,0.04087596330647148,0.14544701271667002,0.10303772585086204,CPD/CTSF,2
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,4/65,434/21728,0.04096824638274873,0.14544701271667002,0.10303772585086204,ABCC3/CP/CALD1/CDKN1A,4
BIOCARTA_HSP27_PATHWAY,BIOCARTA_HSP27_PATHWAY,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,MAPKAPK2,1
BIOCARTA_RANKL_PATHWAY,BIOCARTA_RANKL_PATHWAY,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,TNFRSF11A,1
FARMER_BREAST_CANCER_CLUSTER_6,FARMER_BREAST_CANCER_CLUSTER_6,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,RHOB,1
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,SOD2,1
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,CPD,1
PID_IL5_PATHWAY,PID_IL5_PATHWAY,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,STAT5A,1
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,CDKN1A,1
REACTOME_CS_DS_DEGRADATION,REACTOME_CS_DS_DEGRADATION,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,ARSB,1
REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM,REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,TCN2,1
REACTOME_INTERLEUKIN_15_SIGNALING,REACTOME_INTERLEUKIN_15_SIGNALING,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,STAT5A,1
REACTOME_REGULATION_OF_IFNG_SIGNALING,REACTOME_REGULATION_OF_IFNG_SIGNALING,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,PTPN1,1
REACTOME_RESPONSE_TO_METAL_IONS,REACTOME_RESPONSE_TO_METAL_IONS,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,MT1E,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,CDKN1A,1
YIH_RESPONSE_TO_ARSENITE_C2,YIH_RESPONSE_TO_ARSENITE_C2,1/65,14/21728,0.04108878109245928,0.14544701271667002,0.10303772585086204,PPP1CB,1
FOROUTAN_TGFB_EMT_DN,FOROUTAN_TGFB_EMT_DN,2/65,108/21728,0.04156850898590982,0.14653081297329637,0.10380551276950363,CP/CYP1B1,2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,2/65,108/21728,0.04156850898590982,0.14653081297329637,0.10380551276950363,ABCC3/CYP1B1,2
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,2/65,110/21728,0.042966874938343745,0.14653081297329637,0.10380551276950363,CYP1B1/ACOX2,2
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,2/65,110/21728,0.042966874938343745,0.14653081297329637,0.10380551276950363,CPD/CAV1,2
WP_BURN_WOUND_HEALING,WP_BURN_WOUND_HEALING,2/65,110/21728,0.042966874938343745,0.14653081297329637,0.10380551276950363,CD248/TGFB1,2
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,3/65,261/21728,0.04341489612728047,0.14653081297329637,0.10380551276950363,PTPN1/TGFB1/RHOB,3
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2/65,111/21728,0.0436726317067693,0.14653081297329637,0.10380551276950363,TGFB1/CDKN1A,2
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,3/65,262/21728,0.04382663753870399,0.14653081297329637,0.10380551276950363,MXRA8/OLFML2B/ACOX2,3
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,3/65,262/21728,0.04382663753870399,0.14653081297329637,0.10380551276950363,TBC1D22A/MAPKAPK2/CDKN1A,3
BIOCARTA_ERYTH_PATHWAY,BIOCARTA_ERYTH_PATHWAY,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,TGFB1,1
BIOCARTA_HIF_PATHWAY,BIOCARTA_HIF_PATHWAY,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,P4HB,1
BIOCARTA_IL3_PATHWAY,BIOCARTA_IL3_PATHWAY,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,STAT5A,1
BIOCARTA_LONGEVITY_PATHWAY,BIOCARTA_LONGEVITY_PATHWAY,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,SOD2,1
BIOCARTA_RELA_PATHWAY,BIOCARTA_RELA_PATHWAY,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,RIPK1,1
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,TGFB1,1
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,ARF6,1
IBRAHIM_NRF3_DOWN,IBRAHIM_NRF3_DOWN,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,CDKN1A,1
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,PTPN18,1
MARKS_HDAC_TARGETS_DN,MARKS_HDAC_TARGETS_DN,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,STAT5A,1
NGO_MALIGNANT_GLIOMA_1P_LOH,NGO_MALIGNANT_GLIOMA_1P_LOH,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,P4HB,1
PID_ARF6_DOWNSTREAM_PATHWAY,PID_ARF6_DOWNSTREAM_PATHWAY,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,ARF6,1
REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS,REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,PTGER4,1
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,GAA,1
REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION,REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,CAV1,1
REACTOME_NEGATIVE_REGULATION_OF_FLT3,REACTOME_NEGATIVE_REGULATION_OF_FLT3,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,SH2B3,1
REACTOME_PHASE_2_PLATEAU_PHASE,REACTOME_PHASE_2_PLATEAU_PHASE,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,KCNE4,1
REACTOME_PROLACTIN_RECEPTOR_SIGNALING,REACTOME_PROLACTIN_RECEPTOR_SIGNALING,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,STAT5A,1
SA_G1_AND_S_PHASES,SA_G1_AND_S_PHASES,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,CDKN1A,1
SA_MMP_CYTOKINE_CONNECTION,SA_MMP_CYTOKINE_CONNECTION,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,TGFB1,1
SANCHEZ_MDM2_TARGETS,SANCHEZ_MDM2_TARGETS,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,CDKN1A,1
SCHAVOLT_TARGETS_OF_TP53_AND_TP63,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,CDKN1A,1
TRAYNOR_RETT_SYNDROM_DN,TRAYNOR_RETT_SYNDROM_DN,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,SLC26A2,1
WP_CODEINE_AND_MORPHINE_METABOLISM,WP_CODEINE_AND_MORPHINE_METABOLISM,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,ABCC3,1
WP_FOXP3_IN_COVID19,WP_FOXP3_IN_COVID19,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,STAT5A,1
ZHENG_RESPONSE_TO_ARSENITE_UP,ZHENG_RESPONSE_TO_ARSENITE_UP,1/65,15/21728,0.04395924389198891,0.14653081297329637,0.10380551276950363,MT1E,1
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,3/65,265/21728,0.04507366373444941,0.14863887580679522,0.10529890886102442,IL17RA/TNFRSF11A/TGFB1,3
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,3/65,265/21728,0.04507366373444941,0.14863887580679522,0.10529890886102442,PTGER4/SOD2/STAB1,3
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,3/65,265/21728,0.04507366373444941,0.14863887580679522,0.10529890886102442,SLC26A2/SH2B3/KCNE4,3
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,2/65,113/21728,0.045097135154312906,0.14863887580679522,0.10529890886102442,CAV1/CDKN1A,2
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,4/65,449/21728,0.045443503582323935,0.14863887580679522,0.10529890886102442,ARSB/EMILIN1/RIPK1/RETSAT,4
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,3/65,266/21728,0.045493263669083066,0.14863887580679522,0.10529890886102442,ABCC3/CAVIN1/FSTL1,3
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,2/65,114/21728,0.045815819196662985,0.14863887580679522,0.10529890886102442,SLC26A2/FILIP1L,2
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,2/65,114/21728,0.045815819196662985,0.14863887580679522,0.10529890886102442,RHOB/CDKN1A,2
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,3/65,267/21728,0.04591482105661307,0.14863887580679522,0.10529890886102442,CALD1/LAMB1/PLXND1,3
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,2/65,115/21728,0.04653874993265028,0.14863887580679522,0.10529890886102442,CAV1/LAMB1,2
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,3/65,269/21728,0.046763796386906614,0.14863887580679522,0.10529890886102442,ABCC3/ACTA2/CALD1,3
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,CDKN1A,1
BIOCARTA_IL7_PATHWAY,BIOCARTA_IL7_PATHWAY,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,STAT5A,1
BIOCARTA_P53_PATHWAY,BIOCARTA_P53_PATHWAY,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,CDKN1A,1
FERRANDO_LYL1_NEIGHBORS,FERRANDO_LYL1_NEIGHBORS,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,SOD2,1
GALE_APL_WITH_FLT3_MUTATED_DN,GALE_APL_WITH_FLT3_MUTATED_DN,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,P4HB,1
GEISS_RESPONSE_TO_DSRNA_DN,GEISS_RESPONSE_TO_DSRNA_DN,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,STAB1,1
INGA_TP53_TARGETS,INGA_TP53_TARGETS,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,CDKN1A,1
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,ACOX2,1
REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND,REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,RIPK1,1
REACTOME_GLYCOGEN_STORAGE_DISEASES,REACTOME_GLYCOGEN_STORAGE_DISEASES,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,GAA,1
REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,P2RY6,1
REACTOME_REGULATION_OF_KIT_SIGNALING,REACTOME_REGULATION_OF_KIT_SIGNALING,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,SH2B3,1
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,TGFB1,1
WP_ID_SIGNALING_PATHWAY,WP_ID_SIGNALING_PATHWAY,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,SREBF1,1
WP_OSTEOCLAST_SIGNALING,WP_OSTEOCLAST_SIGNALING,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,TNFRSF11A,1
WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,ACOX2,1
WU_HBX_TARGETS_2_DN,WU_HBX_TARGETS_2_DN,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,TGFB1,1
XU_RESPONSE_TO_TRETINOIN_UP,XU_RESPONSE_TO_TRETINOIN_UP,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,WIPF1,1
ZHANG_GATA6_TARGETS_UP,ZHANG_GATA6_TARGETS_UP,1/65,16/21728,0.046821245879140494,0.14863887580679522,0.10529890886102442,DSC2,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,4/65,454/21728,0.046994140271518985,0.14895131623302374,0.10552024823665788,PTPN1/SOD2/STAT5A/KCNE4,4
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,2/65,116/21728,0.047265896401702236,0.14933932512386172,0.10579512190353574,ADAM8/STAT5A,2
RICKMAN_HEAD_AND_NECK_CANCER_C,RICKMAN_HEAD_AND_NECK_CANCER_C,2/65,116/21728,0.047265896401702236,0.14933932512386172,0.10579512190353574,DSC2/SOD2,2
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,3/65,274/21728,0.04892027995224963,0.1519107388501132,0.1076167655222381,GALNT2/SH2B3/LAMB1,3
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,2/65,119/21728,0.04947232273010239,0.1519107388501132,0.1076167655222381,TGFB1/RHOB,2
BIOCARTA_TNFR2_PATHWAY,BIOCARTA_TNFR2_PATHWAY,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,RIPK1,1
HE_PTEN_TARGETS_UP,HE_PTEN_TARGETS_UP,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,CDKN1A,1
HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,ACTA2,1
LEI_HOXC8_TARGETS_DN,LEI_HOXC8_TARGETS_DN,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,ACTA2,1
MATTHEWS_AP1_TARGETS,MATTHEWS_AP1_TARGETS,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,CAV1,1
REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,CDKN1A,1
REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA,REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,MAPKAPK2,1
REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,CDKN1A,1
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,RIPK1,1
REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,TNFRSF11A,1
REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,MAPKAPK2,1
REACTOME_ZINC_TRANSPORTERS,REACTOME_ZINC_TRANSPORTERS,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,SLC39A8,1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,CP,1
SA_TRKA_RECEPTOR,SA_TRKA_RECEPTOR,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,CDKN1A,1
WP_ACE_INHIBITOR_PATHWAY,WP_ACE_INHIBITOR_PATHWAY,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,TGFB1,1
WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,PPP1CB,1
WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,TGFB1,1
WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,ABCC3,1
WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,1/65,17/21728,0.04967481160398701,0.1519107388501132,0.1076167655222381,TGFB1,1
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,2/65,122/21728,0.05171558965684558,0.1565423712265046,0.11089791140572383,GALNT2/SOD2,2
WP_CELL_CYCLE,WP_CELL_CYCLE,2/65,122/21728,0.05171558965684558,0.1565423712265046,0.11089791140572383,TGFB1/CDKN1A,2
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,3/65,281/21728,0.052020447290551136,0.1565423712265046,0.11089791140572383,HGSNAT/CALD1/MT1E,3
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,2/65,123/21728,0.052471391230645495,0.1565423712265046,0.11089791140572383,CAVIN1/RHOB,2
AMIT_EGF_RESPONSE_40_MCF10A,AMIT_EGF_RESPONSE_40_MCF10A,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,HSDL2,1
BIOCARTA_CALCINEURIN_PATHWAY,BIOCARTA_CALCINEURIN_PATHWAY,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,CDKN1A,1
HAHTOLA_MYCOSIS_FUNGOIDES_UP,HAHTOLA_MYCOSIS_FUNGOIDES_UP,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,SOD2,1
KANG_AR_TARGETS_DN,KANG_AR_TARGETS_DN,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,TGFB1,1
KIM_PTEN_TARGETS_UP,KIM_PTEN_TARGETS_UP,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,CDKN1A,1
ONDER_CDH1_TARGETS_3_UP,ONDER_CDH1_TARGETS_3_UP,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,CYP1B1,1
REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,PTPN1,1
REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,ABCC3,1
REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,SREBF1,1
REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,STAT5A,1
WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,CIITA,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,TGFB1,1
WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,1/65,18/21728,0.0525199655464923,0.1565423712265046,0.11089791140572383,TGFB1,1
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,4/65,474/21728,0.05349048525464565,0.15748714684697707,0.11156721034527955,GAA/WIPF1/TGFB1/CDKN1A,4
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,3/65,285/21728,0.053834060215726565,0.15748714684697707,0.11156721034527955,CREB3L2/P4HB/RHOB,3
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,2/65,125/21728,0.053994884033901076,0.15748714684697707,0.11156721034527955,TGFB1/CDKN1A,2
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,2/65,125/21728,0.053994884033901076,0.15748714684697707,0.11156721034527955,SLC26A2/CYP1B1,2
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,2/65,125/21728,0.053994884033901076,0.15748714684697707,0.11156721034527955,SOD2/CDKN1A,2
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,2/65,126/21728,0.05476251599832016,0.15748714684697707,0.11156721034527955,CALD1/WIPF1,2
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,2/65,126/21728,0.05476251599832016,0.15748714684697707,0.11156721034527955,MAPKAPK2/SH2B3,2
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,2/65,126/21728,0.05476251599832016,0.15748714684697707,0.11156721034527955,ABCC3/CIITA,2
LU_EZH2_TARGETS_UP,LU_EZH2_TARGETS_UP,3/65,288/21728,0.05521418880328781,0.15748714684697707,0.11156721034527955,CYP1B1/SOD2/HSDL2,3
BIOCARTA_EPO_PATHWAY,BIOCARTA_EPO_PATHWAY,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,STAT5A,1
BIOCARTA_TGFB_PATHWAY,BIOCARTA_TGFB_PATHWAY,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,TGFB1,1
BIOCARTA_TOB1_PATHWAY,BIOCARTA_TOB1_PATHWAY,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,TGFB1,1
FARMER_BREAST_CANCER_CLUSTER_4,FARMER_BREAST_CANCER_CLUSTER_4,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,FILIP1L,1
MANN_RESPONSE_TO_AMIFOSTINE_UP,MANN_RESPONSE_TO_AMIFOSTINE_UP,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,CDKN1A,1
REACTOME_LDL_CLEARANCE,REACTOME_LDL_CLEARANCE,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,NPC1,1
REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,STAT5A,1
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,PLXND1,1
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,P4HB,1
REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,RIPK1,1
SA_CASPASE_CASCADE,SA_CASPASE_CASCADE,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,SREBF1,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_5,SHIN_B_CELL_LYMPHOMA_CLUSTER_5,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,CIITA,1
STREICHER_LSM1_TARGETS_DN,STREICHER_LSM1_TARGETS_DN,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,TGFB1,1
VERRECCHIA_RESPONSE_TO_TGFB1_C1,VERRECCHIA_RESPONSE_TO_TGFB1_C1,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,RHOB,1
WAGSCHAL_EHMT2_TARGETS_UP,WAGSCHAL_EHMT2_TARGETS_UP,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,CDKN1A,1
WP_APOPTOSIS_MODULATION_BY_HSP70,WP_APOPTOSIS_MODULATION_BY_HSP70,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,RIPK1,1
WP_ESTROGEN_METABOLISM,WP_ESTROGEN_METABOLISM,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,CYP1B1,1
WP_IL9_SIGNALING_PATHWAY,WP_IL9_SIGNALING_PATHWAY,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,STAT5A,1
WP_PROTEOGLYCAN_BIOSYNTHESIS,WP_PROTEOGLYCAN_BIOSYNTHESIS,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,SLC26A2,1
WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,MAPKAPK2,1
WP_SMALL_LIGAND_GPCRS,WP_SMALL_LIGAND_GPCRS,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,PTGER4,1
WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,SREBF1,1
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN,1/65,19/21728,0.05535673211671244,0.15748714684697707,0.11156721034527955,CD248,1
KIM_WT1_TARGETS_8HR_DN,KIM_WT1_TARGETS_8HR_DN,2/65,127/21728,0.055534032389426335,0.15776713746996118,0.11176556159714095,CALD1/SOD2,2
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,3/65,289/21728,0.055678006759110665,0.15795179222442743,0.11189637491267335,SLC26A2/CALD1/FILIP1L,3
IVANOVA_HEMATOPOIESIS_MATURE_CELL,IVANOVA_HEMATOPOIESIS_MATURE_CELL,3/65,292/21728,0.05708073497111308,0.16051071904824232,0.11370917254680747,ACTA2/HGSNAT/CPD,3
MIKKELSEN_MEF_LCP_WITH_H3K4ME3,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,2/65,129/21728,0.05708860142316605,0.16051071904824232,0.11370917254680747,CP/EMILIN1,2
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,3/65,293/21728,0.05755205684181651,0.16051071904824232,0.11370917254680747,GALNT2/CAV1/CAVIN1,3
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,TGFB1,1
BIOCARTA_ATM_PATHWAY,BIOCARTA_ATM_PATHWAY,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,CDKN1A,1
FARMER_BREAST_CANCER_CLUSTER_7,FARMER_BREAST_CANCER_CLUSTER_7,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,SREBF1,1
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,MT1E,1
LAMB_CCND1_TARGETS,LAMB_CCND1_TARGETS,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,TGFB1,1
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,CALD1,1
MURAKAMI_UV_RESPONSE_24HR,MURAKAMI_UV_RESPONSE_24HR,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,TGFB1,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,NPC1,1
PID_WNT_CANONICAL_PATHWAY,PID_WNT_CANONICAL_PATHWAY,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,CAV1,1
REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,ACTA2,1
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,RHOB,1
REACTOME_SIGNALING_BY_KIT_IN_DISEASE,REACTOME_SIGNALING_BY_KIT_IN_DISEASE,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,STAT5A,1
REACTOME_SIGNALLING_TO_RAS,REACTOME_SIGNALLING_TO_RAS,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,MAPKAPK2,1
WANG_THOC1_TARGETS_DN,WANG_THOC1_TARGETS_DN,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,PPT1,1
WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,MAPKAPK2,1
WP_TP53_NETWORK,WP_TP53_NETWORK,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,CDKN1A,1
ZHU_SKIL_TARGETS_UP,ZHU_SKIL_TARGETS_UP,1/65,20/21728,0.05818513565498784,0.16051071904824232,0.11370917254680747,CDKN1A,1
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,2/65,131/21728,0.058658358431219276,0.16159327391520462,0.11447607720519234,ACTA2/HGSNAT,2
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,3/65,296/21728,0.0589772073624756,0.16203240486624162,0.11478716681576909,ACTA2/DSC2/ARF6,3
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,2/65,132/21728,0.0594488602948876,0.16203240486624162,0.11478716681576909,PTPN1/SREBF1,2
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,2/65,133/21728,0.060243072862951746,0.16203240486624162,0.11478716681576909,DSC2/CAV1,2
BIOCARTA_CERAMIDE_PATHWAY,BIOCARTA_CERAMIDE_PATHWAY,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,RIPK1,1
BIOCARTA_NFKB_PATHWAY,BIOCARTA_NFKB_PATHWAY,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,RIPK1,1
BIOCARTA_P53HYPOXIA_PATHWAY,BIOCARTA_P53HYPOXIA_PATHWAY,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,CDKN1A,1
CHIBA_RESPONSE_TO_TSA_DN,CHIBA_RESPONSE_TO_TSA_DN,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,LAMB1,1
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,CDKN1A,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,CDKN1A,1
KANG_CISPLATIN_RESISTANCE_UP,KANG_CISPLATIN_RESISTANCE_UP,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,CDKN1A,1
LANDEMAINE_LUNG_METASTASIS,LANDEMAINE_LUNG_METASTASIS,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,DSC2,1
MACLACHLAN_BRCA1_TARGETS_UP,MACLACHLAN_BRCA1_TARGETS_UP,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,CDKN1A,1
NUMATA_CSF3_SIGNALING_VIA_STAT3,NUMATA_CSF3_SIGNALING_VIA_STAT3,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,IL17RA,1
OUYANG_PROSTATE_CANCER_MARKERS,OUYANG_PROSTATE_CANCER_MARKERS,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,CDKN1A,1
PID_P38_MK2_PATHWAY,PID_P38_MK2_PATHWAY,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,MAPKAPK2,1
REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM,REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,TCN2,1
REACTOME_INTERLEUKIN_37_SIGNALING,REACTOME_INTERLEUKIN_37_SIGNALING,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,PTPN18,1
REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,PTPN1,1
REACTOME_RHO_GTPASES_ACTIVATE_PAKS,REACTOME_RHO_GTPASES_ACTIVATE_PAKS,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,PPP1CB,1
REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX,REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,MAPKAPK2,1
REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,RIPK1,1
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,SLC39A8,1
STEGER_ADIPOGENESIS_UP,STEGER_ADIPOGENESIS_UP,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,CP,1
WOTTON_RUNX_TARGETS_UP,WOTTON_RUNX_TARGETS_UP,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,CYP1B1,1
WP_GALANIN_RECEPTOR_PATHWAY,WP_GALANIN_RECEPTOR_PATHWAY,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,CDKN1A,1
WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,TGFB1,1
WP_TAMOXIFEN_METABOLISM,WP_TAMOXIFEN_METABOLISM,1/65,21/21728,0.06100520043213997,0.16203240486624162,0.11478716681576909,CYP1B1,1
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,4/65,500/21728,0.06263409596179073,0.16613818557504173,0.1176957883073717,IL17RA/P4HB/ADAM8/STAB1,4
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,3/65,304/21728,0.06285895397261482,0.16618997565018045,0.11773247748691736,ACTA2/CALD1/LAMB1,3
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,2/65,137/21728,0.06345646246076263,0.16618997565018045,0.11773247748691736,ABCC3/CIITA,2
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,2/65,137/21728,0.06345646246076263,0.16618997565018045,0.11773247748691736,CAV1/CDKN1A,2
BIOCARTA_EICOSANOID_PATHWAY,BIOCARTA_EICOSANOID_PATHWAY,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,PTGER4,1
BIOCARTA_IL2_PATHWAY,BIOCARTA_IL2_PATHWAY,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,STAT5A,1
GAVIN_PDE3B_TARGETS,GAVIN_PDE3B_TARGETS,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,TGFB1,1
KANG_FLUOROURACIL_RESISTANCE_UP,KANG_FLUOROURACIL_RESISTANCE_UP,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,CDKN1A,1
PID_PDGFRA_PATHWAY,PID_PDGFRA_PATHWAY,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,CAV1,1
REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,TCN2,1
REACTOME_HS_GAG_DEGRADATION,REACTOME_HS_GAG_DEGRADATION,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,HGSNAT,1
SAGIV_CD24_TARGETS_UP,SAGIV_CD24_TARGETS_UP,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,CAV1,1
WENG_POR_DOSAGE,WENG_POR_DOSAGE,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,RETSAT,1
WENG_POR_TARGETS_LIVER_DN,WENG_POR_TARGETS_LIVER_DN,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,RETSAT,1
WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,1/65,22/21728,0.0638169506496693,0.16618997565018045,0.11773247748691736,CDKN1A,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,2/65,138/21728,0.0642688039158629,0.16714903489171104,0.1184118952443385,PTGER4/WIPF1,2
LIU_SOX4_TARGETS_UP,LIU_SOX4_TARGETS_UP,2/65,139/21728,0.06508468714158727,0.1690511354326942,0.11975938331179287,PPP1CB/HSDL2,2
ONDER_CDH1_TARGETS_1_UP,ONDER_CDH1_TARGETS_1_UP,2/65,140/21728,0.06590408444001522,0.16995002663251882,0.12039617676177387,CYP1B1/TGFB1,2
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2/65,140/21728,0.06590408444001522,0.16995002663251882,0.12039617676177387,ADAM8/LAMB1,2
BIOCARTA_CELLCYCLE_PATHWAY,BIOCARTA_CELLCYCLE_PATHWAY,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,CDKN1A,1
BIOCARTA_GLEEVEC_PATHWAY,BIOCARTA_GLEEVEC_PATHWAY,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,STAT5A,1
BRACHAT_RESPONSE_TO_CISPLATIN,BRACHAT_RESPONSE_TO_CISPLATIN,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,CDKN1A,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,CDKN1A,1
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,PTGER4,1
PID_PRL_SIGNALING_EVENTS_PATHWAY,PID_PRL_SIGNALING_EVENTS_PATHWAY,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,CDKN1A,1
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,MAPKAPK2,1
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,RIPK1,1
WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,CDKN1A,1
WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,ABCC3,1
WP_PROGERIAASSOCIATED_LIPODYSTROPHY,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,TGFB1,1
WU_HBX_TARGETS_1_DN,WU_HBX_TARGETS_1_DN,1/65,23/21728,0.06662041043994738,0.16995002663251882,0.12039617676177387,TGFB1,1
BOYLAN_MULTIPLE_MYELOMA_C_D_UP,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,2/65,141/21728,0.0667269682426383,0.1700050146309256,0.12043513141748731,SOD2/CDKN1A,2
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,3/65,314/21728,0.0678750128387934,0.1727099563328076,0.12235136906524162,SLC39A8/ACTA2/TMEM127,3
DARWICHE_SKIN_TUMOR_PROMOTER_UP,DARWICHE_SKIN_TUMOR_PROMOTER_UP,2/65,143/21728,0.06838308573045765,0.17310624405588831,0.12263210763117142,ACTA2/CD248,2
PECE_MAMMARY_STEM_CELL_DN,PECE_MAMMARY_STEM_CELL_DN,2/65,144/21728,0.06921626492114649,0.17310624405588831,0.12263210763117142,CALD1/P4HB,2
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,2/65,144/21728,0.06921626492114649,0.17310624405588831,0.12263210763117142,TGFB1/PPP1CB,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,3/65,317/21728,0.06941477295606005,0.17310624405588831,0.12263210763117142,GALNT2/CYP1B1/RHOB,3
BIOCARTA_CTCF_PATHWAY,BIOCARTA_CTCF_PATHWAY,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,TGFB1,1
BIOCARTA_G2_PATHWAY,BIOCARTA_G2_PATHWAY,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,CDKN1A,1
BIOCARTA_STRESS_PATHWAY,BIOCARTA_STRESS_PATHWAY,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,RIPK1,1
BIOCARTA_TPO_PATHWAY,BIOCARTA_TPO_PATHWAY,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,STAT5A,1
BRACHAT_RESPONSE_TO_METHOTREXATE_UP,BRACHAT_RESPONSE_TO_METHOTREXATE_UP,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,CDKN1A,1
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,SOD2,1
JEON_SMAD6_TARGETS_UP,JEON_SMAD6_TARGETS_UP,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,FILIP1L,1
OSADA_ASCL1_TARGETS_DN,OSADA_ASCL1_TARGETS_DN,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,CYP1B1,1
REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,SLC26A2,1
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,RHOB,1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,ACOX2,1
WP_KALLMANN_SYNDROME,WP_KALLMANN_SYNDROME,1/65,24/21728,0.06941560386641121,0.17310624405588831,0.12263210763117142,PLXND1,1
JOHNSTONE_PARVB_TARGETS_2_UP,JOHNSTONE_PARVB_TARGETS_2_UP,2/65,145/21728,0.07005282162601108,0.1742607503134604,0.12344998416943039,CAVIN1/TGFB1,2
SMITH_TERT_TARGETS_UP,SMITH_TERT_TARGETS_UP,2/65,145/21728,0.07005282162601108,0.1742607503134604,0.12344998416943039,NPC1/ADAM8,2
BROWNE_HCMV_INFECTION_24HR_UP,BROWNE_HCMV_INFECTION_24HR_UP,2/65,146/21728,0.07089272891604,0.17588929335873202,0.12460367834781755,IL17RA/TSPAN9,2
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,3/65,321/21728,0.07149253444655539,0.17588929335873202,0.12460367834781755,ABCC3/CPD/SOD2,3
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,2/65,147/21728,0.07173595998862055,0.17588929335873202,0.12460367834781755,LAMB1/RHOB,2
REACTOME_RHO_GTPASE_EFFECTORS,REACTOME_RHO_GTPASE_EFFECTORS,3/65,322/21728,0.07201636499158243,0.17588929335873202,0.12460367834781755,WIPF1/PPP1CB/RHOB,3
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,3/65,322/21728,0.07201636499158243,0.17588929335873202,0.12460367834781755,SLC39A8/PTPN18/WIPF1,3
DELACROIX_RAR_TARGETS_DN,DELACROIX_RAR_TARGETS_DN,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,FSTL1,1
GENTILE_UV_LOW_DOSE_UP,GENTILE_UV_LOW_DOSE_UP,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,CDKN1A,1
PID_INTEGRIN_A9B1_PATHWAY,PID_INTEGRIN_A9B1_PATHWAY,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,ADAM8,1
REACTOME_BASIGIN_INTERACTIONS,REACTOME_BASIGIN_INTERACTIONS,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,CAV1,1
REACTOME_DEADENYLATION_OF_MRNA,REACTOME_DEADENYLATION_OF_MRNA,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,TUT7,1
REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,SOD2,1
REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,STAT5A,1
REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,PLXND1,1
REACTOME_SIGNALING_BY_ERYTHROPOIETIN,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,STAT5A,1
STEGER_ADIPOGENESIS_DN,STEGER_ADIPOGENESIS_DN,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,FSTL1,1
WP_IL7_SIGNALING_PATHWAY,WP_IL7_SIGNALING_PATHWAY,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,STAT5A,1
WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,1/65,25/21728,0.07220255492375949,0.17588929335873202,0.12460367834781755,PTGER4,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,3/65,324/21728,0.07306926336587634,0.17621924215779744,0.12483742102336602,DSC2/CP/SOD2,3
REACTOME_RHOA_GTPASE_CYCLE,REACTOME_RHOA_GTPASE_CYCLE,2/65,149/21728,0.07343228690001045,0.17621924215779744,0.12483742102336602,CAV1/CAVIN1,2
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,2/65,150/21728,0.0742853297611371,0.17621924215779744,0.12483742102336602,SLC39A8/SERPINB6,2
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,2/65,150/21728,0.0742853297611371,0.17621924215779744,0.12483742102336602,STAT5A/CDKN1A,2
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,2/65,150/21728,0.0742853297611371,0.17621924215779744,0.12483742102336602,FILIP1L/HSDL2,2
BIOCARTA_NKT_PATHWAY,BIOCARTA_NKT_PATHWAY,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,TGFB1,1
BIOCARTA_RACCYCD_PATHWAY,BIOCARTA_RACCYCD_PATHWAY,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,CDKN1A,1
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,CDKN1A,1
BRACHAT_RESPONSE_TO_METHOTREXATE_DN,BRACHAT_RESPONSE_TO_METHOTREXATE_DN,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,STAT5A,1
CHEN_ETV5_TARGETS_SERTOLI,CHEN_ETV5_TARGETS_SERTOLI,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,ARSB,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,HLX,1
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,ARF6,1
JI_METASTASIS_REPRESSED_BY_STK11,JI_METASTASIS_REPRESSED_BY_STK11,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,CYP1B1,1
KEGG_GALACTOSE_METABOLISM,KEGG_GALACTOSE_METABOLISM,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,GAA,1
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,HLX,1
LI_CISPLATIN_RESISTANCE_UP,LI_CISPLATIN_RESISTANCE_UP,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,CYP1B1,1
PETRETTO_HEART_MASS_QTL_CIS_DN,PETRETTO_HEART_MASS_QTL_CIS_DN,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,SERPINB6,1
PID_HDAC_CLASSIII_PATHWAY,PID_HDAC_CLASSIII_PATHWAY,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,CDKN1A,1
PID_IL3_PATHWAY,PID_IL3_PATHWAY,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,STAT5A,1
PID_VEGFR1_PATHWAY,PID_VEGFR1_PATHWAY,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,CAV1,1
REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY,REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,RIPK1,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,CDKN1A,1
REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,STAT5A,1
REACTOME_REGULATION_OF_IFNA_SIGNALING,REACTOME_REGULATION_OF_IFNA_SIGNALING,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,PTPN1,1
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,MXRA8,1
TERAMOTO_OPN_TARGETS_CLUSTER_6,TERAMOTO_OPN_TARGETS_CLUSTER_6,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,TSPAN9,1
WAGNER_APO2_SENSITIVITY,WAGNER_APO2_SENSITIVITY,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,GALNT2,1
WILLIAMS_ESR1_TARGETS_UP,WILLIAMS_ESR1_TARGETS_UP,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,SLC26A2,1
WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,TGFB1,1
WP_EPO_RECEPTOR_SIGNALING,WP_EPO_RECEPTOR_SIGNALING,1/65,26/21728,0.07498128753814282,0.17621924215779744,0.12483742102336602,STAT5A,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,2/65,151/21728,0.07514159044846759,0.17638870997292863,0.12495747559134841,STAB1/OLFML2B,2
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,2/65,152/21728,0.07600104278398258,0.17819705224849375,0.12623854332972242,IL17RA/CDKN1A,2
BIOCARTA_EGF_PATHWAY,BIOCARTA_EGF_PATHWAY,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,STAT5A,1
BIOCARTA_GH_PATHWAY,BIOCARTA_GH_PATHWAY,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,STAT5A,1
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,MXRA8,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,TCN2,1
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,DSC2,1
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,CREB3L2,1
NAKAMURA_CANCER_MICROENVIRONMENT_UP,NAKAMURA_CANCER_MICROENVIRONMENT_UP,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,RHOB,1
NGUYEN_NOTCH1_TARGETS_UP,NGUYEN_NOTCH1_TARGETS_UP,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,STAT5A,1
PID_GLYPICAN_1PATHWAY,PID_GLYPICAN_1PATHWAY,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,TGFB1,1
REACTOME_GLYCOGEN_METABOLISM,REACTOME_GLYCOGEN_METABOLISM,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,GAA,1
REACTOME_INTEGRIN_SIGNALING,REACTOME_INTEGRIN_SIGNALING,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,PTPN1,1
REACTOME_SYNDECAN_INTERACTIONS,REACTOME_SYNDECAN_INTERACTIONS,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,TGFB1,1
REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,CAV1,1
REICHERT_MITOSIS_LIN9_TARGETS,REICHERT_MITOSIS_LIN9_TARGETS,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,CALD1,1
WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,1/65,27/21728,0.07775182556735738,0.1791516718141875,0.12691481592731393,CDKN1A,1
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,2/65,155/21728,0.07859828974828859,0.1802713067621298,0.12770798889569826,TUT7/STAB1,2
REACTOME_CDC42_GTPASE_CYCLE,REACTOME_CDC42_GTPASE_CYCLE,2/65,155/21728,0.07859828974828859,0.1802713067621298,0.12770798889569826,CAV1/WIPF1,2
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,2/65,155/21728,0.07859828974828859,0.1802713067621298,0.12770798889569826,RIPK1/MAPKAPK2,2
WP_MALE_INFERTILITY,WP_MALE_INFERTILITY,2/65,155/21728,0.07859828974828859,0.1802713067621298,0.12770798889569826,SOD2/TCN2,2
BIOCARTA_NO1_PATHWAY,BIOCARTA_NO1_PATHWAY,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,CAV1,1
BIOCARTA_PDGF_PATHWAY,BIOCARTA_PDGF_PATHWAY,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,STAT5A,1
CHIN_BREAST_CANCER_COPY_NUMBER_UP,CHIN_BREAST_CANCER_COPY_NUMBER_UP,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,PTPN1,1
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,CYP1B1,1
MOREIRA_RESPONSE_TO_TSA_UP,MOREIRA_RESPONSE_TO_TSA_UP,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,TGFB1,1
PID_TRAIL_PATHWAY,PID_TRAIL_PATHWAY,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,RIPK1,1
REACTOME_ENDOGENOUS_STEROLS,REACTOME_ENDOGENOUS_STEROLS,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,CYP1B1,1
REACTOME_SIGNALING_BY_BMP,REACTOME_SIGNALING_BY_BMP,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,FSTL1,1
REACTOME_TRP_CHANNELS,REACTOME_TRP_CHANNELS,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,RIPK1,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_3,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,TGFB1,1
TERAO_AOX4_TARGETS_HG_UP,TERAO_AOX4_TARGETS_HG_UP,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,TMEM127,1
WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,1/65,28/21728,0.08051419280103922,0.18215880724217018,0.1290451339726111,CDKN1A,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,3/65,339/21728,0.08118512628752002,0.18293543003064416,0.12959530990591953,PTGER4/CYP1B1/DDO,3
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,3/65,339/21728,0.08118512628752002,0.18293543003064416,0.12959530990591953,NPC1/CPD/OLFML2B,3
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,2/65,158/21728,0.08122333093360601,0.18293543003064416,0.12959530990591953,CD248/CTSF,2
WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,2/65,158/21728,0.08122333093360601,0.18293543003064416,0.12959530990591953,ACTA2/CALD1,2
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,3/65,341/21728,0.08229596148398269,0.18300750101286,0.12964636650700506,SLC39A8/GALNT2/CYP1B1,3
REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2/65,160/21728,0.08298845995560813,0.18300750101286,0.12964636650700506,P4HB/SOD2,2
WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,2/65,160/21728,0.08298845995560813,0.18300750101286,0.12964636650700506,TGFB1/SREBF1,2
AIYAR_COBRA1_TARGETS_DN,AIYAR_COBRA1_TARGETS_DN,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,CPD,1
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,CP,1
BIOCARTA_BIOPEPTIDES_PATHWAY,BIOCARTA_BIOPEPTIDES_PATHWAY,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,STAT5A,1
BIOCARTA_DEATH_PATHWAY,BIOCARTA_DEATH_PATHWAY,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,RIPK1,1
BIOCARTA_INFLAM_PATHWAY,BIOCARTA_INFLAM_PATHWAY,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,TGFB1,1
BIOCARTA_TNFR1_PATHWAY,BIOCARTA_TNFR1_PATHWAY,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,RIPK1,1
KRIGE_AMINO_ACID_DEPRIVATION,KRIGE_AMINO_ACID_DEPRIVATION,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,CDKN1A,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,RHOB,1
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,TGFB1,1
PID_IGF1_PATHWAY,PID_IGF1_PATHWAY,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,PTPN1,1
REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,PTPN18,1
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,STAT5A,1
REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,LAMB1,1
REACTOME_PEROXISOMAL_LIPID_METABOLISM,REACTOME_PEROXISOMAL_LIPID_METABOLISM,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,ACOX2,1
REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,RIPK1,1
WATANABE_COLON_CANCER_MSI_VS_MSS_UP,WATANABE_COLON_CANCER_MSI_VS_MSS_UP,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,MT1E,1
WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,ACOX2,1
WP_PDGFRBETA_PATHWAY,WP_PDGFRBETA_PATHWAY,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,STAT5A,1
WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,1/65,29/21728,0.0832684129608513,0.18300750101286,0.12964636650700506,TGFB1,1
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,2/65,161/21728,0.08387547932384463,0.18413936185256782,0.13044820055450332,ARF6/PTPN1,2
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,3/65,345/21728,0.08453750937517193,0.18517655479156137,0.1311829698681272,CREB3L2/LAMB1/CDKN1A,3
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,PTGER4,1
CHOW_RASSF1_TARGETS_DN,CHOW_RASSF1_TARGETS_DN,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,P4HB,1
KEGG_O_GLYCAN_BIOSYNTHESIS,KEGG_O_GLYCAN_BIOSYNTHESIS,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,GALNT2,1
MARSON_FOXP3_TARGETS_STIMULATED_UP,MARSON_FOXP3_TARGETS_STIMULATED_UP,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,PTGER4,1
PID_IL2_STAT5_PATHWAY,PID_IL2_STAT5_PATHWAY,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,STAT5A,1
PID_P38_ALPHA_BETA_PATHWAY,PID_P38_ALPHA_BETA_PATHWAY,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,RIPK1,1
REACTOME_LAMININ_INTERACTIONS,REACTOME_LAMININ_INTERACTIONS,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,LAMB1,1
REACTOME_MET_ACTIVATES_PTK2_SIGNALING,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,LAMB1,1
REACTOME_SIGNALING_BY_CSF3_G_CSF,REACTOME_SIGNALING_BY_CSF3_G_CSF,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,STAT5A,1
REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,RIPK1,1
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,ARF6,1
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,SLC39A8,1
VALK_AML_CLUSTER_12,VALK_AML_CLUSTER_12,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,P4HB,1
WP_DOPAMINERGIC_NEUROGENESIS,WP_DOPAMINERGIC_NEUROGENESIS,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,TGFB1,1
WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,ACOX2,1
WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,TGFB1,1
WP_TLR4_SIGNALING_AND_TOLERANCE,WP_TLR4_SIGNALING_AND_TOLERANCE,1/65,30/21728,0.08601450970068025,0.18517655479156137,0.1311829698681272,RIPK1,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,2/65,164/21728,0.08655405763028205,0.18573832109502586,0.13158093694416045,PTGER4/CDKN1A,2
REACTOME_PROTEIN_LOCALIZATION,REACTOME_PROTEIN_LOCALIZATION,2/65,164/21728,0.08655405763028205,0.18573832109502586,0.13158093694416045,ACOX2/DDO,2
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,2/65,164/21728,0.08655405763028205,0.18573832109502586,0.13158093694416045,STAB1/TGFB1,2
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,2/65,166/21728,0.0883541296793266,0.18665090769047618,0.13222743250072685,CD248/RHOB,2
BIOCARTA_IL1R_PATHWAY,BIOCARTA_IL1R_PATHWAY,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,TGFB1,1
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,PTGER4,1
BURTON_ADIPOGENESIS_1,BURTON_ADIPOGENESIS_1,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,RHOB,1
DASU_IL6_SIGNALING_SCAR_UP,DASU_IL6_SIGNALING_SCAR_UP,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,SREBF1,1
KIM_TIAL1_TARGETS,KIM_TIAL1_TARGETS,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,WIPF1,1
PID_CD40_PATHWAY,PID_CD40_PATHWAY,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,STAT5A,1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,PTPN18,1
REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,CAV1,1
REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,STAT5A,1
REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION,REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,DDO,1
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,MAPKAPK2,1
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,CAVIN1,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_2,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,STAT5A,1
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,CALD1,1
THEODOROU_MAMMARY_TUMORIGENESIS,THEODOROU_MAMMARY_TUMORIGENESIS,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,LAMB1,1
VALK_AML_CLUSTER_13,VALK_AML_CLUSTER_13,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,CAV1,1
WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,SREBF1,1
WP_ONECARBON_METABOLISM,WP_ONECARBON_METABOLISM,1/65,31/21728,0.08875250660682144,0.18665090769047618,0.13222743250072685,TCN2,1
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,1/65,32/21728,0.09148242719817334,0.190390067009726,0.13487633168162697,WIPF1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,1/65,32/21728,0.09148242719817334,0.190390067009726,0.13487633168162697,NPC1,1
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,1/65,32/21728,0.09148242719817334,0.190390067009726,0.13487633168162697,DDO,1
LI_PROSTATE_CANCER_EPIGENETIC,LI_PROSTATE_CANCER_EPIGENETIC,1/65,32/21728,0.09148242719817334,0.190390067009726,0.13487633168162697,CAV1,1
PID_IL12_STAT4_PATHWAY,PID_IL12_STAT4_PATHWAY,1/65,32/21728,0.09148242719817334,0.190390067009726,0.13487633168162697,TGFB1,1
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,1/65,32/21728,0.09148242719817334,0.190390067009726,0.13487633168162697,STAT5A,1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,1/65,32/21728,0.09148242719817334,0.190390067009726,0.13487633168162697,CDKN1A,1
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,1/65,32/21728,0.09148242719817334,0.190390067009726,0.13487633168162697,CP,1
WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,1/65,32/21728,0.09148242719817334,0.190390067009726,0.13487633168162697,ABCC3,1
WP_IL17_SIGNALING_PATHWAY,WP_IL17_SIGNALING_PATHWAY,1/65,32/21728,0.09148242719817334,0.190390067009726,0.13487633168162697,IL17RA,1
BURTON_ADIPOGENESIS_12,BURTON_ADIPOGENESIS_12,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,CYP1B1,1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,TCN2,1
DOANE_BREAST_CANCER_CLASSES_DN,DOANE_BREAST_CANCER_CLASSES_DN,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,DSC2,1
DUTTA_APOPTOSIS_VIA_NFKB,DUTTA_APOPTOSIS_VIA_NFKB,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,SOD2,1
GROSS_ELK3_TARGETS_DN,GROSS_ELK3_TARGETS_DN,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,ACOX2,1
PID_INTEGRIN_A4B1_PATHWAY,PID_INTEGRIN_A4B1_PATHWAY,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,ARF6,1
PID_NCADHERIN_PATHWAY,PID_NCADHERIN_PATHWAY,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,PTPN1,1
PID_SYNDECAN_2_PATHWAY,PID_SYNDECAN_2_PATHWAY,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,TGFB1,1
REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,NPC1,1
SCHRAETS_MLL_TARGETS_UP,SCHRAETS_MLL_TARGETS_UP,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,ACTA2,1
TANG_SENESCENCE_TP53_TARGETS_UP,TANG_SENESCENCE_TP53_TARGETS_UP,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,CDKN1A,1
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,RIPK1,1
WP_INFLAMMATORY_RESPONSE_PATHWAY,WP_INFLAMMATORY_RESPONSE_PATHWAY,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,LAMB1,1
WP_PREGNANE_X_RECEPTOR_PATHWAY,WP_PREGNANE_X_RECEPTOR_PATHWAY,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,ABCC3,1
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,1/65,33/21728,0.09420429492642346,0.1930415879639825,0.13675472494711605,TCN2,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,2/65,175/21728,0.09659094600346098,0.19403029664913068,0.13745514699459468,HSDL2/KCNJ8,2
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,3/65,366/21728,0.09672895932344681,0.19403029664913068,0.13745514699459468,PTGER4/ADAM8/SERPINB6,3
BIOCARTA_INTEGRIN_PATHWAY,BIOCARTA_INTEGRIN_PATHWAY,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,CAV1,1
BIOCARTA_NUCLEARRS_PATHWAY,BIOCARTA_NUCLEARRS_PATHWAY,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,ABCC3,1
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,SOD2,1
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,ACTA2,1
MURAKAMI_UV_RESPONSE_6HR_UP,MURAKAMI_UV_RESPONSE_6HR_UP,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,CDKN1A,1
PID_MAPK_TRK_PATHWAY,PID_MAPK_TRK_PATHWAY,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,MAPKAPK2,1
REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,CYP1B1,1
REACTOME_PLASMA_LIPOPROTEIN_REMODELING,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,P4HB,1
REACTOME_RAF_ACTIVATION,REACTOME_RAF_ACTIVATION,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,PPP1CB,1
REACTOME_SIGNALLING_TO_ERKS,REACTOME_SIGNALLING_TO_ERKS,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,MAPKAPK2,1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,ACOX2,1
SCHOEN_NFKB_SIGNALING,SCHOEN_NFKB_SIGNALING,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,PTGER4,1
VALK_AML_CLUSTER_3,VALK_AML_CLUSTER_3,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,IL17RA,1
VALK_AML_CLUSTER_6,VALK_AML_CLUSTER_6,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,DSC2,1
VANTVEER_BREAST_CANCER_BRCA1_UP,VANTVEER_BREAST_CANCER_BRCA1_UP,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,PPP1CB,1
WANG_RESPONSE_TO_BEXAROTENE_UP,WANG_RESPONSE_TO_BEXAROTENE_UP,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,LAMB1,1
WP_FLUOROPYRIMIDINE_ACTIVITY,WP_FLUOROPYRIMIDINE_ACTIVITY,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,ABCC3,1
WP_OXIDATIVE_STRESS_RESPONSE,WP_OXIDATIVE_STRESS_RESPONSE,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,SOD2,1
WP_PURINERGIC_SIGNALING,WP_PURINERGIC_SIGNALING,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,P2RY6,1
WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,MAPKAPK2,1
ZWANG_EGF_PERSISTENTLY_UP,ZWANG_EGF_PERSISTENTLY_UP,1/65,34/21728,0.09691813317624076,0.19403029664913068,0.13745514699459468,HSDL2,1
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,2/65,177/21728,0.09845054671175914,0.19457805715910378,0.13784319207165985,SLC26A2/CP,2
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,2/65,178/21728,0.09938418806804032,0.19457805715910378,0.13784319207165985,CALD1/CDKN1A,2
ABE_VEGFA_TARGETS_2HR,ABE_VEGFA_TARGETS_2HR,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,CDKN1A,1
AIGNER_ZEB1_TARGETS,AIGNER_ZEB1_TARGETS,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,DSC2,1
FRASOR_RESPONSE_TO_ESTRADIOL_UP,FRASOR_RESPONSE_TO_ESTRADIOL_UP,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,CYP1B1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,CDKN1A,1
GHANDHI_DIRECT_IRRADIATION_DN,GHANDHI_DIRECT_IRRADIATION_DN,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,OLFML2B,1
JIANG_AGING_HYPOTHALAMUS_DN,JIANG_AGING_HYPOTHALAMUS_DN,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,FSTL1,1
KEGG_PRIMARY_IMMUNODEFICIENCY,KEGG_PRIMARY_IMMUNODEFICIENCY,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,CIITA,1
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,CALD1,1
NAKAMURA_ADIPOGENESIS_EARLY_DN,NAKAMURA_ADIPOGENESIS_EARLY_DN,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,CALD1,1
NAKAMURA_ADIPOGENESIS_LATE_DN,NAKAMURA_ADIPOGENESIS_LATE_DN,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,CALD1,1
PID_ARF6_PATHWAY,PID_ARF6_PATHWAY,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,ARF6,1
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,PTPN1,1
PID_HIV_NEF_PATHWAY,PID_HIV_NEF_PATHWAY,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,RIPK1,1
PID_PI3KCI_AKT_PATHWAY,PID_PI3KCI_AKT_PATHWAY,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,CDKN1A,1
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,RHOB,1
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,KCNJ8,1
REACTOME_REGULATION_OF_TNFR1_SIGNALING,REACTOME_REGULATION_OF_TNFR1_SIGNALING,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,RIPK1,1
RODRIGUES_NTN1_AND_DCC_TARGETS,RODRIGUES_NTN1_AND_DCC_TARGETS,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,MT1E,1
WP_ALPHA_6_BETA_4_SIGNALING_PATHWAY,WP_ALPHA_6_BETA_4_SIGNALING_PATHWAY,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,LAMB1,1
WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,ABCC3,1
WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,TGFB1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,NPC1,1
YOKOE_CANCER_TESTIS_ANTIGENS,YOKOE_CANCER_TESTIS_ANTIGENS,1/65,35/21728,0.09962396526546113,0.19457805715910378,0.13784319207165985,PTGER4,1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,2/65,179/21728,0.10032035937491819,0.19574704268276719,0.1386713260268446,RHOB/KCNJ8,2
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,3/65,375/21728,0.10216395180098736,0.19677272008707114,0.139397937493262,WIPF1/CDKN1A/SREBF1,3
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,2/65,181/21728,0.10220020035360261,0.19677272008707114,0.139397937493262,TGFB1/CTSF,2
GUTIERREZ_MULTIPLE_MYELOMA_UP,GUTIERREZ_MULTIPLE_MYELOMA_UP,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,RHOB,1
KAAB_FAILED_HEART_ATRIUM_UP,KAAB_FAILED_HEART_ATRIUM_UP,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,CAVIN1,1
KIM_ALL_DISORDERS_CALB1_CORR_DN,KIM_ALL_DISORDERS_CALB1_CORR_DN,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,APOBEC3C,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,SLC26A2,1
MARZEC_IL2_SIGNALING_DN,MARZEC_IL2_SIGNALING_DN,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,TNFRSF11A,1
PID_GMCSF_PATHWAY,PID_GMCSF_PATHWAY,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,STAT5A,1
PID_PI3K_PLC_TRK_PATHWAY,PID_PI3K_PLC_TRK_PATHWAY,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,STAT5A,1
REACTOME_INTERLEUKIN_7_SIGNALING,REACTOME_INTERLEUKIN_7_SIGNALING,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,STAT5A,1
REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,WIPF1,1
RIZ_ERYTHROID_DIFFERENTIATION_12HR,RIZ_ERYTHROID_DIFFERENTIATION_12HR,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,CAVIN1,1
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,STAT5A,1
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,HLX,1
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,1/65,36/21728,0.10232181444527699,0.19677272008707114,0.139397937493262,GAA,1
DARWICHE_PAPILLOMA_RISK_HIGH_DN,DARWICHE_PAPILLOMA_RISK_HIGH_DN,2/65,182/21728,0.10314382455777567,0.19759353363558557,0.13997941909131487,ACTA2/CP,2
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,2/65,182/21728,0.10314382455777567,0.19759353363558557,0.13997941909131487,ACTA2/CP,2
KEGG_HUNTINGTONS_DISEASE,KEGG_HUNTINGTONS_DISEASE,2/65,182/21728,0.10314382455777567,0.19759353363558557,0.13997941909131487,CREB3L2/SOD2,2
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,2/65,182/21728,0.10314382455777567,0.19759353363558557,0.13997941909131487,PTGER4/STAT5A,2
HATADA_METHYLATED_IN_LUNG_CANCER_UP,HATADA_METHYLATED_IN_LUNG_CANCER_UP,3/65,377/21728,0.10338824915650278,0.19787224718947902,0.14017686564054674,HLX/CAVIN1/MT1E,3
LI_AMPLIFIED_IN_LUNG_CANCER,LI_AMPLIFIED_IN_LUNG_CANCER,2/65,183/21728,0.1040898877764015,0.1981855991499834,0.14039885076625142,ABCC3/P4HB,2
WU_CELL_MIGRATION,WU_CELL_MIGRATION,2/65,183/21728,0.1040898877764015,0.1981855991499834,0.14039885076625142,PTGER4/MT1E,2
BIOCARTA_ALK_PATHWAY,BIOCARTA_ALK_PATHWAY,1/65,37/21728,0.10501170390042414,0.1981855991499834,0.14039885076625142,TGFB1,1
BIOCARTA_IL2RB_PATHWAY,BIOCARTA_IL2RB_PATHWAY,1/65,37/21728,0.10501170390042414,0.1981855991499834,0.14039885076625142,STAT5A,1
GENTILE_UV_RESPONSE_CLUSTER_D7,GENTILE_UV_RESPONSE_CLUSTER_D7,1/65,37/21728,0.10501170390042414,0.1981855991499834,0.14039885076625142,PTPN1,1
PID_IL23_PATHWAY,PID_IL23_PATHWAY,1/65,37/21728,0.10501170390042414,0.1981855991499834,0.14039885076625142,STAT5A,1
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,1/65,37/21728,0.10501170390042414,0.1981855991499834,0.14039885076625142,PPT1,1
REACTOME_RHOH_GTPASE_CYCLE,REACTOME_RHOH_GTPASE_CYCLE,1/65,37/21728,0.10501170390042414,0.1981855991499834,0.14039885076625142,CAV1,1
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,1/65,37/21728,0.10501170390042414,0.1981855991499834,0.14039885076625142,CP,1
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,1/65,37/21728,0.10501170390042414,0.1981855991499834,0.14039885076625142,LAMB1,1
WP_NEOVASCULARISATION_PROCESSES,WP_NEOVASCULARISATION_PROCESSES,1/65,37/21728,0.10501170390042414,0.1981855991499834,0.14039885076625142,TGFB1,1
WP_TYPE_II_INTERFERON_SIGNALING_IFNG,WP_TYPE_II_INTERFERON_SIGNALING_IFNG,1/65,37/21728,0.10501170390042414,0.1981855991499834,0.14039885076625142,CIITA,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,2/65,184/21728,0.1050383675494912,0.1981855991499834,0.14039885076625142,HLX/PLXND1,2
REACTOME_RAC1_GTPASE_CYCLE,REACTOME_RAC1_GTPASE_CYCLE,2/65,184/21728,0.1050383675494912,0.1981855991499834,0.14039885076625142,CAV1/WIPF1,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,2/65,184/21728,0.1050383675494912,0.1981855991499834,0.14039885076625142,ACTA2/FSTL1,2
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,2/65,185/21728,0.10598924152580294,0.19979121871027888,0.1415363054652818,ABCC3/P4HB,2
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,3/65,382/21728,0.10647479296097304,0.19985087396543075,0.1415785665039315,CP/FSTL1/RHOB,3
GRADE_COLON_VS_RECTAL_CANCER_UP,GRADE_COLON_VS_RECTAL_CANCER_UP,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,FSTL1,1
LEE_AGING_MUSCLE_UP,LEE_AGING_MUSCLE_UP,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,RHOB,1
MA_MYELOID_DIFFERENTIATION_UP,MA_MYELOID_DIFFERENTIATION_UP,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,CDKN1A,1
PID_ERBB4_PATHWAY,PID_ERBB4_PATHWAY,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,STAT5A,1
PID_FAS_PATHWAY,PID_FAS_PATHWAY,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,RIPK1,1
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,MAPKAPK2,1
REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,CDKN1A,1
REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,SOD2,1
REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,STAT5A,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,CDKN1A,1
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,CIITA,1
VALK_AML_CLUSTER_11,VALK_AML_CLUSTER_11,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,CIITA,1
WEINMANN_ADAPTATION_TO_HYPOXIA_DN,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,SOD2,1
WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,1/65,38/21728,0.10769365674936937,0.19985087396543075,0.1415785665039315,ACTA2,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,3/65,384/21728,0.10771962106736718,0.19985087396543075,0.1415785665039315,CYP1B1/MT1E/ACOX2,3
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,3/65,384/21728,0.10771962106736718,0.19985087396543075,0.1415785665039315,CALD1/STAT5A/LAMB1,3
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,2/65,187/21728,0.1078980832242689,0.1999964471256143,0.1416816935953036,CYP1B1/SOD2,2
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,3/65,386/21728,0.10897022091139513,0.20140090519068618,0.14267664125613877,IL17RA/P4HB/DEXI,3
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,2/65,189/21728,0.10981623622040873,0.20140090519068618,0.14267664125613877,RETSAT/TCN2,2
AMIT_SERUM_RESPONSE_480_MCF10A,AMIT_SERUM_RESPONSE_480_MCF10A,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,SLC26A2,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,CAVIN1,1
GYORFFY_DOXORUBICIN_RESISTANCE,GYORFFY_DOXORUBICIN_RESISTANCE,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,P2RY6,1
HAN_JNK_SINGALING_DN,HAN_JNK_SINGALING_DN,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,CP,1
HEIDENBLAD_AMPLICON_8Q24_DN,HEIDENBLAD_AMPLICON_8Q24_DN,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,ADAM8,1
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,CREB3L2,1
LANDIS_ERBB2_BREAST_TUMORS_65_DN,LANDIS_ERBB2_BREAST_TUMORS_65_DN,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,ACTA2,1
NEWMAN_ERCC6_TARGETS_DN,NEWMAN_ERCC6_TARGETS_DN,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,CDKN1A,1
PID_ECADHERIN_NASCENT_AJ_PATHWAY,PID_ECADHERIN_NASCENT_AJ_PATHWAY,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,ARF6,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_1,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,SERPINB6,1
REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,RIPK1,1
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,PTPN1,1
SPIRA_SMOKERS_LUNG_CANCER_UP,SPIRA_SMOKERS_LUNG_CANCER_UP,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,SLC39A8,1
WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_HUTCHINSONGILFORD_PROGERIA_SYNDROME,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_HUTCHINSONGILFORD_PROGERIA_SYNDROME,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,SREBF1,1
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,1/65,39/21728,0.11036769604449603,0.20140090519068618,0.14267664125613877,WIPF1,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,3/65,390/21728,0.11148856734495674,0.2032608338103131,0.14399425384667447,IL17RA/SREBF1/TCN2,3
AIYAR_COBRA1_TARGETS_UP,AIYAR_COBRA1_TARGETS_UP,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,ACOX2,1
BALDWIN_PRKCI_TARGETS_UP,BALDWIN_PRKCI_TARGETS_UP,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,RHOB,1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,SLC39A8,1
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,CREB3L2,1
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,ARF6,1
KEGG_TRYPTOPHAN_METABOLISM,KEGG_TRYPTOPHAN_METABOLISM,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,CYP1B1,1
NABA_BASEMENT_MEMBRANES,NABA_BASEMENT_MEMBRANES,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,LAMB1,1
TOMLINS_PROSTATE_CANCER_DN,TOMLINS_PROSTATE_CANCER_DN,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,CAVIN1,1
WP_G13_SIGNALING_PATHWAY,WP_G13_SIGNALING_PATHWAY,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,PPP1CB,1
WP_IL5_SIGNALING_PATHWAY,WP_IL5_SIGNALING_PATHWAY,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,STAT5A,1
WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,SREBF1,1
WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,TGFB1,1
ZHAN_MULTIPLE_MYELOMA_LB_DN,ZHAN_MULTIPLE_MYELOMA_LB_DN,1/65,40/21728,0.11303384477228928,0.203664585175296,0.1442802798136571,WIPF1,1
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,2/65,193/21728,0.11367977804862686,0.20464406489401776,0.14497416386702522,IL17RA/EMILIN1,2
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,2/65,194/21728,0.11465121177838877,0.20476482451951006,0.14505971252803188,CAV1/CDKN1A,2
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2/65,194/21728,0.11465121177838877,0.20476482451951006,0.14505971252803188,CAV1/TGFB1,2
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,3/65,395/21728,0.1146682143421767,0.20476482451951006,0.14505971252803188,ACTA2/CAV1/CAVIN1,3
PLASARI_TGFB1_TARGETS_10HR_UP,PLASARI_TGFB1_TARGETS_10HR_UP,2/65,195/21728,0.11562482208561548,0.20476482451951006,0.14505971252803188,CREB3L2/TGFB1,2
GALLUZZI_PERMEABILIZE_MITOCHONDRIA,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,SOD2,1
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,CIITA,1
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,CP,1
LI_LUNG_CANCER,LI_LUNG_CANCER,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,P4HB,1
LIAO_HAVE_SOX4_BINDING_SITES,LIAO_HAVE_SOX4_BINDING_SITES,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,LAMB1,1
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,CDKN1A,1
ONO_AML1_TARGETS_DN,ONO_AML1_TARGETS_DN,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,IL17RA,1
PID_ECADHERIN_STABILIZATION_PATHWAY,PID_ECADHERIN_STABILIZATION_PATHWAY,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,ARF6,1
PIONTEK_PKD1_TARGETS_UP,PIONTEK_PKD1_TARGETS_UP,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,ACOX2,1
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,SLC26A2,1
REACTOME_MET_PROMOTES_CELL_MOTILITY,REACTOME_MET_PROMOTES_CELL_MOTILITY,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,LAMB1,1
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,CP,1
WP_BLADDER_CANCER,WP_BLADDER_CANCER,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,CDKN1A,1
WP_OXIDATIVE_DAMAGE_RESPONSE,WP_OXIDATIVE_DAMAGE_RESPONSE,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,CDKN1A,1
ZHU_CMV_8_HR_UP,ZHU_CMV_8_HR_UP,1/65,41/21728,0.11569212585352318,0.20476482451951006,0.14505971252803188,RIPK1,1
NABA_ECM_GLYCOPROTEINS,NABA_ECM_GLYCOPROTEINS,2/65,196/21728,0.11660058778706119,0.20600810563085015,0.1459404790416444,EMILIN1/LAMB1,2
REACTOME_CELLULAR_SENESCENCE,REACTOME_CELLULAR_SENESCENCE,2/65,196/21728,0.11660058778706119,0.20600810563085015,0.1459404790416444,MAPKAPK2/CDKN1A,2
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,STAT5A,1
CHESLER_BRAIN_HIGHEST_EXPRESSION,CHESLER_BRAIN_HIGHEST_EXPRESSION,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,PPP1CB,1
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,CDKN1A,1
PID_UPA_UPAR_PATHWAY,PID_UPA_UPAR_PATHWAY,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,TGFB1,1
REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,SREBF1,1
REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION,REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,ARSB,1
REACTOME_RHOF_GTPASE_CYCLE,REACTOME_RHOF_GTPASE_CYCLE,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,CAV1,1
WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,PPP1CB,1
WP_IL2_SIGNALING_PATHWAY,WP_IL2_SIGNALING_PATHWAY,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,STAT5A,1
WP_MELATONIN_METABOLISM_AND_EFFECTS,WP_MELATONIN_METABOLISM_AND_EFFECTS,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,CYP1B1,1
WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,RIPK1,1
WP_TRYPTOPHAN_METABOLISM,WP_TRYPTOPHAN_METABOLISM,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,CYP1B1,1
ZHAN_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,CIITA,1
ZHAN_MULTIPLE_MYELOMA_MF_DN,ZHAN_MULTIPLE_MYELOMA_MF_DN,1/65,42/21728,0.1183425621434443,0.2065315220653478,0.1463112782631359,CREB3L2,1
AFFAR_YY1_TARGETS_UP,AFFAR_YY1_TARGETS_UP,2/65,199/21728,0.11954060697659408,0.20844046552152412,0.1476636139957745,CDKN1A/CTSF,2
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,2/65,200/21728,0.12052478448934943,0.20931691424213947,0.14828450872101037,ARSB/CYP1B1,2
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,2/65,200/21728,0.12052478448934943,0.20931691424213947,0.14828450872101037,SLC26A2/CYP1B1,2
REACTOME_MITOTIC_G2_G2_M_PHASES,REACTOME_MITOTIC_G2_G2_M_PHASES,2/65,200/21728,0.12052478448934943,0.20931691424213947,0.14828450872101037,PPP1CB/CDKN1A,2
ABBUD_LIF_SIGNALING_1_UP,ABBUD_LIF_SIGNALING_1_UP,1/65,43/21728,0.12098517643195661,0.20931691424213947,0.14828450872101037,PTPN1,1
HARRIS_BRAIN_CANCER_PROGENITORS,HARRIS_BRAIN_CANCER_PROGENITORS,1/65,43/21728,0.12098517643195661,0.20931691424213947,0.14828450872101037,CAV1,1
LEIN_ASTROCYTE_MARKERS,LEIN_ASTROCYTE_MARKERS,1/65,43/21728,0.12098517643195661,0.20931691424213947,0.14828450872101037,STAB1,1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,1/65,43/21728,0.12098517643195661,0.20931691424213947,0.14828450872101037,TUT7,1
LUI_THYROID_CANCER_CLUSTER_2,LUI_THYROID_CANCER_CLUSTER_2,1/65,43/21728,0.12098517643195661,0.20931691424213947,0.14828450872101037,ABCC3,1
PID_INTEGRIN3_PATHWAY,PID_INTEGRIN3_PATHWAY,1/65,43/21728,0.12098517643195661,0.20931691424213947,0.14828450872101037,LAMB1,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,3/65,405/21728,0.1211306945464611,0.20938754459198114,0.148334544747793,DSC2/CP/TNFRSF11A,3
SHEPARD_BMYB_MORPHOLINO_DN,SHEPARD_BMYB_MORPHOLINO_DN,2/65,202/21728,0.12249927202099754,0.2093963798173321,0.14834080380743633,HLX/TCN2,2
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,2/65,203/21728,0.12348954100607316,0.2093963798173321,0.14834080380743633,CIITA/PTPN1,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,2/65,203/21728,0.12348954100607316,0.2093963798173321,0.14834080380743633,CAVIN1/DEXI,2
CHOI_ATL_STAGE_PREDICTOR,CHOI_ATL_STAGE_PREDICTOR,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,IL17RA,1
KAAB_FAILED_HEART_VENTRICLE_DN,KAAB_FAILED_HEART_VENTRICLE_DN,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,DEXI,1
KEGG_ABC_TRANSPORTERS,KEGG_ABC_TRANSPORTERS,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,ABCC3,1
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,CREB3L2,1
KORKOLA_SEMINOMA_UP,KORKOLA_SEMINOMA_UP,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,TSPAN9,1
LIU_TARGETS_OF_VMYB_VS_CMYB_DN,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,MAPKAPK2,1
MARTIN_NFKB_TARGETS_UP,MARTIN_NFKB_TARGETS_UP,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,CP,1
NAKAYAMA_FRA2_TARGETS,NAKAYAMA_FRA2_TARGETS,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,WIPF1,1
PARENT_MTOR_SIGNALING_DN,PARENT_MTOR_SIGNALING_DN,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,CD248,1
PID_CERAMIDE_PATHWAY,PID_CERAMIDE_PATHWAY,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,RIPK1,1
REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,STAT5A,1
REACTOME_TBC_RABGAPS,REACTOME_TBC_RABGAPS,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,ARF6,1
REACTOME_TNF_SIGNALING,REACTOME_TNF_SIGNALING,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,RIPK1,1
WHITFIELD_CELL_CYCLE_LITERATURE,WHITFIELD_CELL_CYCLE_LITERATURE,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,CDKN1A,1
WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,MAPKAPK2,1
WP_INTERLEUKIN11_SIGNALING_PATHWAY,WP_INTERLEUKIN11_SIGNALING_PATHWAY,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,TGFB1,1
WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,CP,1
WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,CREB3L2,1
WP_VASOPRESSINREGULATED_WATER_REABSORPTION,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,CREB3L2,1
WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,1/65,44/21728,0.12361999144380453,0.2093963798173321,0.14834080380743633,RETSAT,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,3/65,409/21728,0.12375326047204327,0.2093963798173321,0.14834080380743633,FILIP1L/CD248/SREBF1,3
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,3/65,409/21728,0.12375326047204327,0.2093963798173321,0.14834080380743633,PTPN1/RIPK1/STAT5A,3
PAL_PRMT5_TARGETS_UP,PAL_PRMT5_TARGETS_UP,2/65,204/21728,0.12448179961634939,0.21045105598706576,0.1490879586097845,CYP1B1/FSTL1,2
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,3/65,411/21728,0.12507242292136142,0.2111154345129718,0.14955861834445267,HLX/ARF6/MAPKAPK2,3
CHIBA_RESPONSE_TO_TSA,CHIBA_RESPONSE_TO_TSA,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,CDKN1A,1
FAELT_B_CLL_WITH_VH3_21_UP,FAELT_B_CLL_WITH_VH3_21_UP,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,PTPN1,1
HALMOS_CEBPA_TARGETS_DN,HALMOS_CEBPA_TARGETS_DN,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,RHOB,1
PID_NFAT_TFPATHWAY,PID_NFAT_TFPATHWAY,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,PTPN1,1
REACTOME_GLYCOSPHINGOLIPID_METABOLISM,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,ARSB,1
ROVERSI_GLIOMA_LOH_REGIONS,ROVERSI_GLIOMA_LOH_REGIONS,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,KCNJ8,1
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,P4HB,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,RHOB,1
WANG_TARGETS_OF_MLL_CBP_FUSION_UP,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,CPD,1
WP_INTEGRATED_CANCER_PATHWAY,WP_INTEGRATED_CANCER_PATHWAY,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,CDKN1A,1
WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,PTGER4,1
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,1/65,45/21728,0.12624702983875713,0.2111154345129718,0.14955861834445267,CYP1B1,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,2/65,206/21728,0.12647220475188603,0.21131529616021055,0.14970020454297026,CP/SOD2,2
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,2/65,207/21728,0.1274703110463802,0.21247537380344686,0.15052202796812605,ADAM8/SOD2,2
MIKKELSEN_MEF_ICP_WITH_H3K27ME3,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,2/65,208/21728,0.12847032650374163,0.21247537380344686,0.15052202796812605,ABCC3/CIITA,2
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,CAV1,1
BIOCARTA_KERATINOCYTE_PATHWAY,BIOCARTA_KERATINOCYTE_PATHWAY,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,RIPK1,1
BURTON_ADIPOGENESIS_PEAK_AT_2HR,BURTON_ADIPOGENESIS_PEAK_AT_2HR,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,RHOB,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,HLX,1
JIANG_TIP30_TARGETS_UP,JIANG_TIP30_TARGETS_UP,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,LAMB1,1
LUI_THYROID_CANCER_PAX8_PPARG_DN,LUI_THYROID_CANCER_PAX8_PPARG_DN,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,PPT1,1
NUTT_GBM_VS_AO_GLIOMA_UP,NUTT_GBM_VS_AO_GLIOMA_UP,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,GALNT2,1
PID_A6B1_A6B4_INTEGRIN_PATHWAY,PID_A6B1_A6B4_INTEGRIN_PATHWAY,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,LAMB1,1
PID_PLK1_PATHWAY,PID_PLK1_PATHWAY,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,PPP1CB,1
PID_SYNDECAN_1_PATHWAY,PID_SYNDECAN_1_PATHWAY,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,TGFB1,1
SESTO_RESPONSE_TO_UV_C5,SESTO_RESPONSE_TO_UV_C5,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,SREBF1,1
STOSSI_RESPONSE_TO_ESTRADIOL,STOSSI_RESPONSE_TO_ESTRADIOL,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,ACOX2,1
WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,TGFB1,1
WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,1/65,46/21728,0.1288663142117905,0.21247537380344686,0.15052202796812605,ACOX2,1
BILD_MYC_ONCOGENIC_SIGNATURE,BILD_MYC_ONCOGENIC_SIGNATURE,2/65,209/21728,0.12947223125632984,0.21312301441371168,0.15098083021097683,ABCC3/ADAM8,2
RIZKI_TUMOR_INVASIVENESS_3D_UP,RIZKI_TUMOR_INVASIVENESS_3D_UP,2/65,209/21728,0.12947223125632984,0.21312301441371168,0.15098083021097683,CYP1B1/FILIP1L,2
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,CPD,1
DELACROIX_RAR_TARGETS_UP,DELACROIX_RAR_TARGETS_UP,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,CP,1
MCDOWELL_ACUTE_LUNG_INJURY_DN,MCDOWELL_ACUTE_LUNG_INJURY_DN,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,CAV1,1
MCDOWELL_ACUTE_LUNG_INJURY_UP,MCDOWELL_ACUTE_LUNG_INJURY_UP,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,CDKN1A,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,SLC26A2,1
REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,CDKN1A,1
REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,SREBF1,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,CDKN1A,1
TSENG_ADIPOGENIC_POTENTIAL_DN,TSENG_ADIPOGENIC_POTENTIAL_DN,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,HLX,1
WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,PPP1CB,1
WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,1/65,47/21728,0.13147786709326925,0.21448265431202163,0.15194402773893745,STAT5A,1
APRELIKOVA_BRCA1_TARGETS,APRELIKOVA_BRCA1_TARGETS,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,ACTA2,1
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,ACTA2,1
ENGELMANN_CANCER_PROGENITORS_UP,ENGELMANN_CANCER_PROGENITORS_UP,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,WIPF1,1
GERHOLD_ADIPOGENESIS_UP,GERHOLD_ADIPOGENESIS_UP,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,STAT5A,1
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,TGFB1,1
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,TGFB1,1
PID_HES_HEY_PATHWAY,PID_HES_HEY_PATHWAY,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,GAA,1
PID_PI3KCI_PATHWAY,PID_PI3KCI_PATHWAY,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,ARF6,1
REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,STAT5A,1
REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,RETSAT,1
WOOD_EBV_EBNA1_TARGETS_DN,WOOD_EBV_EBNA1_TARGETS_DN,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,P2RY6,1
WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,SREBF1,1
WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,ACTA2,1
WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,1/65,48/21728,0.1340817109491308,0.21626082411150127,0.15320372066004254,TGFB1,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,2/65,214/21728,0.13450940594483074,0.21677583552752738,0.153568565589501,TUT7/CTSF,2
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,2/65,215/21728,0.13552223473006955,0.21823226204520058,0.1546003287962316,FSTL1/GAA,2
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,3/65,428/21728,0.1364906980608876,0.21833525268540627,0.1546732895339773,CYP1B1/SOD2/RHOB,3
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,2/65,216/21728,0.136536816469675,0.21833525268540627,0.1546732895339773,P2RY6/CTSF,2
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,1/65,49/21728,0.1366778681810643,0.21833525268540627,0.1546732895339773,CALD1,1
JIANG_AGING_CEREBRAL_CORTEX_DN,JIANG_AGING_CEREBRAL_CORTEX_DN,1/65,49/21728,0.1366778681810643,0.21833525268540627,0.1546732895339773,PPP1CB,1
NADLER_OBESITY_DN,NADLER_OBESITY_DN,1/65,49/21728,0.1366778681810643,0.21833525268540627,0.1546732895339773,SREBF1,1
PID_ARF6_TRAFFICKING_PATHWAY,PID_ARF6_TRAFFICKING_PATHWAY,1/65,49/21728,0.1366778681810643,0.21833525268540627,0.1546732895339773,ARF6,1
PID_FOXO_PATHWAY,PID_FOXO_PATHWAY,1/65,49/21728,0.1366778681810643,0.21833525268540627,0.1546732895339773,SOD2,1
REACTOME_SIGNALING_BY_NOTCH3,REACTOME_SIGNALING_BY_NOTCH3,1/65,49/21728,0.1366778681810643,0.21833525268540627,0.1546732895339773,PLXND1,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/65,49/21728,0.1366778681810643,0.21833525268540627,0.1546732895339773,CDKN1A,1
WP_MICROTUBULE_CYTOSKELETON_REGULATION,WP_MICROTUBULE_CYTOSKELETON_REGULATION,1/65,49/21728,0.1366778681810643,0.21833525268540627,0.1546732895339773,MAPKAPK2,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,3/65,430/21728,0.13785746707853844,0.22004384210461042,0.1558836902488451,CP/ARF6/MAPKAPK2,3
WONG_MITOCHONDRIA_GENE_MODULE,WONG_MITOCHONDRIA_GENE_MODULE,2/65,218/21728,0.13857116254089874,0.22035816633970023,0.15610636415433504,CP/SOD2,2
CHIBA_RESPONSE_TO_TSA_UP,CHIBA_RESPONSE_TO_TSA_UP,1/65,50/21728,0.13926636112669055,0.22035816633970023,0.15610636415433504,TGFB1,1
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,1/65,50/21728,0.13926636112669055,0.22035816633970023,0.15610636415433504,ARSB,1
REACTOME_SIGNALING_BY_ERBB2,REACTOME_SIGNALING_BY_ERBB2,1/65,50/21728,0.13926636112669055,0.22035816633970023,0.15610636415433504,PTPN18,1
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,1/65,50/21728,0.13926636112669055,0.22035816633970023,0.15610636415433504,FSTL1,1
TSUNODA_CISPLATIN_RESISTANCE_DN,TSUNODA_CISPLATIN_RESISTANCE_DN,1/65,50/21728,0.13926636112669055,0.22035816633970023,0.15610636415433504,GALNT2,1
WARTERS_IR_RESPONSE_5GY,WARTERS_IR_RESPONSE_5GY,1/65,50/21728,0.13926636112669055,0.22035816633970023,0.15610636415433504,CDKN1A,1
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,1/65,50/21728,0.13926636112669055,0.22035816633970023,0.15610636415433504,MAPKAPK2,1
WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,1/65,50/21728,0.13926636112669055,0.22035816633970023,0.15610636415433504,CDKN1A,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,1/65,50/21728,0.13926636112669055,0.22035816633970023,0.15610636415433504,RHOB,1
ZHOU_TNF_SIGNALING_4HR,ZHOU_TNF_SIGNALING_4HR,1/65,50/21728,0.13926636112669055,0.22035816633970023,0.15610636415433504,SOD2,1
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,2/65,220/21728,0.14061229256658983,0.22231192500646613,0.1574904479256334,PTPN1/SOD2,2
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,1/65,51/21728,0.1418472120597457,0.22373377296489858,0.1584977149530282,TBC1D22A,1
TAVOR_CEBPA_TARGETS_UP,TAVOR_CEBPA_TARGETS_UP,1/65,51/21728,0.1418472120597457,0.22373377296489858,0.1584977149530282,SOD2,1
WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,1/65,51/21728,0.1418472120597457,0.22373377296489858,0.1584977149530282,CDKN1A,1
REACTOME_BIOLOGICAL_OXIDATIONS,REACTOME_BIOLOGICAL_OXIDATIONS,2/65,222/21728,0.14266005646668212,0.2248385444707362,0.159280358346111,SLC26A2/CYP1B1,2
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,3/65,438/21728,0.1433719377356985,0.22578257911133626,0.15994913235992558,GALNT2/TUT7/TSPAN9,3
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,2/65,223/21728,0.14368637963000291,0.22609973191188498,0.1601738100807354,HLX/TUT7,2
BIOCARTA_PPARA_PATHWAY,BIOCARTA_PPARA_PATHWAY,1/65,52/21728,0.1444204431902577,0.22618706842640204,0.16023568110628275,STAT5A,1
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,1/65,52/21728,0.1444204431902577,0.22618706842640204,0.16023568110628275,SH2B3,1
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,1/65,52/21728,0.1444204431902577,0.22618706842640204,0.16023568110628275,HSDL2,1
KEGG_STARCH_AND_SUCROSE_METABOLISM,KEGG_STARCH_AND_SUCROSE_METABOLISM,1/65,52/21728,0.1444204431902577,0.22618706842640204,0.16023568110628275,GAA,1
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,1/65,52/21728,0.1444204431902577,0.22618706842640204,0.16023568110628275,SOD2,1
WANG_BARRETTS_ESOPHAGUS_UP,WANG_BARRETTS_ESOPHAGUS_UP,1/65,52/21728,0.1444204431902577,0.22618706842640204,0.16023568110628275,TCN2,1
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,3/65,441/21728,0.14545902494935525,0.22763540680650274,0.16126171450608037,GALNT2/TUT7/OLFML2B,3
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,2/65,225/21728,0.1457438162187712,0.2279027618745445,0.16145111446480892,CAV1/TUT7,2
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,1/65,53/21728,0.14698607666472885,0.22877210375833285,0.16206697455721897,PTGER4,1
JI_RESPONSE_TO_FSH_DN,JI_RESPONSE_TO_FSH_DN,1/65,53/21728,0.14698607666472885,0.22877210375833285,0.16206697455721897,ARF6,1
REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1/65,53/21728,0.14698607666472885,0.22877210375833285,0.16206697455721897,GALNT2,1
REACTOME_RHOD_GTPASE_CYCLE,REACTOME_RHOD_GTPASE_CYCLE,1/65,53/21728,0.14698607666472885,0.22877210375833285,0.16206697455721897,CAV1,1
SCHEIDEREIT_IKK_INTERACTING_PROTEINS,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,1/65,53/21728,0.14698607666472885,0.22877210375833285,0.16206697455721897,RIPK1,1
WP_CARDIAC_PROGENITOR_DIFFERENTIATION,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,1/65,53/21728,0.14698607666472885,0.22877210375833285,0.16206697455721897,TGFB1,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,2/65,227/21728,0.14780751801635567,0.2298717231980648,0.16284596811820803,RIPK1/TGFB1,2
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,2/65,228/21728,0.1488416730351295,0.2298910600558196,0.1628596667553333,CIITA/CAVIN1,2
BORLAK_LIVER_CANCER_EGF_UP,BORLAK_LIVER_CANCER_EGF_UP,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,SERPINB6,1
BROWNE_HCMV_INFECTION_30MIN_UP,BROWNE_HCMV_INFECTION_30MIN_UP,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,RHOB,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,CYP1B1,1
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,CDKN1A,1
KYNG_DNA_DAMAGE_BY_UV,KYNG_DNA_DAMAGE_BY_UV,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,PTPN18,1
PID_RAC1_PATHWAY,PID_RAC1_PATHWAY,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,STAT5A,1
PID_TAP63_PATHWAY,PID_TAP63_PATHWAY,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,CDKN1A,1
REACTOME_SIGNALING_BY_PTK6,REACTOME_SIGNALING_BY_PTK6,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,PTPN1,1
STARK_HYPPOCAMPUS_22Q11_DELETION_UP,STARK_HYPPOCAMPUS_22Q11_DELETION_UP,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,OLFML2B,1
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,RHOB,1
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,CDKN1A,1
WP_COPPER_HOMEOSTASIS,WP_COPPER_HOMEOSTASIS,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,MT1E,1
WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,SOD2,1
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,1/65,54/21728,0.14954413456631066,0.2298910600558196,0.1628596667553333,FSTL1,1
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,RIPK1,1
KEGG_STEROID_HORMONE_BIOSYNTHESIS,KEGG_STEROID_HORMONE_BIOSYNTHESIS,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,CYP1B1,1
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,CAV1,1
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,HGSNAT,1
REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,SREBF1,1
REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,TGFB1,1
REACTOME_RHOJ_GTPASE_CYCLE,REACTOME_RHOJ_GTPASE_CYCLE,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,CAV1,1
REACTOME_SIGNALING_BY_ALK_IN_CANCER,REACTOME_SIGNALING_BY_ALK_IN_CANCER,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,STAT5A,1
REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,SOD2,1
RICKMAN_HEAD_AND_NECK_CANCER_F,RICKMAN_HEAD_AND_NECK_CANCER_F,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,CYP1B1,1
WP_IL4_SIGNALING_PATHWAY,WP_IL4_SIGNALING_PATHWAY,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,STAT5A,1
WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,STAT5A,1
WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,TGFB1,1
WP_RANKLRANK_SIGNALING_PATHWAY,WP_RANKLRANK_SIGNALING_PATHWAY,1/65,55/21728,0.1520946389149861,0.23132264473762143,0.16387383148254658,TNFRSF11A,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,3/65,453/21728,0.15390812644067797,0.23288796937913275,0.16498274041279617,SLC39A8/CYP1B1/STAT5A,3
BIOCARTA_HIVNEF_PATHWAY,BIOCARTA_HIVNEF_PATHWAY,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,RIPK1,1
CROONQUIST_STROMAL_STIMULATION_UP,CROONQUIST_STROMAL_STIMULATION_UP,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,ACTA2,1
DIRMEIER_LMP1_RESPONSE_LATE_UP,DIRMEIER_LMP1_RESPONSE_LATE_UP,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,STAT5A,1
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,FILIP1L,1
MAYBURD_RESPONSE_TO_L663536_DN,MAYBURD_RESPONSE_TO_L663536_DN,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,HSDL2,1
MODY_HIPPOCAMPUS_POSTNATAL,MODY_HIPPOCAMPUS_POSTNATAL,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,RHOB,1
PETROVA_PROX1_TARGETS_DN,PETROVA_PROX1_TARGETS_DN,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,TCN2,1
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,TUT7,1
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,CPD,1
REACTOME_REGULATED_NECROSIS,REACTOME_REGULATED_NECROSIS,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,RIPK1,1
WP_CCL18_SIGNALING_PATHWAY,WP_CCL18_SIGNALING_PATHWAY,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,ACTA2,1
XU_GH1_EXOGENOUS_TARGETS_UP,XU_GH1_EXOGENOUS_TARGETS_UP,1/65,56/21728,0.15463761166774415,0.23288796937913275,0.16498274041279617,TNFRSF11A,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,3/65,456/21728,0.15604485456080228,0.23476187411315835,0.16631025397700588,ADAM8/PLXND1/SREBF1,3
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,2/65,235/21728,0.15612210141012509,0.23476187411315835,0.16631025397700588,CALD1/CYP1B1,2
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,2/65,236/21728,0.15716785742386977,0.23476187411315835,0.16631025397700588,CP/GAA,2
ASTIER_INTEGRIN_SIGNALING,ASTIER_INTEGRIN_SIGNALING,1/65,57/21728,0.15717307471875952,0.23476187411315835,0.16631025397700588,GAA,1
BYSTROEM_CORRELATED_WITH_IL5_DN,BYSTROEM_CORRELATED_WITH_IL5_DN,1/65,57/21728,0.15717307471875952,0.23476187411315835,0.16631025397700588,MAPKAPK2,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,1/65,57/21728,0.15717307471875952,0.23476187411315835,0.16631025397700588,RETSAT,1
KEGG_ACUTE_MYELOID_LEUKEMIA,KEGG_ACUTE_MYELOID_LEUKEMIA,1/65,57/21728,0.15717307471875952,0.23476187411315835,0.16631025397700588,STAT5A,1
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,1/65,57/21728,0.15717307471875952,0.23476187411315835,0.16631025397700588,HGSNAT,1
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,1/65,57/21728,0.15717307471875952,0.23476187411315835,0.16631025397700588,CAV1,1
WP_CARDIAC_HYPERTROPHIC_RESPONSE,WP_CARDIAC_HYPERTROPHIC_RESPONSE,1/65,57/21728,0.15717307471875952,0.23476187411315835,0.16631025397700588,TGFB1,1
WP_IL1_SIGNALING_PATHWAY,WP_IL1_SIGNALING_PATHWAY,1/65,57/21728,0.15717307471875952,0.23476187411315835,0.16631025397700588,MAPKAPK2,1
MARKEY_RB1_ACUTE_LOF_UP,MARKEY_RB1_ACUTE_LOF_UP,2/65,237/21728,0.15821498496978997,0.23614176861162683,0.16728780029013146,PTGER4/CAV1,2
JIANG_HYPOXIA_CANCER,JIANG_HYPOXIA_CANCER,1/65,58/21728,0.15970104989956724,0.2367695328384985,0.16773252168453634,PPT1,1
KOHOUTEK_CCNT2_TARGETS,KOHOUTEK_CCNT2_TARGETS,1/65,58/21728,0.15970104989956724,0.2367695328384985,0.16773252168453634,RETSAT,1
LIANG_SILENCED_BY_METHYLATION_2,LIANG_SILENCED_BY_METHYLATION_2,1/65,58/21728,0.15970104989956724,0.2367695328384985,0.16773252168453634,SOD2,1
LUCAS_HNF4A_TARGETS_UP,LUCAS_HNF4A_TARGETS_UP,1/65,58/21728,0.15970104989956724,0.2367695328384985,0.16773252168453634,DSC2,1
NADLER_HYPERGLYCEMIA_AT_OBESITY,NADLER_HYPERGLYCEMIA_AT_OBESITY,1/65,58/21728,0.15970104989956724,0.2367695328384985,0.16773252168453634,PTPN18,1
REACTOME_IRON_UPTAKE_AND_TRANSPORT,REACTOME_IRON_UPTAKE_AND_TRANSPORT,1/65,58/21728,0.15970104989956724,0.2367695328384985,0.16773252168453634,CP,1
REACTOME_SIGNALING_BY_ERBB4,REACTOME_SIGNALING_BY_ERBB4,1/65,58/21728,0.15970104989956724,0.2367695328384985,0.16773252168453634,STAT5A,1
REACTOME_SIGNALING_BY_PDGF,REACTOME_SIGNALING_BY_PDGF,1/65,58/21728,0.15970104989956724,0.2367695328384985,0.16773252168453634,STAT5A,1
WP_TGFBETA_RECEPTOR_SIGNALING,WP_TGFBETA_RECEPTOR_SIGNALING,1/65,58/21728,0.15970104989956724,0.2367695328384985,0.16773252168453634,TGFB1,1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,2/65,239/21728,0.16031328606538475,0.23750116454131073,0.16825082498558122,CAV1/CDKN1A,2
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,2/65,240/21728,0.16136442553700198,0.2383858324456143,0.1688775423535773,ADAM8/CDKN1A,2
BILD_SRC_ONCOGENIC_SIGNATURE,BILD_SRC_ONCOGENIC_SIGNATURE,1/65,59/21728,0.1622215589792405,0.2383858324456143,0.1688775423535773,IL17RA,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1/65,59/21728,0.1622215589792405,0.2383858324456143,0.1688775423535773,CDKN1A,1
GALE_APL_WITH_FLT3_MUTATED_UP,GALE_APL_WITH_FLT3_MUTATED_UP,1/65,59/21728,0.1622215589792405,0.2383858324456143,0.1688775423535773,WIPF1,1
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,1/65,59/21728,0.1622215589792405,0.2383858324456143,0.1688775423535773,WIPF1,1
ONDER_CDH1_TARGETS_3_DN,ONDER_CDH1_TARGETS_3_DN,1/65,59/21728,0.1622215589792405,0.2383858324456143,0.1688775423535773,DSC2,1
PID_NOTCH_PATHWAY,PID_NOTCH_PATHWAY,1/65,59/21728,0.1622215589792405,0.2383858324456143,0.1688775423535773,CDKN1A,1
REACTOME_RHOQ_GTPASE_CYCLE,REACTOME_RHOQ_GTPASE_CYCLE,1/65,59/21728,0.1622215589792405,0.2383858324456143,0.1688775423535773,CAV1,1
WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,1/65,59/21728,0.1622215589792405,0.2383858324456143,0.1688775423535773,CDKN1A,1
WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,1/65,59/21728,0.1622215589792405,0.2383858324456143,0.1688775423535773,CDKN1A,1
ZHENG_IL22_SIGNALING_UP,ZHENG_IL22_SIGNALING_UP,1/65,59/21728,0.1622215589792405,0.2383858324456143,0.1688775423535773,DSC2,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,3/65,467/21728,0.16395957718159876,0.24066416897672416,0.17049156391719514,MXRA8/MAPKAPK2/RHOB,3
CHICAS_RB1_TARGETS_GROWING,CHICAS_RB1_TARGETS_GROWING,2/65,243/21728,0.16452559700082264,0.24066416897672416,0.17049156391719514,CAV1/CAVIN1,2
CHYLA_CBFA2T3_TARGETS_DN,CHYLA_CBFA2T3_TARGETS_DN,2/65,243/21728,0.16452559700082264,0.24066416897672416,0.17049156391719514,SLC39A8/CREB3L2,2
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,2/65,243/21728,0.16452559700082264,0.24066416897672416,0.17049156391719514,PLXND1/CDKN1A,2
LEE_LIVER_CANCER_CIPROFIBRATE_UP,LEE_LIVER_CANCER_CIPROFIBRATE_UP,1/65,60/21728,0.1647346236645677,0.24066416897672416,0.17049156391719514,CDKN1A,1
PID_FCER1_PATHWAY,PID_FCER1_PATHWAY,1/65,60/21728,0.1647346236645677,0.24066416897672416,0.17049156391719514,WIPF1,1
REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1/65,60/21728,0.1647346236645677,0.24066416897672416,0.17049156391719514,CDKN1A,1
WP_KIT_RECEPTOR_SIGNALING_PATHWAY,WP_KIT_RECEPTOR_SIGNALING_PATHWAY,1/65,60/21728,0.1647346236645677,0.24066416897672416,0.17049156391719514,STAT5A,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,2/65,245/21728,0.16663933836815467,0.2432585681457805,0.17232949090748453,ACTA2/PLXND1,2
ISSAEVA_MLL2_TARGETS,ISSAEVA_MLL2_TARGETS,1/65,61/21728,0.1672402656002241,0.2432585681457805,0.17232949090748453,FSTL1,1
MADAN_DPPA4_TARGETS,MADAN_DPPA4_TARGETS,1/65,61/21728,0.1672402656002241,0.2432585681457805,0.17232949090748453,SERPINB6,1
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1/65,61/21728,0.1672402656002241,0.2432585681457805,0.17232949090748453,MAPKAPK2,1
WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,1/65,61/21728,0.1672402656002241,0.2432585681457805,0.17232949090748453,SH2B3,1
WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_RLR_PATHWAY,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_RLR_PATHWAY,1/65,61/21728,0.1672402656002241,0.2432585681457805,0.17232949090748453,RIPK1,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,3/65,472/21728,0.1675973897870369,0.24360085724860012,0.1725719757140083,SLC26A2/SOD2/LAMB1,3
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,3/65,473/21728,0.16832787613168199,0.24448493265313287,0.1731982733426931,SLC39A8/DSC2/ADAM8,3
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/65,62/21728,0.16973850636894972,0.24540326668891538,0.17384884050698957,STAT5A,1
KEGG_COLORECTAL_CANCER,KEGG_COLORECTAL_CANCER,1/65,62/21728,0.16973850636894972,0.24540326668891538,0.17384884050698957,TGFB1,1
MASSARWEH_RESPONSE_TO_ESTRADIOL,MASSARWEH_RESPONSE_TO_ESTRADIOL,1/65,62/21728,0.16973850636894972,0.24540326668891538,0.17384884050698957,SLC26A2,1
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,1/65,62/21728,0.16973850636894972,0.24540326668891538,0.17384884050698957,GALNT2,1
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,1/65,62/21728,0.16973850636894972,0.24540326668891538,0.17384884050698957,CAVIN1,1
WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,1/65,62/21728,0.16973850636894972,0.24540326668891538,0.17384884050698957,TGFB1,1
BILD_E2F3_ONCOGENIC_SIGNATURE,BILD_E2F3_ONCOGENIC_SIGNATURE,2/65,248/21728,0.16981906054872944,0.24540326668891538,0.17384884050698957,PLXND1/SREBF1,2
HSIAO_LIVER_SPECIFIC_GENES,HSIAO_LIVER_SPECIFIC_GENES,2/65,249/21728,0.1708813319805859,0.24604195355960573,0.174301299732226,CP/ACOX2,2
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,2/65,249/21728,0.1708813319805859,0.24604195355960573,0.174301299732226,MAPKAPK2/TGFB1,2
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,2/65,250/21728,0.17194475845587803,0.24604195355960573,0.174301299732226,CYP1B1/ADAM8,2
BURTON_ADIPOGENESIS_PEAK_AT_0HR,BURTON_ADIPOGENESIS_PEAK_AT_0HR,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,ACTA2,1
JOHNSTONE_PARVB_TARGETS_1_DN,JOHNSTONE_PARVB_TARGETS_1_DN,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,PTGER4,1
LEE_LIVER_CANCER_E2F1_UP,LEE_LIVER_CANCER_E2F1_UP,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,RHOB,1
LEE_LIVER_CANCER_MYC_DN,LEE_LIVER_CANCER_MYC_DN,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,MAPKAPK2,1
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,CDKN1A,1
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,STAT5A,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,PTPN1,1
VILLANUEVA_LIVER_CANCER_KRT19_DN,VILLANUEVA_LIVER_CANCER_KRT19_DN,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,RETSAT,1
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,CDKN1A,1
WP_LUNG_FIBROSIS,WP_LUNG_FIBROSIS,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,TGFB1,1
WP_NOTCH_SIGNALING_PATHWAY,WP_NOTCH_SIGNALING_PATHWAY,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,CDKN1A,1
WP_OXIDATION_BY_CYTOCHROME_P450,WP_OXIDATION_BY_CYTOCHROME_P450,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,CYP1B1,1
ZWANG_EGF_PERSISTENTLY_DN,ZWANG_EGF_PERSISTENTLY_DN,1/65,63/21728,0.17222936749172402,0.24604195355960573,0.174301299732226,ABCC3,1
BILBAN_B_CLL_LPL_UP,BILBAN_B_CLL_LPL_UP,1/65,64/21728,0.17471287042793593,0.24781967436586658,0.17556067457708235,CREB3L2,1
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,1/65,64/21728,0.17471287042793593,0.24781967436586658,0.17556067457708235,HGSNAT,1
KEGG_RETINOL_METABOLISM,KEGG_RETINOL_METABOLISM,1/65,64/21728,0.17471287042793593,0.24781967436586658,0.17556067457708235,RETSAT,1
LEE_LIVER_CANCER_E2F1_DN,LEE_LIVER_CANCER_E2F1_DN,1/65,64/21728,0.17471287042793593,0.24781967436586658,0.17556067457708235,MAPKAPK2,1
LEE_LIVER_CANCER_MYC_E2F1_DN,LEE_LIVER_CANCER_MYC_E2F1_DN,1/65,64/21728,0.17471287042793593,0.24781967436586658,0.17556067457708235,MAPKAPK2,1
PID_ERA_GENOMIC_PATHWAY,PID_ERA_GENOMIC_PATHWAY,1/65,64/21728,0.17471287042793593,0.24781967436586658,0.17556067457708235,STAT5A,1
PID_IL4_2PATHWAY,PID_IL4_2PATHWAY,1/65,64/21728,0.17471287042793593,0.24781967436586658,0.17556067457708235,STAT5A,1
REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,1/65,64/21728,0.17471287042793593,0.24781967436586658,0.17556067457708235,RIPK1,1
WP_G1_TO_S_CELL_CYCLE_CONTROL,WP_G1_TO_S_CELL_CYCLE_CONTROL,1/65,64/21728,0.17471287042793593,0.24781967436586658,0.17556067457708235,CDKN1A,1
ZHAN_MULTIPLE_MYELOMA_UP,ZHAN_MULTIPLE_MYELOMA_UP,1/65,64/21728,0.17471287042793593,0.24781967436586658,0.17556067457708235,CDKN1A,1
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,2/65,254/21728,0.1762096948274863,0.24956202334586267,0.17679499127554277,CYP1B1/SERPINB6,2
BROWNE_HCMV_INFECTION_6HR_UP,BROWNE_HCMV_INFECTION_6HR_UP,1/65,65/21728,0.1771890365755625,0.24956202334586267,0.17679499127554277,RIPK1,1
DELPUECH_FOXO3_TARGETS_UP,DELPUECH_FOXO3_TARGETS_UP,1/65,65/21728,0.1771890365755625,0.24956202334586267,0.17679499127554277,CAV1,1
KEGG_GLIOMA,KEGG_GLIOMA,1/65,65/21728,0.1771890365755625,0.24956202334586267,0.17679499127554277,CDKN1A,1
LEE_LIVER_CANCER_MYC_TGFA_DN,LEE_LIVER_CANCER_MYC_TGFA_DN,1/65,65/21728,0.1771890365755625,0.24956202334586267,0.17679499127554277,MAPKAPK2,1
PID_RB_1PATHWAY,PID_RB_1PATHWAY,1/65,65/21728,0.1771890365755625,0.24956202334586267,0.17679499127554277,CDKN1A,1
REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,1/65,65/21728,0.1771890365755625,0.24956202334586267,0.17679499127554277,P4HB,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,1/65,65/21728,0.1771890365755625,0.24956202334586267,0.17679499127554277,CAV1,1
WP_ENDOCHONDRAL_OSSIFICATION,WP_ENDOCHONDRAL_OSSIFICATION,1/65,65/21728,0.1771890365755625,0.24956202334586267,0.17679499127554277,TGFB1,1
WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1/65,65/21728,0.1771890365755625,0.24956202334586267,0.17679499127554277,TGFB1,1
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,HSDL2,1
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,ABCC3,1
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,CDKN1A,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,HSDL2,1
KYNG_RESPONSE_TO_H2O2,KYNG_RESPONSE_TO_H2O2,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,PTGER4,1
LEE_LIVER_CANCER_CIPROFIBRATE_DN,LEE_LIVER_CANCER_CIPROFIBRATE_DN,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,MAPKAPK2,1
PID_HIF1_TFPATHWAY,PID_HIF1_TFPATHWAY,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,CP,1
PID_INTEGRIN1_PATHWAY,PID_INTEGRIN1_PATHWAY,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,LAMB1,1
RAMASWAMY_METASTASIS_UP,RAMASWAMY_METASTASIS_UP,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,P4HB,1
REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,CYP1B1,1
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,SOD2,1
WP_AGERAGE_PATHWAY,WP_AGERAGE_PATHWAY,1/65,66/21728,0.17965788727133858,0.25091883697114326,0.1777561866121889,STAT5A,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,2/65,258/21728,0.1804918419187777,0.25173199709731897,0.1783322463647323,CAV1/RHOB,2
WP_GPCRS_CLASS_A_RHODOPSINLIKE,WP_GPCRS_CLASS_A_RHODOPSINLIKE,2/65,258/21728,0.1804918419187777,0.25173199709731897,0.1783322463647323,PTGER4/P2RY6,2
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,2/65,259/21728,0.1815649509538234,0.25294367193184464,0.1791906223264542,ABCC3/DSC2,2
PID_TELOMERASE_PATHWAY,PID_TELOMERASE_PATHWAY,1/65,67/21728,0.18211944379092815,0.25294367193184464,0.1791906223264542,TGFB1,1
REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,1/65,67/21728,0.18211944379092815,0.25294367193184464,0.1791906223264542,P4HB,1
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,1/65,67/21728,0.18211944379092815,0.25294367193184464,0.1791906223264542,CAV1,1
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,1/65,67/21728,0.18211944379092815,0.25294367193184464,0.1791906223264542,PTPN1,1
WP_PPAR_SIGNALING_PATHWAY,WP_PPAR_SIGNALING_PATHWAY,1/65,67/21728,0.18211944379092815,0.25294367193184464,0.1791906223264542,ACOX2,1
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,1/65,68/21728,0.1845737273491017,0.25501718189449174,0.18065954043683471,PTPN18,1
DANG_REGULATED_BY_MYC_UP,DANG_REGULATED_BY_MYC_UP,1/65,68/21728,0.1845737273491017,0.25501718189449174,0.18065954043683471,SREBF1,1
KEGG_P53_SIGNALING_PATHWAY,KEGG_P53_SIGNALING_PATHWAY,1/65,68/21728,0.1845737273491017,0.25501718189449174,0.18065954043683471,CDKN1A,1
LINDVALL_IMMORTALIZED_BY_TERT_UP,LINDVALL_IMMORTALIZED_BY_TERT_UP,1/65,68/21728,0.1845737273491017,0.25501718189449174,0.18065954043683471,CALD1,1
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,1/65,68/21728,0.1845737273491017,0.25501718189449174,0.18065954043683471,RHOB,1
REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,1/65,68/21728,0.1845737273491017,0.25501718189449174,0.18065954043683471,CDKN1A,1
WP_MELANOMA,WP_MELANOMA,1/65,68/21728,0.1845737273491017,0.25501718189449174,0.18065954043683471,CDKN1A,1
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,3/65,495/21728,0.184632439691612,0.25501718189449174,0.18065954043683471,SOD2/RHOB/ACOX2,3
ENGELMANN_CANCER_PROGENITORS_DN,ENGELMANN_CANCER_PROGENITORS_DN,1/65,69/21728,0.18702075909990057,0.25672032820851143,0.18186608514139813,ABCC3,1
KEGG_PPAR_SIGNALING_PATHWAY,KEGG_PPAR_SIGNALING_PATHWAY,1/65,69/21728,0.18702075909990057,0.25672032820851143,0.18186608514139813,ACOX2,1
LEE_AGING_NEOCORTEX_DN,LEE_AGING_NEOCORTEX_DN,1/65,69/21728,0.18702075909990057,0.25672032820851143,0.18186608514139813,CP,1
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1/65,69/21728,0.18702075909990057,0.25672032820851143,0.18186608514139813,LAMB1,1
PID_MTOR_4PATHWAY,PID_MTOR_4PATHWAY,1/65,69/21728,0.18702075909990057,0.25672032820851143,0.18186608514139813,SREBF1,1
RIZKI_TUMOR_INVASIVENESS_2D_UP,RIZKI_TUMOR_INVASIVENESS_2D_UP,1/65,69/21728,0.18702075909990057,0.25672032820851143,0.18186608514139813,STAT5A,1
WATANABE_COLON_CANCER_MSI_VS_MSS_DN,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,1/65,69/21728,0.18702075909990057,0.25672032820851143,0.18186608514139813,SLC26A2,1
WP_DNA_DAMAGE_RESPONSE,WP_DNA_DAMAGE_RESPONSE,1/65,69/21728,0.18702075909990057,0.25672032820851143,0.18186608514139813,CDKN1A,1
WP_RAC1PAK1P38MMP2_PATHWAY,WP_RAC1PAK1P38MMP2_PATHWAY,1/65,69/21728,0.18702075909990057,0.25672032820851143,0.18186608514139813,STAT5A,1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,2/65,265/21728,0.18802403511607654,0.25774370817830916,0.1825910690568443,RIPK1/SERPINB6,2
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,2/65,265/21728,0.18802403511607654,0.25774370817830916,0.1825910690568443,CAVIN1/DDO,2
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,SERPINB6,1
HUANG_DASATINIB_RESISTANCE_DN,HUANG_DASATINIB_RESISTANCE_DN,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,RHOB,1
KEGG_LONG_TERM_POTENTIATION,KEGG_LONG_TERM_POTENTIATION,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,PPP1CB,1
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,CYP1B1,1
KEGG_PANCREATIC_CANCER,KEGG_PANCREATIC_CANCER,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,TGFB1,1
KEGG_RENAL_CELL_CARCINOMA,KEGG_RENAL_CELL_CARCINOMA,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,TGFB1,1
KEGG_VIRAL_MYOCARDITIS,KEGG_VIRAL_MYOCARDITIS,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,CAV1,1
MAHAJAN_RESPONSE_TO_IL1A_DN,MAHAJAN_RESPONSE_TO_IL1A_DN,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,GALNT2,1
PID_AP1_PATHWAY,PID_AP1_PATHWAY,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,TGFB1,1
SESTO_RESPONSE_TO_UV_C7,SESTO_RESPONSE_TO_UV_C7,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,MT1E,1
VERNELL_RETINOBLASTOMA_PATHWAY_UP,VERNELL_RETINOBLASTOMA_PATHWAY_UP,1/65,70/21728,0.18946056013681378,0.2577694695738963,0.18260931897182345,CDKN1A,1
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,2/65,267/21728,0.19018448533014304,0.25857849806953503,0.18318245179031278,MAPKAPK2/TGFB1,2
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,2/65,268/21728,0.19126603534800188,0.25896511672462386,0.18345634058491778,ABCC3/SLC26A2,2
BAE_BRCA1_TARGETS_UP,BAE_BRCA1_TARGETS_UP,1/65,71/21728,0.19189315149294628,0.25896511672462386,0.18345634058491778,GAA,1
BASSO_CD40_SIGNALING_DN,BASSO_CD40_SIGNALING_DN,1/65,71/21728,0.19189315149294628,0.25896511672462386,0.18345634058491778,PTPN18,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,1/65,71/21728,0.19189315149294628,0.25896511672462386,0.18345634058491778,FILIP1L,1
KEGG_MELANOMA,KEGG_MELANOMA,1/65,71/21728,0.19189315149294628,0.25896511672462386,0.18345634058491778,CDKN1A,1
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/65,71/21728,0.19189315149294628,0.25896511672462386,0.18345634058491778,RIPK1,1
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,1/65,71/21728,0.19189315149294628,0.25896511672462386,0.18345634058491778,WIPF1,1
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,1/65,71/21728,0.19189315149294628,0.25896511672462386,0.18345634058491778,PTPN1,1
SESTO_RESPONSE_TO_UV_C8,SESTO_RESPONSE_TO_UV_C8,1/65,71/21728,0.19189315149294628,0.25896511672462386,0.18345634058491778,LAMB1,1
WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,1/65,71/21728,0.19189315149294628,0.25896511672462386,0.18345634058491778,SLC26A2,1
WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,1/65,71/21728,0.19189315149294628,0.25896511672462386,0.18345634058491778,CAV1,1
CHANG_IMMORTALIZED_BY_HPV31_UP,CHANG_IMMORTALIZED_BY_HPV31_UP,1/65,72/21728,0.19431855414118726,0.26100544545491905,0.18490175241174797,CP,1
CROMER_METASTASIS_UP,CROMER_METASTASIS_UP,1/65,72/21728,0.19431855414118726,0.26100544545491905,0.18490175241174797,PPT1,1
KEGG_LEISHMANIA_INFECTION,KEGG_LEISHMANIA_INFECTION,1/65,72/21728,0.19431855414118726,0.26100544545491905,0.18490175241174797,TGFB1,1
LIU_NASOPHARYNGEAL_CARCINOMA,LIU_NASOPHARYNGEAL_CARCINOMA,1/65,72/21728,0.19431855414118726,0.26100544545491905,0.18490175241174797,ADAM8,1
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,1/65,72/21728,0.19431855414118726,0.26100544545491905,0.18490175241174797,CPD,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,1/65,72/21728,0.19431855414118726,0.26100544545491905,0.18490175241174797,CAV1,1
WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1/65,72/21728,0.19431855414118726,0.26100544545491905,0.18490175241174797,CDKN1A,1
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,2/65,272/21728,0.1956007279618457,0.262551312700464,0.18599687731306558,PTGER4/P2RY6,2
FURUKAWA_DUSP6_TARGETS_PCI35_DN,FURUKAWA_DUSP6_TARGETS_PCI35_DN,1/65,73/21728,0.19673678899438374,0.26284140146210255,0.18620238229894215,ACOX2,1
KEGG_ADHERENS_JUNCTION,KEGG_ADHERENS_JUNCTION,1/65,73/21728,0.19673678899438374,0.26284140146210255,0.18620238229894215,PTPN1,1
PID_E2F_PATHWAY,PID_E2F_PATHWAY,1/65,73/21728,0.19673678899438374,0.26284140146210255,0.18620238229894215,CDKN1A,1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,1/65,73/21728,0.19673678899438374,0.26284140146210255,0.18620238229894215,CAV1,1
WP_FOLATE_METABOLISM,WP_FOLATE_METABOLISM,1/65,73/21728,0.19673678899438374,0.26284140146210255,0.18620238229894215,SOD2,1
WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,1/65,73/21728,0.19673678899438374,0.26284140146210255,0.18620238229894215,SREBF1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,1/65,73/21728,0.19673678899438374,0.26284140146210255,0.18620238229894215,SOD2,1
NABA_CORE_MATRISOME,NABA_CORE_MATRISOME,2/65,275/21728,0.1988602617164314,0.26482430439562066,0.1876071124823713,EMILIN1/LAMB1,2
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,1/65,74/21728,0.19914787690550673,0.26482430439562066,0.1876071124823713,CAVIN1,1
FOROUTAN_INTEGRATED_TGFB_EMT_DN,FOROUTAN_INTEGRATED_TGFB_EMT_DN,1/65,74/21728,0.19914787690550673,0.26482430439562066,0.1876071124823713,CP,1
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,1/65,74/21728,0.19914787690550673,0.26482430439562066,0.1876071124823713,DSC2,1
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,1/65,74/21728,0.19914787690550673,0.26482430439562066,0.1876071124823713,TSPAN9,1
REACTOME_RHOG_GTPASE_CYCLE,REACTOME_RHOG_GTPASE_CYCLE,1/65,74/21728,0.19914787690550673,0.26482430439562066,0.1876071124823713,CAV1,1
WP_CYTOSOLIC_DNASENSING_PATHWAY,WP_CYTOSOLIC_DNASENSING_PATHWAY,1/65,74/21728,0.19914787690550673,0.26482430439562066,0.1876071124823713,RIPK1,1
ANDERSEN_LIVER_CANCER_KRT19_DN,ANDERSEN_LIVER_CANCER_KRT19_DN,1/65,75/21728,0.20155183866782056,0.2669560777057226,0.18911730557468562,RETSAT,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1/65,75/21728,0.20155183866782056,0.2669560777057226,0.18911730557468562,RHOB,1
JAIN_NFKB_SIGNALING,JAIN_NFKB_SIGNALING,1/65,75/21728,0.20155183866782056,0.2669560777057226,0.18911730557468562,ARSB,1
REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1/65,75/21728,0.20155183866782056,0.2669560777057226,0.18911730557468562,CAV1,1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,1/65,75/21728,0.20155183866782056,0.2669560777057226,0.18911730557468562,PTGER4,1
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,1/65,75/21728,0.20155183866782056,0.2669560777057226,0.18911730557468562,RHOB,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,2/65,279/21728,0.20321693216711187,0.26835354607243594,0.19010730158605202,OLFML2B/PPP1CB,2
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,2/65,279/21728,0.20321693216711187,0.26835354607243594,0.19010730158605202,ACTA2/ARF6,2
BRUECKNER_TARGETS_OF_MIRLET7A3_DN,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,1/65,76/21728,0.2039486950150513,0.26835354607243594,0.19010730158605202,CALD1,1
KEGG_VEGF_SIGNALING_PATHWAY,KEGG_VEGF_SIGNALING_PATHWAY,1/65,76/21728,0.2039486950150513,0.26835354607243594,0.19010730158605202,MAPKAPK2,1
LEIN_OLIGODENDROCYTE_MARKERS,LEIN_OLIGODENDROCYTE_MARKERS,1/65,76/21728,0.2039486950150513,0.26835354607243594,0.19010730158605202,NPC1,1
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,1/65,76/21728,0.2039486950150513,0.26835354607243594,0.19010730158605202,CDKN1A,1
SHEPARD_BMYB_TARGETS,SHEPARD_BMYB_TARGETS,1/65,76/21728,0.2039486950150513,0.26835354607243594,0.19010730158605202,HLX,1
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,1/65,76/21728,0.2039486950150513,0.26835354607243594,0.19010730158605202,DSC2,1
WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1/65,76/21728,0.2039486950150513,0.26835354607243594,0.19010730158605202,CDKN1A,1
WP_LEPTIN_SIGNALING_PATHWAY,WP_LEPTIN_SIGNALING_PATHWAY,1/65,76/21728,0.2039486950150513,0.26835354607243594,0.19010730158605202,PTPN1,1
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,2/65,280/21728,0.2043079042694813,0.2684729359651528,0.19019187989952407,CP/RHOB,2
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,2/65,280/21728,0.2043079042694813,0.2684729359651528,0.19019187989952407,CAVIN1/STAT5A,2
CROMER_METASTASIS_DN,CROMER_METASTASIS_DN,1/65,77/21728,0.2063384666215553,0.2698998909372862,0.1912027648429407,CAV1,1
FRASOR_RESPONSE_TO_ESTRADIOL_DN,FRASOR_RESPONSE_TO_ESTRADIOL_DN,1/65,77/21728,0.2063384666215553,0.2698998909372862,0.1912027648429407,LAMB1,1
GROSS_HYPOXIA_VIA_HIF1A_UP,GROSS_HYPOXIA_VIA_HIF1A_UP,1/65,77/21728,0.2063384666215553,0.2698998909372862,0.1912027648429407,ACOX2,1
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,1/65,77/21728,0.2063384666215553,0.2698998909372862,0.1912027648429407,CDKN1A,1
LEE_AGING_NEOCORTEX_UP,LEE_AGING_NEOCORTEX_UP,1/65,77/21728,0.2063384666215553,0.2698998909372862,0.1912027648429407,LAMB1,1
MUNSHI_MULTIPLE_MYELOMA_UP,MUNSHI_MULTIPLE_MYELOMA_UP,1/65,77/21728,0.2063384666215553,0.2698998909372862,0.1912027648429407,ABCC3,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,1/65,77/21728,0.2063384666215553,0.2698998909372862,0.1912027648429407,CP,1
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,1/65,78/21728,0.20872117410248436,0.27177236211260986,0.19252926284398575,SLC39A8,1
GUO_HEX_TARGETS_UP,GUO_HEX_TARGETS_UP,1/65,78/21728,0.20872117410248436,0.27177236211260986,0.19252926284398575,PTPN1,1
MORI_PRE_BI_LYMPHOCYTE_DN,MORI_PRE_BI_LYMPHOCYTE_DN,1/65,78/21728,0.20872117410248436,0.27177236211260986,0.19252926284398575,TUT7,1
REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,1/65,78/21728,0.20872117410248436,0.27177236211260986,0.19252926284398575,CDKN1A,1
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1/65,78/21728,0.20872117410248436,0.27177236211260986,0.19252926284398575,SOD2,1
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,1/65,78/21728,0.20872117410248436,0.27177236211260986,0.19252926284398575,CAV1,1
WOO_LIVER_CANCER_RECURRENCE_DN,WOO_LIVER_CANCER_RECURRENCE_DN,1/65,78/21728,0.20872117410248436,0.27177236211260986,0.19252926284398575,ACOX2,1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,2/65,285/21728,0.20977290688425948,0.27296409483963496,0.19337351139692038,CALD1/CAV1,2
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,1/65,79/21728,0.21109683801395462,0.2737961582541565,0.1939629626368919,RHOB,1
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,1/65,79/21728,0.21109683801395462,0.2737961582541565,0.1939629626368919,ACTA2,1
PID_P73PATHWAY,PID_P73PATHWAY,1/65,79/21728,0.21109683801395462,0.2737961582541565,0.1939629626368919,CDKN1A,1
REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1/65,79/21728,0.21109683801395462,0.2737961582541565,0.1939629626368919,CDKN1A,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,1/65,79/21728,0.21109683801395462,0.2737961582541565,0.1939629626368919,SLC39A8,1
LIAN_LIPA_TARGETS_6M,LIAN_LIPA_TARGETS_6M,1/65,80/21728,0.21346547885321265,0.27633071696208755,0.19575849738472104,ADAM8,1
REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,1/65,80/21728,0.21346547885321265,0.27633071696208755,0.19575849738472104,RHOB,1
SCIBETTA_KDM5B_TARGETS_DN,SCIBETTA_KDM5B_TARGETS_DN,1/65,80/21728,0.21346547885321265,0.27633071696208755,0.19575849738472104,CAV1,1
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,1/65,81/21728,0.21582711705879976,0.2784866026565158,0.19728577219772123,CAVIN1,1
MORI_PRE_BI_LYMPHOCYTE_UP,MORI_PRE_BI_LYMPHOCYTE_UP,1/65,81/21728,0.21582711705879976,0.2784866026565158,0.19728577219772123,CDKN1A,1
ROSS_AML_WITH_MLL_FUSIONS,ROSS_AML_WITH_MLL_FUSIONS,1/65,81/21728,0.21582711705879976,0.2784866026565158,0.19728577219772123,DEXI,1
ROSS_LEUKEMIA_WITH_MLL_FUSIONS,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,1/65,81/21728,0.21582711705879976,0.2784866026565158,0.19728577219772123,DEXI,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,1/65,81/21728,0.21582711705879976,0.2784866026565158,0.19728577219772123,CAV1,1
BROWNE_HCMV_INFECTION_14HR_DN,BROWNE_HCMV_INFECTION_14HR_DN,2/65,291/21728,0.21635145305738115,0.2789831760894663,0.1976375552718009,CYP1B1/MT1E,2
FOROUTAN_PRODRANK_TGFB_EMT_DN,FOROUTAN_PRODRANK_TGFB_EMT_DN,1/65,82/21728,0.21818177301071784,0.2797202218086126,0.19815969397599612,CYP1B1,1
PID_SMAD2_3NUCLEAR_PATHWAY,PID_SMAD2_3NUCLEAR_PATHWAY,1/65,82/21728,0.21818177301071784,0.2797202218086126,0.19815969397599612,CDKN1A,1
REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1/65,82/21728,0.21818177301071784,0.2797202218086126,0.19815969397599612,RIPK1,1
REACTOME_ONCOGENIC_MAPK_SIGNALING,REACTOME_ONCOGENIC_MAPK_SIGNALING,1/65,82/21728,0.21818177301071784,0.2797202218086126,0.19815969397599612,PPP1CB,1
REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1/65,82/21728,0.21818177301071784,0.2797202218086126,0.19815969397599612,MAPKAPK2,1
REACTOME_SIGNALING_BY_NOTCH4,REACTOME_SIGNALING_BY_NOTCH4,1/65,82/21728,0.21818177301071784,0.2797202218086126,0.19815969397599612,ACTA2,1
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,1/65,82/21728,0.21818177301071784,0.2797202218086126,0.19815969397599612,SOD2,1
SATOH_COLORECTAL_CANCER_MYC_UP,SATOH_COLORECTAL_CANCER_MYC_UP,1/65,82/21728,0.21818177301071784,0.2797202218086126,0.19815969397599612,PPT1,1
WARTERS_RESPONSE_TO_IR_SKIN,WARTERS_RESPONSE_TO_IR_SKIN,1/65,82/21728,0.21818177301071784,0.2797202218086126,0.19815969397599612,CDKN1A,1
WANG_MLL_TARGETS,WANG_MLL_TARGETS,2/65,293/21728,0.21854882585751845,0.28001130795325874,0.1983659055289928,EMILIN1/STAT5A,2
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,1/65,83/21728,0.22052946703059706,0.28146709257255526,0.1993972140013997,TGFB1,1
KESHELAVA_MULTIPLE_DRUG_RESISTANCE,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,1/65,83/21728,0.22052946703059706,0.28146709257255526,0.1993972140013997,HGSNAT,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,1/65,83/21728,0.22052946703059706,0.28146709257255526,0.1993972140013997,SOD2,1
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,1/65,83/21728,0.22052946703059706,0.28146709257255526,0.1993972140013997,CDKN1A,1
STEIN_ESR1_TARGETS,STEIN_ESR1_TARGETS,1/65,83/21728,0.22052946703059706,0.28146709257255526,0.1993972140013997,SLC39A8,1
WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,1/65,83/21728,0.22052946703059706,0.28146709257255526,0.1993972140013997,CDKN1A,1
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,2/65,295/21728,0.22074828882249584,0.28156669492665287,0.19946777440593408,CAV1/SREBF1,2
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,2/65,296/21728,0.22184877236984302,0.28260990110808026,0.20020680362709267,PTGER4/KCNE4,2
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,2/65,296/21728,0.22184877236984302,0.28260990110808026,0.20020680362709267,DSC2/ADAM8,2
COATES_MACROPHAGE_M1_VS_M2_DN,COATES_MACROPHAGE_M1_VS_M2_DN,1/65,84/21728,0.22287021938185658,0.28275173176927304,0.20030727945339027,ADAM8,1
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,1/65,84/21728,0.22287021938185658,0.28275173176927304,0.20030727945339027,CDKN1A,1
KEGG_ECM_RECEPTOR_INTERACTION,KEGG_ECM_RECEPTOR_INTERACTION,1/65,84/21728,0.22287021938185658,0.28275173176927304,0.20030727945339027,LAMB1,1
KEGG_SMALL_CELL_LUNG_CANCER,KEGG_SMALL_CELL_LUNG_CANCER,1/65,84/21728,0.22287021938185658,0.28275173176927304,0.20030727945339027,LAMB1,1
ONDER_CDH1_SIGNALING_VIA_CTNNB1,ONDER_CDH1_SIGNALING_VIA_CTNNB1,1/65,84/21728,0.22287021938185658,0.28275173176927304,0.20030727945339027,ACTA2,1
PID_CMYB_PATHWAY,PID_CMYB_PATHWAY,1/65,84/21728,0.22287021938185658,0.28275173176927304,0.20030727945339027,CDKN1A,1
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,2/65,297/21728,0.22294974050007177,0.28275173176927304,0.20030727945339027,RIPK1/TGFB1,2
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,2/65,299/21728,0.22515308053939892,0.28506841806312744,0.2019484687962998,SLC26A2/CP,2
KIM_GLIS2_TARGETS_UP,KIM_GLIS2_TARGETS_UP,1/65,85/21728,0.22520405026987067,0.28506841806312744,0.2019484687962998,ADAM8,1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/65,85/21728,0.22520405026987067,0.28506841806312744,0.2019484687962998,CDKN1A,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,2/65,300/21728,0.2262554276339789,0.2862181247741669,0.2027629452347519,CREB3L2/SH2B3,2
HILLION_HMGA1B_TARGETS,HILLION_HMGA1B_TARGETS,1/65,86/21728,0.22753097984213266,0.28692431253736783,0.20326322351331425,ARF6,1
KEGG_TGF_BETA_SIGNALING_PATHWAY,KEGG_TGF_BETA_SIGNALING_PATHWAY,1/65,86/21728,0.22753097984213266,0.28692431253736783,0.20326322351331425,TGFB1,1
LEIN_MEDULLA_MARKERS,LEIN_MEDULLA_MARKERS,1/65,86/21728,0.22753097984213266,0.28692431253736783,0.20326322351331425,FSTL1,1
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1/65,86/21728,0.22753097984213266,0.28692431253736783,0.20326322351331425,RHOB,1
WP_APOPTOSIS,WP_APOPTOSIS,1/65,86/21728,0.22753097984213266,0.28692431253736783,0.20326322351331425,RIPK1,1
KAYO_CALORIE_RESTRICTION_MUSCLE_DN,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,1/65,87/21728,0.22985102818841563,0.28839526748860184,0.20430527896824108,DDO,1
KEGG_APOPTOSIS,KEGG_APOPTOSIS,1/65,87/21728,0.22985102818841563,0.28839526748860184,0.20430527896824108,RIPK1,1
REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,1/65,87/21728,0.22985102818841563,0.28839526748860184,0.20430527896824108,RIPK1,1
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1/65,87/21728,0.22985102818841563,0.28839526748860184,0.20430527896824108,MAPKAPK2,1
REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1/65,87/21728,0.22985102818841563,0.28839526748860184,0.20430527896824108,PPP1CB,1
SMITH_TERT_TARGETS_DN,SMITH_TERT_TARGETS_DN,1/65,87/21728,0.22985102818841563,0.28839526748860184,0.20430527896824108,SERPINB6,1
WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,1/65,87/21728,0.22985102818841563,0.28839526748860184,0.20430527896824108,TGFB1,1
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,1/65,87/21728,0.22985102818841563,0.28839526748860184,0.20430527896824108,CDKN1A,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,HOEBEKE_LYMPHOID_STEM_CELL_DN,1/65,88/21728,0.23216421534093856,0.28948156526301566,0.2050748351810627,SLC39A8,1
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,1/65,88/21728,0.23216421534093856,0.28948156526301566,0.2050748351810627,CIITA,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,1/65,88/21728,0.23216421534093856,0.28948156526301566,0.2050748351810627,SLC26A2,1
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,1/65,88/21728,0.23216421534093856,0.28948156526301566,0.2050748351810627,CDKN1A,1
REACTOME_RAC2_GTPASE_CYCLE,REACTOME_RAC2_GTPASE_CYCLE,1/65,88/21728,0.23216421534093856,0.28948156526301566,0.2050748351810627,CAV1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,1/65,88/21728,0.23216421534093856,0.28948156526301566,0.2050748351810627,CDKN1A,1
RICKMAN_HEAD_AND_NECK_CANCER_E,RICKMAN_HEAD_AND_NECK_CANCER_E,1/65,88/21728,0.23216421534093856,0.28948156526301566,0.2050748351810627,CP,1
SASSON_RESPONSE_TO_FORSKOLIN_UP,SASSON_RESPONSE_TO_FORSKOLIN_UP,1/65,88/21728,0.23216421534093856,0.28948156526301566,0.2050748351810627,RHOB,1
VANLOO_SP3_TARGETS_DN,VANLOO_SP3_TARGETS_DN,1/65,88/21728,0.23216421534093856,0.28948156526301566,0.2050748351810627,SERPINB6,1
WP_RETINOBLASTOMA_GENE_IN_CANCER,WP_RETINOBLASTOMA_GENE_IN_CANCER,1/65,88/21728,0.23216421534093856,0.28948156526301566,0.2050748351810627,CDKN1A,1
SWEET_KRAS_ONCOGENIC_SIGNATURE,SWEET_KRAS_ONCOGENIC_SIGNATURE,1/65,89/21728,0.23447056127452637,0.2919932269919382,0.20685414922692047,CDKN1A,1
WP_ALLOGRAFT_REJECTION,WP_ALLOGRAFT_REJECTION,1/65,89/21728,0.23447056127452637,0.2919932269919382,0.20685414922692047,TGFB1,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,2/65,308/21728,0.2350888431247438,0.29239905861286536,0.2071416488910089,CALD1/SOD2,2
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,2/65,308/21728,0.2350888431247438,0.29239905861286536,0.2071416488910089,PTGER4/WIPF1,2
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,2/65,309/21728,0.23619466982793863,0.2935772918868837,0.20797633414723452,SLC26A2/CYP1B1,2
KEGG_DILATED_CARDIOMYOPATHY,KEGG_DILATED_CARDIOMYOPATHY,1/65,90/21728,0.23677008590677173,0.2935772918868837,0.20797633414723452,TGFB1,1
REACTOME_COLLAGEN_FORMATION,REACTOME_COLLAGEN_FORMATION,1/65,90/21728,0.23677008590677173,0.2935772918868837,0.20797633414723452,P4HB,1
REACTOME_SPHINGOLIPID_METABOLISM,REACTOME_SPHINGOLIPID_METABOLISM,1/65,90/21728,0.23677008590677173,0.2935772918868837,0.20797633414723452,ARSB,1
TIEN_INTESTINE_PROBIOTICS_2HR_DN,TIEN_INTESTINE_PROBIOTICS_2HR_DN,1/65,90/21728,0.23677008590677173,0.2935772918868837,0.20797633414723452,CALD1,1
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,2/65,310/21728,0.23730082373390887,0.294053065345612,0.20831338208168096,GAA/DEXI,2
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,1/65,91/21728,0.23906280909819688,0.2955040903562384,0.20934131874710368,PTGER4,1
MORI_IMMATURE_B_LYMPHOCYTE_DN,MORI_IMMATURE_B_LYMPHOCYTE_DN,1/65,91/21728,0.23906280909819688,0.2955040903562384,0.20934131874710368,CDKN1A,1
WP_APOPTOSIS_MODULATION_AND_SIGNALING,WP_APOPTOSIS_MODULATION_AND_SIGNALING,1/65,91/21728,0.23906280909819688,0.2955040903562384,0.20934131874710368,RIPK1,1
WP_SELENIUM_MICRONUTRIENT_NETWORK,WP_SELENIUM_MICRONUTRIENT_NETWORK,1/65,91/21728,0.23906280909819688,0.2955040903562384,0.20934131874710368,SOD2,1
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1/65,92/21728,0.24134875065241512,0.29777760722074664,0.21095192595743423,CPD,1
LEIN_PONS_MARKERS,LEIN_PONS_MARKERS,1/65,92/21728,0.24134875065241512,0.29777760722074664,0.21095192595743423,FSTL1,1
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,1/65,92/21728,0.24134875065241512,0.29777760722074664,0.21095192595743423,CREB3L2,1
BRUINS_UVC_RESPONSE_EARLY_LATE,BRUINS_UVC_RESPONSE_EARLY_LATE,2/65,314/21728,0.24172847947179382,0.298062243491731,0.21115356828414208,CALD1/FILIP1L,2
CAMPS_COLON_CANCER_COPY_NUMBER_UP,CAMPS_COLON_CANCER_COPY_NUMBER_UP,1/65,93/21728,0.2436279303162896,0.29966535094254565,0.21228924335192975,P4HB,1
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,1/65,93/21728,0.2436279303162896,0.29966535094254565,0.21228924335192975,CALD1,1
WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING_PATHWAY,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING_PATHWAY,1/65,93/21728,0.2436279303162896,0.29966535094254565,0.21228924335192975,TGFB1,1
WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,1/65,93/21728,0.2436279303162896,0.29966535094254565,0.21228924335192975,CDKN1A,1
REACTOME_MITOCHONDRIAL_BIOGENESIS,REACTOME_MITOCHONDRIAL_BIOGENESIS,1/65,94/21728,0.24590036778009583,0.3017182426749642,0.21374355507394838,SOD2,1
REACTOME_RAC3_GTPASE_CYCLE,REACTOME_RAC3_GTPASE_CYCLE,1/65,94/21728,0.24590036778009583,0.3017182426749642,0.21374355507394838,CAV1,1
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1/65,94/21728,0.24590036778009583,0.3017182426749642,0.21374355507394838,MAPKAPK2,1
WP_TNFALPHA_SIGNALING_PATHWAY,WP_TNFALPHA_SIGNALING_PATHWAY,1/65,94/21728,0.24590036778009583,0.3017182426749642,0.21374355507394838,RIPK1,1
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,2/65,318/21728,0.24616045049617163,0.3018521771872123,0.21383843710209885,ARSB/ARF6,2
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,2/65,319/21728,0.24726903294234154,0.30302577566463423,0.2146698389708409,ABCC3/SOD2,2
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,1/65,96/21728,0.2504250945866112,0.3063303909316345,0.21701089799683163,MXRA8,1
GUO_TARGETS_OF_IRS1_AND_IRS2,GUO_TARGETS_OF_IRS1_AND_IRS2,1/65,96/21728,0.2504250945866112,0.3063303909316345,0.21701089799683163,GALNT2,1
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,1/65,96/21728,0.2504250945866112,0.3063303909316345,0.21701089799683163,ARF6,1
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,2/65,323/21728,0.25170538931667713,0.3077082998981383,0.21798703771731276,SLC39A8/SLC26A2,2
NAKAMURA_ADIPOGENESIS_LATE_UP,NAKAMURA_ADIPOGENESIS_LATE_UP,1/65,97/21728,0.25267742302835827,0.30870790840361423,0.21869518142698152,TGFB1,1
IGARASHI_ATF4_TARGETS_DN,IGARASHI_ATF4_TARGETS_DN,1/65,98/21728,0.2549230874684283,0.3106923674203879,0.22010101397254853,CREB3L2,1
KONG_E2F3_TARGETS,KONG_E2F3_TARGETS,1/65,98/21728,0.2549230874684283,0.3106923674203879,0.22010101397254853,HLX,1
REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,1/65,98/21728,0.2549230874684283,0.3106923674203879,0.22010101397254853,STAB1,1
WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1/65,98/21728,0.2549230874684283,0.3106923674203879,0.22010101397254853,PTPN18,1
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,2/65,327/21728,0.25614446641827826,0.31199082389558863,0.2210208678755065,SLC39A8/CPD,2
WP_COMPLEMENT_SYSTEM,WP_COMPLEMENT_SYSTEM,1/65,99/21728,0.2571621073165352,0.31303969241209395,0.22176390841404137,LAMB1,1
BENPORATH_ES_CORE_NINE_CORRELATED,BENPORATH_ES_CORE_NINE_CORRELATED,1/65,100/21728,0.25939450192675395,0.3147991528237305,0.22301034721091648,CREB3L2,1
MENSE_HYPOXIA_UP,MENSE_HYPOXIA_UP,1/65,100/21728,0.25939450192675395,0.3147991528237305,0.22301034721091648,SOD2,1
REACTOME_UCH_PROTEINASES,REACTOME_UCH_PROTEINASES,1/65,100/21728,0.25939450192675395,0.3147991528237305,0.22301034721091648,TGFB1,1
REACTOME_VISUAL_PHOTOTRANSDUCTION,REACTOME_VISUAL_PHOTOTRANSDUCTION,1/65,100/21728,0.25939450192675395,0.3147991528237305,0.22301034721091648,RETSAT,1
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,1/65,100/21728,0.25939450192675395,0.3147991528237305,0.22301034721091648,PTGER4,1
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2/65,331/21728,0.26058558118361175,0.3159665345382597,0.2238373449939461,PTGER4/P2RY6,2
KEGG_MELANOGENESIS,KEGG_MELANOGENESIS,1/65,101/21728,0.261620290597679,0.3159665345382597,0.2238373449939461,CREB3L2,1
MCCLUNG_CREB1_TARGETS_UP,MCCLUNG_CREB1_TARGETS_UP,1/65,101/21728,0.261620290597679,0.3159665345382597,0.2238373449939461,FSTL1,1
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,1/65,101/21728,0.261620290597679,0.3159665345382597,0.2238373449939461,STAT5A,1
REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,1/65,101/21728,0.261620290597679,0.3159665345382597,0.2238373449939461,MAPKAPK2,1
REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1/65,101/21728,0.261620290597679,0.3159665345382597,0.2238373449939461,TNFRSF11A,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1/65,101/21728,0.261620290597679,0.3159665345382597,0.2238373449939461,SLC26A2,1
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,1/65,101/21728,0.261620290597679,0.3159665345382597,0.2238373449939461,TGFB1,1
BROWNE_HCMV_INFECTION_20HR_DN,BROWNE_HCMV_INFECTION_20HR_DN,1/65,102/21728,0.2638394925725783,0.3176875286846217,0.22505653347868468,FILIP1L,1
BURTON_ADIPOGENESIS_3,BURTON_ADIPOGENESIS_3,1/65,102/21728,0.2638394925725783,0.3176875286846217,0.22505653347868468,ADAM8,1
GRADE_COLON_AND_RECTAL_CANCER_DN,GRADE_COLON_AND_RECTAL_CANCER_DN,1/65,102/21728,0.2638394925725783,0.3176875286846217,0.22505653347868468,STAT5A,1
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/65,102/21728,0.2638394925725783,0.3176875286846217,0.22505653347868468,RIPK1,1
WP_NEURAL_CREST_DIFFERENTIATION,WP_NEURAL_CREST_DIFFERENTIATION,1/65,102/21728,0.2638394925725783,0.3176875286846217,0.22505653347868468,RHOB,1
DER_IFN_BETA_RESPONSE_UP,DER_IFN_BETA_RESPONSE_UP,1/65,103/21728,0.2660521270395525,0.31958213458204504,0.2263987121828593,CALD1,1
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1/65,103/21728,0.2660521270395525,0.31958213458204504,0.2263987121828593,ABCC3,1
REACTOME_POTASSIUM_CHANNELS,REACTOME_POTASSIUM_CHANNELS,1/65,103/21728,0.2660521270395525,0.31958213458204504,0.2263987121828593,KCNJ8,1
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1/65,103/21728,0.2660521270395525,0.31958213458204504,0.2263987121828593,MAPKAPK2,1
CHICAS_RB1_TARGETS_LOW_SERUM,CHICAS_RB1_TARGETS_LOW_SERUM,1/65,104/21728,0.26825821313168796,0.32165253373104075,0.2278654265273584,MT1E,1
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,1/65,104/21728,0.26825821313168796,0.32165253373104075,0.2278654265273584,CAV1,1
WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,1/65,104/21728,0.26825821313168796,0.32165253373104075,0.2278654265273584,RIPK1,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,1/65,105/21728,0.27045776992721327,0.323514078860303,0.22918418428735152,CPD,1
LE_EGR2_TARGETS_DN,LE_EGR2_TARGETS_DN,1/65,105/21728,0.27045776992721327,0.323514078860303,0.22918418428735152,CDKN1A,1
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1/65,105/21728,0.27045776992721327,0.323514078860303,0.22918418428735152,CDKN1A,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,1/65,105/21728,0.27045776992721327,0.323514078860303,0.22918418428735152,RHOB,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,2/65,341/21728,0.27169293849392706,0.32476637683137816,0.23007133853422895,CALD1/SOD2,2
JAZAG_TGFB1_SIGNALING_UP,JAZAG_TGFB1_SIGNALING_UP,1/65,106/21728,0.2726508164496537,0.32476637683137816,0.23007133853422895,EMILIN1,1
REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1/65,106/21728,0.2726508164496537,0.32476637683137816,0.23007133853422895,CYP1B1,1
REACTOME_STIMULI_SENSING_CHANNELS,REACTOME_STIMULI_SENSING_CHANNELS,1/65,106/21728,0.2726508164496537,0.32476637683137816,0.23007133853422895,RIPK1,1
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1/65,106/21728,0.2726508164496537,0.32476637683137816,0.23007133853422895,SLC26A2,1
ROESSLER_LIVER_CANCER_METASTASIS_UP,ROESSLER_LIVER_CANCER_METASTASIS_UP,1/65,106/21728,0.2726508164496537,0.32476637683137816,0.23007133853422895,SERPINB6,1
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,1/65,106/21728,0.2726508164496537,0.32476637683137816,0.23007133853422895,P4HB,1
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,2/65,342/21728,0.27280375653835764,0.32476637683137816,0.23007133853422895,SLC39A8/WIPF1,2
NABA_SECRETED_FACTORS,NABA_SECRETED_FACTORS,2/65,343/21728,0.27391455021147315,0.3258947652724249,0.23087071266141265,FSTL1/TGFB1,2
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,1/65,107/21728,0.2748373716679854,0.3264101801282487,0.23123584339611727,CYP1B1,1
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,1/65,107/21728,0.2748373716679854,0.3264101801282487,0.23123584339611727,DSC2,1
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,1/65,107/21728,0.2748373716679854,0.3264101801282487,0.23123584339611727,RIPK1,1
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,2/65,345/21728,0.2761360259015021,0.3277578942451063,0.232190592449428,CPD/DEXI,2
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,1/65,108/21728,0.27701745449679016,0.3284142910453944,0.23265559776163205,ACOX2,1
WP_THERMOGENESIS,WP_THERMOGENESIS,1/65,108/21728,0.27701745449679016,0.3284142910453944,0.23265559776163205,CREB3L2,1
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,1/65,109/21728,0.27919108379640634,0.32981817341571923,0.23365013758818853,CPD,1
REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,1/65,109/21728,0.27919108379640634,0.32981817341571923,0.23365013758818853,SLC26A2,1
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,1/65,109/21728,0.27919108379640634,0.32981817341571923,0.23365013758818853,CAVIN1,1
SESTO_RESPONSE_TO_UV_C0,SESTO_RESPONSE_TO_UV_C0,1/65,109/21728,0.27919108379640634,0.32981817341571923,0.23365013758818853,DSC2,1
VANTVEER_BREAST_CANCER_METASTASIS_DN,VANTVEER_BREAST_CANCER_METASTASIS_DN,1/65,109/21728,0.27919108379640634,0.32981817341571923,0.23365013758818853,CP,1
WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,1/65,109/21728,0.27919108379640634,0.32981817341571923,0.23365013758818853,TGFB1,1
REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,1/65,110/21728,0.2813582783730859,0.33179042260977115,0.23504732043829052,CDKN1A,1
SUNG_METASTASIS_STROMA_UP,SUNG_METASTASIS_STROMA_UP,1/65,110/21728,0.2813582783730859,0.33179042260977115,0.23504732043829052,GAA,1
WOOD_EBV_EBNA1_TARGETS_UP,WOOD_EBV_EBNA1_TARGETS_UP,1/65,110/21728,0.2813582783730859,0.33179042260977115,0.23504732043829052,WIPF1,1
REACTOME_O_LINKED_GLYCOSYLATION,REACTOME_O_LINKED_GLYCOSYLATION,1/65,111/21728,0.2835190569791435,0.3339447078670712,0.23657346146793579,GALNT2,1
ZWANG_EGF_INTERVAL_UP,ZWANG_EGF_INTERVAL_UP,1/65,111/21728,0.2835190569791435,0.3339447078670712,0.23657346146793579,SLC39A8,1
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,1/65,112/21728,0.2856734383131101,0.33608639801542367,0.23809067985724225,FSTL1,1
MARKEY_RB1_CHRONIC_LOF_UP,MARKEY_RB1_CHRONIC_LOF_UP,1/65,112/21728,0.2856734383131101,0.33608639801542367,0.23809067985724225,CDKN1A,1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,2/65,354/21728,0.28612895217077006,0.33642439996563206,0.23833012755460042,SH2B3/RETSAT,2
BROWNE_HCMV_INFECTION_12HR_UP,BROWNE_HCMV_INFECTION_12HR_UP,1/65,113/21728,0.28782144101988505,0.337620458674352,0.23917744072404096,IL17RA,1
DITTMER_PTHLH_TARGETS_UP,DITTMER_PTHLH_TARGETS_UP,1/65,113/21728,0.28782144101988505,0.337620458674352,0.23917744072404096,CPD,1
HOSHIDA_LIVER_CANCER_SURVIVAL_DN,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,1/65,113/21728,0.28782144101988505,0.337620458674352,0.23917744072404096,PTPN18,1
KEGG_OOCYTE_MEIOSIS,KEGG_OOCYTE_MEIOSIS,1/65,113/21728,0.28782144101988505,0.337620458674352,0.23917744072404096,PPP1CB,1
BOSCO_TH1_CYTOTOXIC_MODULE,BOSCO_TH1_CYTOTOXIC_MODULE,1/65,114/21728,0.28996308369088686,0.3397341343771375,0.24067481309033004,STAB1,1
MATZUK_SPERMATOZOA,MATZUK_SPERMATOZOA,1/65,114/21728,0.28996308369088686,0.3397341343771375,0.24067481309033004,TGFB1,1
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,2/65,359/21728,0.2916762302204231,0.341141789731489,0.24167202577820227,CP/HSDL2,2
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,2/65,359/21728,0.2916762302204231,0.341141789731489,0.24167202577820227,CALD1/CAV1,2
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,2/65,359/21728,0.2916762302204231,0.341141789731489,0.24167202577820227,SLC39A8/RHOB,2
HOSHIDA_LIVER_CANCER_SUBCLASS_S2,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,1/65,115/21728,0.2920983848642048,0.3412364309161271,0.2417390715858459,CPD,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,1/65,115/21728,0.2920983848642048,0.3412364309161271,0.2417390715858459,ACOX2,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,2/65,360/21728,0.29278517829247575,0.34183908732338086,0.24216600607224778,MT1E/SERPINB6,2
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,2/65,361/21728,0.2938939366997352,0.3429223345276789,0.24293340119697676,ABCC3/TGFB1,2
LENAOUR_DENDRITIC_CELL_MATURATION_UP,LENAOUR_DENDRITIC_CELL_MATURATION_UP,1/65,116/21728,0.2942273630247485,0.3429223345276789,0.24293340119697676,SERPINB6,1
REACTOME_PARASITE_INFECTION,REACTOME_PARASITE_INFECTION,1/65,116/21728,0.2942273630247485,0.3429223345276789,0.24293340119697676,WIPF1,1
BURTON_ADIPOGENESIS_5,BURTON_ADIPOGENESIS_5,1/65,118/21728,0.2984664239821554,0.3470539813745993,0.24586034680537408,CAVIN1,1
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,1/65,118/21728,0.2984664239821554,0.3470539813745993,0.24586034680537408,FSTL1,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,1/65,118/21728,0.2984664239821554,0.3470539813745993,0.24586034680537408,PTPN1,1
PUJANA_BRCA_CENTERED_NETWORK,PUJANA_BRCA_CENTERED_NETWORK,1/65,118/21728,0.2984664239821554,0.3470539813745993,0.24586034680537408,STAT5A,1
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,1/65,119/21728,0.3005765434842914,0.3493045246766896,0.24745467906043384,SLC26A2,1
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1/65,120/21728,0.3026804133844957,0.3512252272760362,0.24881534521765516,SREBF1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1/65,120/21728,0.3026804133844957,0.3512252272760362,0.24881534521765516,CDKN1A,1
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,2/65,369/21728,0.3027561459119432,0.3512252272760362,0.24881534521765516,CREB3L2/RHOB,2
CERVERA_SDHB_TARGETS_1_UP,CERVERA_SDHB_TARGETS_1_UP,1/65,121/21728,0.3047780519040264,0.3531611261923829,0.2501867767657618,FSTL1,1
REACTOME_L1CAM_INTERACTIONS,REACTOME_L1CAM_INTERACTIONS,1/65,121/21728,0.3047780519040264,0.3531611261923829,0.2501867767657618,LAMB1,1
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,1/65,122/21728,0.3068694772118541,0.3547624014009874,0.25132115383459425,FSTL1,1
HOLLERN_EMT_BREAST_TUMOR_DN,HOLLERN_EMT_BREAST_TUMOR_DN,1/65,122/21728,0.3068694772118541,0.3547624014009874,0.25132115383459425,DSC2,1
MISSIAGLIA_REGULATED_BY_METHYLATION_DN,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,1/65,122/21728,0.3068694772118541,0.3547624014009874,0.25132115383459425,CAV1,1
REACTOME_RAB_REGULATION_OF_TRAFFICKING,REACTOME_RAB_REGULATION_OF_TRAFFICKING,1/65,122/21728,0.3068694772118541,0.3547624014009874,0.25132115383459425,ARF6,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,1/65,123/21728,0.3089547074248148,0.35614375495655887,0.25229973377448855,CYP1B1,1
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,1/65,123/21728,0.3089547074248148,0.35614375495655887,0.25229973377448855,MT1E,1
KARLSSON_TGFB1_TARGETS_UP,KARLSSON_TGFB1_TARGETS_UP,1/65,123/21728,0.3089547074248148,0.35614375495655887,0.25229973377448855,CYP1B1,1
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1/65,123/21728,0.3089547074248148,0.35614375495655887,0.25229973377448855,TCN2,1
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1/65,123/21728,0.3089547074248148,0.35614375495655887,0.25229973377448855,PPP1CB,1
KAYO_AGING_MUSCLE_DN,KAYO_AGING_MUSCLE_DN,1/65,124/21728,0.31103376060775345,0.3581275309242987,0.25370508243374007,SOD2,1
REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,1/65,124/21728,0.31103376060775345,0.3581275309242987,0.25370508243374007,MAPKAPK2,1
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,1/65,125/21728,0.3131066547736715,0.360099660464257,0.25510218051836314,MAPKAPK2,1
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,1/65,125/21728,0.3131066547736715,0.360099660464257,0.25510218051836314,OLFML2B,1
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,1/65,126/21728,0.3151734078838744,0.36143739436224126,0.25604985937451413,SOD2,1
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,1/65,126/21728,0.3151734078838744,0.36143739436224126,0.25604985937451413,CP,1
CHEBOTAEV_GR_TARGETS_DN,CHEBOTAEV_GR_TARGETS_DN,1/65,126/21728,0.3151734078838744,0.36143739436224126,0.25604985937451413,PTGER4,1
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,1/65,126/21728,0.3151734078838744,0.36143739436224126,0.25604985937451413,CTSF,1
WHITFIELD_CELL_CYCLE_M_G1,WHITFIELD_CELL_CYCLE_M_G1,1/65,126/21728,0.3151734078838744,0.36143739436224126,0.25604985937451413,DEXI,1
REACTOME_CARDIAC_CONDUCTION,REACTOME_CARDIAC_CONDUCTION,1/65,127/21728,0.317234037848116,0.36317577315182137,0.2572813635065009,KCNE4,1
SCHLOSSER_SERUM_RESPONSE_UP,SCHLOSSER_SERUM_RESPONSE_UP,1/65,127/21728,0.317234037848116,0.36317577315182137,0.2572813635065009,PTPN1,1
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,1/65,127/21728,0.317234037848116,0.36317577315182137,0.2572813635065009,LAMB1,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,2/65,383/21728,0.31822162153517464,0.36388979020603157,0.25778718821964136,DDO/KCNE4,2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,2/65,383/21728,0.31822162153517464,0.36388979020603157,0.25778718821964136,CAVIN1/CDKN1A,2
WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,1/65,128/21728,0.3192885625247458,0.3649012143139952,0.25850370235086195,TGFB1,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,2/65,385/21728,0.3204254470021447,0.3659913729322041,0.25927599366670884,MXRA8/RHOB,2
GAL_LEUKEMIC_STEM_CELL_UP,GAL_LEUKEMIC_STEM_CELL_UP,1/65,129/21728,0.32133699972085206,0.3666138045873954,0.2597169373550707,TSPAN9,1
REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,1/65,129/21728,0.32133699972085206,0.3666138045873954,0.2597169373550707,DSC2,1
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,2/65,387/21728,0.3226277067162212,0.3678765184905601,0.26061147046752314,RHOB/TCN2,2
SANSOM_APC_TARGETS_UP,SANSOM_APC_TARGETS_UP,1/65,131/21728,0.325415682644417,0.3708440827856604,0.26271375548921,NPC1,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,1/65,132/21728,0.3274459637310547,0.3727330264440008,0.2640519229440133,TGFB1,1
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1/65,132/21728,0.3274459637310547,0.3727330264440008,0.2640519229440133,TGFB1,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,2/65,392/21728,0.32812611821942916,0.373294787507883,0.2644498863082161,NPC1/GAA,2
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,1/65,133/21728,0.32947022805581305,0.3737608939941157,0.2647800859558315,CPD,1
QI_HYPOXIA,QI_HYPOXIA,1/65,133/21728,0.32947022805581305,0.3737608939941157,0.2647800859558315,CDKN1A,1
REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,1/65,133/21728,0.32947022805581305,0.3737608939941157,0.2647800859558315,PTGER4,1
SENESE_HDAC2_TARGETS_DN,SENESE_HDAC2_TARGETS_DN,1/65,133/21728,0.32947022805581305,0.3737608939941157,0.2647800859558315,GALNT2,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,1/65,133/21728,0.32947022805581305,0.3737608939941157,0.2647800859558315,OLFML2B,1
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,2/65,395/21728,0.33141991227913903,0.3754116570460296,0.2659495212547136,TNFRSF11A/LAMB1,2
REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,1/65,134/21728,0.3314884931716441,0.3754116570460296,0.2659495212547136,GALNT2,1
REACTOME_SIGNALING_BY_NTRKS,REACTOME_SIGNALING_BY_NTRKS,1/65,134/21728,0.3314884931716441,0.3754116570460296,0.2659495212547136,MAPKAPK2,1
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,1/65,135/21728,0.33350077658110233,0.37705005831667876,0.26711019920749984,ABCC3,1
TSENG_IRS1_TARGETS_DN,TSENG_IRS1_TARGETS_DN,1/65,135/21728,0.33350077658110233,0.37705005831667876,0.26711019920749984,HLX,1
YEGNASUBRAMANIAN_PROSTATE_CANCER,YEGNASUBRAMANIAN_PROSTATE_CANCER,1/65,135/21728,0.33350077658110233,0.37705005831667876,0.26711019920749984,SLC39A8,1
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1/65,136/21728,0.3355070957364872,0.37910406297908156,0.2685652993525494,CDKN1A,1
LI_INDUCED_T_TO_NATURAL_KILLER_DN,LI_INDUCED_T_TO_NATURAL_KILLER_DN,1/65,137/21728,0.33750746803998555,0.38093393683971283,0.2698616205190808,ACTA2,1
ZHANG_BREAST_CANCER_PROGENITORS_DN,ZHANG_BREAST_CANCER_PROGENITORS_DN,1/65,137/21728,0.33750746803998555,0.38093393683971283,0.2698616205190808,CPD,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,2/65,402/21728,0.33908887684433,0.3825029631633728,0.2709731517988947,CP/SOD2,2
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,1/65,138/21728,0.3395019108438112,0.3825373643310549,0.27099752231031576,TGFB1,1
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,1/65,138/21728,0.3395019108438112,0.3825373643310549,0.27099752231031576,STAT5A,1
PECE_MAMMARY_STEM_CELL_UP,PECE_MAMMARY_STEM_CELL_UP,1/65,139/21728,0.3414904414503491,0.3845613079395824,0.27243132657193575,MT1E,1
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,1/65,140/21728,0.343473077112294,0.38614173930555823,0.27355093742383235,DSC2,1
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,1/65,140/21728,0.343473077112294,0.38614173930555823,0.27355093742383235,PTPN18,1
REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,1/65,140/21728,0.343473077112294,0.38614173930555823,0.27355093742383235,RHOB,1
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,2/65,407/21728,0.3445514942907354,0.3871365104390286,0.2742556542373329,PTGER4/RHOB,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,1/65,141/21728,0.3454498350327916,0.38770881640384003,0.27466108783135196,FSTL1,1
REACTOME_DEATH_RECEPTOR_SIGNALLING,REACTOME_DEATH_RECEPTOR_SIGNALLING,1/65,141/21728,0.3454498350327916,0.38770881640384003,0.27466108783135196,RIPK1,1
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,2/65,408/21728,0.3456424098240234,0.38770881640384003,0.27466108783135196,SLC39A8/CDKN1A,2
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,1/65,142/21728,0.34742073236557824,0.38948512597037915,0.2759194629242792,MT1E,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,1/65,143/21728,0.3493857862151215,0.39059338872568083,0.27670457959198236,PTGER4,1
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/65,143/21728,0.3493857862151215,0.39059338872568083,0.27670457959198236,CDKN1A,1
REACTOME_DISEASES_OF_GLYCOSYLATION,REACTOME_DISEASES_OF_GLYCOSYLATION,1/65,143/21728,0.3493857862151215,0.39059338872568083,0.27670457959198236,SLC26A2,1
REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1/65,143/21728,0.3493857862151215,0.39059338872568083,0.27670457959198236,WIPF1,1
RUIZ_TNC_TARGETS_DN,RUIZ_TNC_TARGETS_DN,1/65,143/21728,0.3493857862151215,0.39059338872568083,0.27670457959198236,CAV1,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,1/65,144/21728,0.3513450136367573,0.39190743294674546,0.2776354761822734,PTPN1,1
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,1/65,144/21728,0.3513450136367573,0.39190743294674546,0.2776354761822734,PTGER4,1
WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,1/65,144/21728,0.3513450136367573,0.39190743294674546,0.2776354761822734,STAT5A,1
WP_ECTODERM_DIFFERENTIATION,WP_ECTODERM_DIFFERENTIATION,1/65,144/21728,0.3513450136367573,0.39190743294674546,0.2776354761822734,SERPINB6,1
DAZARD_UV_RESPONSE_CLUSTER_G6,DAZARD_UV_RESPONSE_CLUSTER_G6,1/65,145/21728,0.3532984316368324,0.3929904690064876,0.27840272172775393,CREB3L2,1
MIKKELSEN_ES_LCP_WITH_H3K4ME3,MIKKELSEN_ES_LCP_WITH_H3K4ME3,1/65,145/21728,0.3532984316368324,0.3929904690064876,0.27840272172775393,EMILIN1,1
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/65,145/21728,0.3532984316368324,0.3929904690064876,0.27840272172775393,ARF6,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,1/65,145/21728,0.3532984316368324,0.3929904690064876,0.27840272172775393,HSDL2,1
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,1/65,145/21728,0.3532984316368324,0.3929904690064876,0.27840272172775393,TGFB1,1
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1/65,146/21728,0.35524605717283764,0.39427975268905396,0.2793160774312983,MAPKAPK2,1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,1/65,146/21728,0.35524605717283764,0.39427975268905396,0.2793160774312983,CALD1,1
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,1/65,146/21728,0.35524605717283764,0.39427975268905396,0.2793160774312983,DSC2,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1/65,146/21728,0.35524605717283764,0.39427975268905396,0.2793160774312983,KCNE4,1
ELVIDGE_HYPOXIA_DN,ELVIDGE_HYPOXIA_DN,1/65,147/21728,0.35718790715355153,0.3959954624762212,0.2805315223647336,MAPKAPK2,1
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,1/65,147/21728,0.35718790715355153,0.3959954624762212,0.2805315223647336,ACOX2,1
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,1/65,149/21728,0.3610543478414654,0.39961742981899884,0.2830974002823013,PTPN1,1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1/65,149/21728,0.3610543478414654,0.39961742981899884,0.2830974002823013,CDKN1A,1
VANTVEER_BREAST_CANCER_ESR1_UP,VANTVEER_BREAST_CANCER_ESR1_UP,1/65,149/21728,0.3610543478414654,0.39961742981899884,0.2830974002823013,SREBF1,1
DARWICHE_PAPILLOMA_RISK_HIGH_UP,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1/65,150/21728,0.36297897212388397,0.40063904207934214,0.28382113191515507,CD248,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,1/65,150/21728,0.36297897212388397,0.40063904207934214,0.28382113191515507,CD248,1
GOLDRATH_HOMEOSTATIC_PROLIFERATION,GOLDRATH_HOMEOSTATIC_PROLIFERATION,1/65,150/21728,0.36297897212388397,0.40063904207934214,0.28382113191515507,WIPF1,1
REACTOME_SIGNALING_BY_HEDGEHOG,REACTOME_SIGNALING_BY_HEDGEHOG,1/65,150/21728,0.36297897212388397,0.40063904207934214,0.28382113191515507,P4HB,1
WHITFIELD_CELL_CYCLE_S,WHITFIELD_CELL_CYCLE_S,1/65,150/21728,0.36297897212388397,0.40063904207934214,0.28382113191515507,CALD1,1
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1/65,151/21728,0.36489788800171985,0.4025349012705128,0.2851641984790055,PPP1CB,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1/65,152/21728,0.36681111214223483,0.40419957260852324,0.2863434867005644,SERPINB6,1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,1/65,152/21728,0.36681111214223483,0.40419957260852324,0.2863434867005644,CDKN1A,1
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,1/65,154/21728,0.3706205516410074,0.40817241370154994,0.2891579309696244,CDKN1A,1
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,1/65,155/21728,0.3725168000948562,0.4100331082626739,0.2904760861692417,STAT5A,1
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,2/65,433/21728,0.37272009541077056,0.4100331082626739,0.2904760861692417,ARSB/CYP1B1,2
REACTOME_SARS_COV_INFECTIONS,REACTOME_SARS_COV_INFECTIONS,1/65,156/21728,0.37440742300283547,0.4112107885808188,0.2913103796998853,RIPK1,1
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,1/65,156/21728,0.37440742300283547,0.4112107885808188,0.2913103796998853,OLFML2B,1
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,1/65,156/21728,0.37440742300283547,0.4112107885808188,0.2913103796998853,CDKN1A,1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,1/65,157/21728,0.3762924367940842,0.4126013561338643,0.29229548702956915,ABCC3,1
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,1/65,157/21728,0.3762924367940842,0.4126013561338643,0.29229548702956915,PTGER4,1
REACTOME_INFLUENZA_INFECTION,REACTOME_INFLUENZA_INFECTION,1/65,157/21728,0.3762924367940842,0.4126013561338643,0.29229548702956915,TGFB1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1/65,159/21728,0.38004570250697434,0.41626035323874516,0.2948875976101848,CAV1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,1/65,159/21728,0.38004570250697434,0.41626035323874516,0.2948875976101848,CPD,1
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,1/65,160/21728,0.38191398705132273,0.41739233557521616,0.2956895177285479,NPC1,1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1/65,160/21728,0.38191398705132273,0.41739233557521616,0.2956895177285479,WIPF1,1
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,1/65,160/21728,0.38191398705132273,0.41739233557521616,0.2956895177285479,GAA,1
SENGUPTA_EBNA1_ANTICORRELATED,SENGUPTA_EBNA1_ANTICORRELATED,1/65,160/21728,0.38191398705132273,0.41739233557521616,0.2956895177285479,SREBF1,1
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,1/65,161/21728,0.38377672772461946,0.4191990472142212,0.29696943028965356,DDO,1
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,1/65,162/21728,0.3856339407212299,0.4205386485509595,0.2979184320787325,CAVIN1,1
REACTOME_S_PHASE,REACTOME_S_PHASE,1/65,162/21728,0.3856339407212299,0.4205386485509595,0.2979184320787325,CDKN1A,1
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1/65,162/21728,0.3856339407212299,0.4205386485509595,0.2979184320787325,KCNJ8,1
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,1/65,164/21728,0.38933184822919986,0.42410876713420465,0.3004475792434945,ABCC3,1
WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,1/65,164/21728,0.38933184822919986,0.42410876713420465,0.3004475792434945,TGFB1,1
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,2/65,451/21728,0.39195086640622023,0.4267293047427547,0.3023040232546042,SLC39A8/SOD2,2
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,2/65,452/21728,0.3930119901796517,0.42765178474390825,0.302957527508053,CALD1/TCN2,2
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,1/65,167/21728,0.39483765410514216,0.42893824454659657,0.30386888271564166,CP,1
KIM_WT1_TARGETS_12HR_UP,KIM_WT1_TARGETS_12HR_UP,1/65,167/21728,0.39483765410514216,0.42893824454659657,0.30386888271564166,CREB3L2,1
KIM_WT1_TARGETS_8HR_UP,KIM_WT1_TARGETS_8HR_UP,1/65,167/21728,0.39483765410514216,0.42893824454659657,0.30386888271564166,PLXND1,1
PUJANA_XPRSS_INT_NETWORK,PUJANA_XPRSS_INT_NETWORK,1/65,168/21728,0.39666203852530635,0.4302191307215904,0.304776289448032,STAT5A,1
SASAKI_ADULT_T_CELL_LEUKEMIA,SASAKI_ADULT_T_CELL_LEUKEMIA,1/65,168/21728,0.39666203852530635,0.4302191307215904,0.304776289448032,CAV1,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1/65,168/21728,0.39666203852530635,0.4302191307215904,0.304776289448032,KCNJ8,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,1/65,170/21728,0.40029457635407384,0.4327508933557555,0.30656984339834054,CP,1
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,1/65,170/21728,0.40029457635407384,0.4327508933557555,0.30656984339834054,FSTL1,1
NABA_ECM_AFFILIATED,NABA_ECM_AFFILIATED,1/65,170/21728,0.40029457635407384,0.4327508933557555,0.30656984339834054,PLXND1,1
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,1/65,170/21728,0.40029457635407384,0.4327508933557555,0.30656984339834054,DSC2,1
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1/65,170/21728,0.40029457635407384,0.4327508933557555,0.30656984339834054,SH2B3,1
TIEN_INTESTINE_PROBIOTICS_6HR_DN,TIEN_INTESTINE_PROBIOTICS_6HR_DN,1/65,170/21728,0.40029457635407384,0.4327508933557555,0.30656984339834054,CALD1,1
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,1/65,171/21728,0.4021027613683136,0.43447083886365595,0.3077882890055163,NPC1,1
REACTOME_GPCR_LIGAND_BINDING,REACTOME_GPCR_LIGAND_BINDING,2/65,463/21728,0.4046307762054462,0.4367094104090611,0.3093741402161033,PTGER4/P2RY6,2
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,2/65,463/21728,0.4046307762054462,0.4367094104090611,0.3093741402161033,CALD1/RHOB,2
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1/65,173/21728,0.40570304227001774,0.4367094104090611,0.3093741402161033,STAB1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,1/65,173/21728,0.40570304227001774,0.4367094104090611,0.3093741402161033,CTSF,1
HOLLERN_SQUAMOUS_BREAST_TUMOR,HOLLERN_SQUAMOUS_BREAST_TUMOR,1/65,173/21728,0.40570304227001774,0.4367094104090611,0.3093741402161033,CYP1B1,1
MOHANKUMAR_HOXA1_TARGETS_DN,MOHANKUMAR_HOXA1_TARGETS_DN,1/65,173/21728,0.40570304227001774,0.4367094104090611,0.3093741402161033,DSC2,1
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,1/65,173/21728,0.40570304227001774,0.4367094104090611,0.3093741402161033,NPC1,1
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,1/65,174/21728,0.407495169491194,0.43816684891526236,0.3104066203368122,OLFML2B,1
MIKKELSEN_IPS_LCP_WITH_H3K4ME3,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,1/65,174/21728,0.407495169491194,0.43816684891526236,0.3104066203368122,EMILIN1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,2/65,466/21728,0.4077820115905547,0.4382396685551367,0.31045820730274426,CREB3L2/FILIP1L,2
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,2/65,467/21728,0.40883071023317363,0.43913073064787717,0.31108945444844355,TMEM127/TSPAN9,2
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,1/65,175/21728,0.40928197537330746,0.43937946899979335,0.3112656659335378,ADAM8,1
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,1/65,177/21728,0.4128396852932702,0.44296103572239287,0.31380292320123204,CREB3L2,1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,1/65,179/21728,0.4163762959290497,0.446037810314997,0.31598257509683475,LAMB1,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1/65,179/21728,0.4163762959290497,0.446037810314997,0.31598257509683475,HLX,1
REACTOME_APOPTOSIS,REACTOME_APOPTOSIS,1/65,179/21728,0.4163762959290497,0.446037810314997,0.31598257509683475,RIPK1,1
BROWNE_HCMV_INFECTION_48HR_UP,BROWNE_HCMV_INFECTION_48HR_UP,1/65,180/21728,0.41813672753908304,0.4473044162670517,0.31687986541865876,PPT1,1
LEE_LIVER_CANCER_SURVIVAL_DN,LEE_LIVER_CANCER_SURVIVAL_DN,1/65,180/21728,0.41813672753908304,0.4473044162670517,0.31687986541865876,LAMB1,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,2/65,476/21728,0.4182296292096933,0.4473044162670517,0.31687986541865876,WIPF1/CDKN1A,2
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,1/65,181/21728,0.4198919304678912,0.4488422559785047,0.31796930344582497,ARF6,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,1/65,183/21728,0.4233867113891683,0.4516479117134518,0.319956889034898,ARSB,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,1/65,183/21728,0.4233867113891683,0.4516479117134518,0.319956889034898,MXRA8,1
REACTOME_ION_CHANNEL_TRANSPORT,REACTOME_ION_CHANNEL_TRANSPORT,1/65,183/21728,0.4233867113891683,0.4516479117134518,0.319956889034898,RIPK1,1
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,2/65,481/21728,0.4234199172313611,0.4516479117134518,0.319956889034898,CPD/PTPN1,2
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,2/65,482/21728,0.42445522981672545,0.4525109059879802,0.3205682523472745,DSC2/CDKN1A,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,1/65,184/21728,0.4251263198254507,0.452984890597177,0.32090403302305287,MAPKAPK2,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,2/65,483/21728,0.42548961846143263,0.45313058409098256,0.32100724536129616,FILIP1L/ADAM8,2
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,2/65,484/21728,0.42652307939697776,0.4538657740227362,0.3215280693866332,ACTA2/NPC1,2
WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,1/65,185/21728,0.4268607604683834,0.4538657740227362,0.3215280693866332,CYP1B1,1
WP_RAS_SIGNALING,WP_RAS_SIGNALING,1/65,185/21728,0.4268607604683834,0.4538657740227362,0.3215280693866332,ARF6,1
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,2/65,485/21728,0.42755560888484856,0.45436302750780927,0.32188033422395335,CAVIN1/LAMB1,2
JISON_SICKLE_CELL_DISEASE_DN,JISON_SICKLE_CELL_DISEASE_DN,1/65,187/21728,0.4303141987811495,0.4568091282177808,0.3236132034637542,TGFB1,1
LEE_LIVER_CANCER_SURVIVAL_UP,LEE_LIVER_CANCER_SURVIVAL_UP,1/65,187/21728,0.4303141987811495,0.4568091282177808,0.3236132034637542,ACOX2,1
DARWICHE_SKIN_TUMOR_PROMOTER_DN,DARWICHE_SKIN_TUMOR_PROMOTER_DN,1/65,189/21728,0.43374714670714687,0.46020917422508956,0.3260218676352477,CP,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,1/65,190/21728,0.4354559742044323,0.4617772791139261,0.327132746151234,FSTL1,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,2/65,493/21728,0.43578187383676814,0.4618779796892084,0.3272040845587761,OLFML2B/PPP1CB,2
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,1/65,191/21728,0.4371597239340598,0.4628477754728002,0.3278911083086259,CP,1
SHEPARD_CRASH_AND_BURN_MUTANT_DN,SHEPARD_CRASH_AND_BURN_MUTANT_DN,1/65,191/21728,0.4371597239340598,0.4628477754728002,0.3278911083086259,HLX,1
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,2/65,496/21728,0.43885091809346055,0.4643925059190058,0.32898542787735896,PTGER4/WIPF1,2
BURTON_ADIPOGENESIS_6,BURTON_ADIPOGENESIS_6,1/65,193/21728,0.4405520494614906,0.46569984086838334,0.329911571478339,RETSAT,1
FUJII_YBX1_TARGETS_DN,FUJII_YBX1_TARGETS_DN,1/65,193/21728,0.4405520494614906,0.46569984086838334,0.329911571478339,SLC26A2,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,1/65,194/21728,0.44224065483808706,0.46674475444652985,0.33065181025527857,WIPF1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,1/65,194/21728,0.44224065483808706,0.46674475444652985,0.33065181025527857,CAV1,1
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,1/65,194/21728,0.44224065483808706,0.46674475444652985,0.33065181025527857,CAV1,1
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,1/65,195/21728,0.44392424160485233,0.4682745164608147,0.33173552587171407,GAA,1
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,1/65,197/21728,0.4472764179992387,0.47131340147443485,0.33388833599188916,CDKN1A,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,1/65,197/21728,0.4472764179992387,0.47131340147443485,0.33388833599188916,SLC39A8,1
XU_GH1_AUTOCRINE_TARGETS_UP,XU_GH1_AUTOCRINE_TARGETS_UP,1/65,199/21728,0.450608695603273,0.47432494274028736,0.3360217752254878,SLC26A2,1
YAMAZAKI_TCEB3_TARGETS_DN,YAMAZAKI_TCEB3_TARGETS_DN,1/65,199/21728,0.450608695603273,0.47432494274028736,0.3360217752254878,SOD2,1
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,1/65,200/21728,0.4522674087244487,0.47582052469694763,0.3370812769695219,P4HB,1
HAMAI_APOPTOSIS_VIA_TRAIL_DN,HAMAI_APOPTOSIS_VIA_TRAIL_DN,1/65,203/21728,0.45721401891537783,0.48026682659178344,0.34023113083817924,EMILIN1,1
HOLLMANN_APOPTOSIS_VIA_CD40_UP,HOLLMANN_APOPTOSIS_VIA_CD40_UP,1/65,203/21728,0.45721401891537783,0.48026682659178344,0.34023113083817924,HGSNAT,1
REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1/65,203/21728,0.45721401891537783,0.48026682659178344,0.34023113083817924,GALNT2,1
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,1/65,204/21728,0.45885309388729445,0.4814827847715577,0.3410925412118509,PTGER4,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,1/65,204/21728,0.45885309388729445,0.4814827847715577,0.3410925412118509,SLC39A8,1
KYNG_DNA_DAMAGE_UP,KYNG_DNA_DAMAGE_UP,1/65,205/21728,0.4604872951926895,0.4829442005167168,0.3421278388923689,DSC2,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,1/65,207/21728,0.46374113382568105,0.48610181742733866,0.3443647611879989,RHOB,1
REACTOME_PROGRAMMED_CELL_DEATH,REACTOME_PROGRAMMED_CELL_DEATH,1/65,208/21728,0.465360799561536,0.48754405401941964,0.34538647195270467,RIPK1,1
GROSS_HYPOXIA_VIA_ELK3_UP,GROSS_HYPOXIA_VIA_ELK3_UP,1/65,209/21728,0.46697564844761885,0.4889797365943653,0.34640353971369253,STAB1,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,1/65,211/21728,0.4701909520379468,0.49183153978864724,0.3484238171344839,CYP1B1,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,1/65,211/21728,0.4701909520379468,0.49183153978864724,0.3484238171344839,CAVIN1,1
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,1/65,213/21728,0.473387156925991,0.49491600305906014,0.3506089158513132,PPP1CB,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1/65,215/21728,0.4765643747946382,0.49797740312919353,0.3527776761115235,P4HB,1
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1/65,216/21728,0.47814589832173116,0.49936908440911876,0.3537635724287757,P2RY6,1
REACTOME_KERATINIZATION,REACTOME_KERATINIZATION,1/65,217/21728,0.479722716683998,0.5007544015490585,0.35474496025528046,DSC2,1
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,1/65,218/21728,0.481294843661616,0.5021333788853584,0.3557218568314171,SH2B3,1
AMUNDSON_RESPONSE_TO_ARSENITE,AMUNDSON_RESPONSE_TO_ARSENITE,1/65,219/21728,0.482862292995042,0.5029815552031688,0.3563227227912975,MT1E,1
REACTOME_ESR_MEDIATED_SIGNALING,REACTOME_ESR_MEDIATED_SIGNALING,1/65,219/21728,0.482862292995042,0.5029815552031688,0.3563227227912975,CAV1,1
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,1/65,219/21728,0.482862292995042,0.5029815552031688,0.3563227227912975,RIPK1,1
PEDRIOLI_MIR31_TARGETS_UP,PEDRIOLI_MIR31_TARGETS_UP,1/65,223/21728,0.4890855873120795,0.5086693575788659,0.3603520817374492,OLFML2B,1
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1/65,223/21728,0.4890855873120795,0.5086693575788659,0.3603520817374492,PTGER4,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1/65,223/21728,0.4890855873120795,0.5086693575788659,0.3603520817374492,CDKN1A,1
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,1/65,224/21728,0.49062985314908114,0.5094806367072493,0.36092680895155677,TNFRSF11A,1
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,1/65,224/21728,0.49062985314908114,0.5094806367072493,0.36092680895155677,TGFB1,1
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,1/65,224/21728,0.49062985314908114,0.5094806367072493,0.36092680895155677,KCNJ8,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,1/65,228/21728,0.4967610906658496,0.5155797515992212,0.36524755034344836,SLC26A2,1
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,1/65,229/21728,0.4982825106243014,0.5166226134000015,0.3659863355981064,CP,1
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,1/65,229/21728,0.4982825106243014,0.5166226134000015,0.3659863355981064,RHOB,1
KAUFFMANN_DNA_REPAIR_GENES,KAUFFMANN_DNA_REPAIR_GENES,1/65,230/21728,0.49979940149408253,0.5179268409265103,0.36691027783530694,CDKN1A,1
REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1/65,232/21728,0.5028196490194221,0.5207867933914263,0.3689363283709789,CAV1,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,1/65,233/21728,0.5043230321052863,0.5220735322000893,0.36984788123227386,MT1E,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,1/65,235/21728,0.5073163827135345,0.5249005511779974,0.37185060099241296,FILIP1L,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/65,236/21728,0.5088063764381714,0.5256264219402597,0.37236482312188934,RHOB,1
GAL_LEUKEMIC_STEM_CELL_DN,GAL_LEUKEMIC_STEM_CELL_DN,1/65,236/21728,0.5088063764381714,0.5256264219402597,0.37236482312188934,CYP1B1,1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,1/65,236/21728,0.5088063764381714,0.5256264219402597,0.37236482312188934,WIPF1,1
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,1/65,237/21728,0.5102919331816815,0.5268889346222835,0.37325921368504933,PTGER4,1
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,1/65,239/21728,0.5132497877151208,0.5296695435656561,0.3752290555996701,FILIP1L,1
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/65,242/21728,0.5176536161102664,0.5336635217631611,0.3780584738385343,LAMB1,1
KAYO_AGING_MUSCLE_UP,KAYO_AGING_MUSCLE_UP,1/65,242/21728,0.5176536161102664,0.5336635217631611,0.3780584738385343,CDKN1A,1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1/65,243/21728,0.5191128228008015,0.5348921409590948,0.37892885354260086,SH2B3,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,1/65,250/21728,0.5292062727690678,0.5450116094429124,0.38609769805797894,DDO,1
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,1/65,253/21728,0.533467911298003,0.5491177676767915,0.38900658699629553,ACOX2,1
MASSARWEH_TAMOXIFEN_RESISTANCE_DN,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,1/65,257/21728,0.5390910608193126,0.5546204329416796,0.39290479091552677,SLC26A2,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,1/65,259/21728,0.5418775568819715,0.5572005726292766,0.3947326161889507,ARF6,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1/65,262/21728,0.5460262278239666,0.5611780347625556,0.39755033410021046,KCNJ8,1
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,1/65,265/21728,0.5501379020155582,0.5651134073092534,0.4003382348622396,CDKN1A,1
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,1/65,266/21728,0.5515002948017014,0.566222068584909,0.4011236338501514,ACOX2,1
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,1/65,267/21728,0.5528586249124967,0.5673254232042039,0.40190527349097815,STAB1,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/65,268/21728,0.5542129042741615,0.5684234915632425,0.4026831682337498,PLXND1,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,1/65,270/21728,0.556909358282786,0.5708963180756391,0.40443497059463707,ABCC3,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/65,271/21728,0.5582515566102919,0.5719790539039875,0.4052020034498776,SERPINB6,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,1/65,272/21728,0.5595897515499539,0.5730565812083501,0.4059653464770734,RIPK1,1
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,1/65,274/21728,0.5622541782514345,0.5754904588039248,0.4076895566053068,STAB1,1
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,1/65,278/21728,0.5675355059459655,0.5805989830649263,0.41130854273967943,HLX,1
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,1/65,280/21728,0.5701525925853522,0.5829781110279675,0.4129939670756023,WIPF1,1
BHAT_ESR1_TARGETS_VIA_AKT1_UP,BHAT_ESR1_TARGETS_VIA_AKT1_UP,1/65,281/21728,0.5714552819494867,0.5840115298410697,0.4137260627189894,CYP1B1,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,1/65,282/21728,0.572754083957846,0.5850399223267068,0.4144545976061829,WIPF1,1
REACTOME_SENSORY_PERCEPTION,REACTOME_SENSORY_PERCEPTION,1/65,284/21728,0.5753400715523772,0.5873813900483688,0.4161133426342656,RETSAT,1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,1/65,290/21728,0.5830059186518104,0.5946006309554415,0.4212276048768549,CALD1,1
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,1/65,290/21728,0.5830059186518104,0.5946006309554415,0.4212276048768549,SOD2,1
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,1/65,292/21728,0.5855307955038043,0.5965672903757558,0.42262082781356175,DSC2,1
REACTOME_CELL_CYCLE_CHECKPOINTS,REACTOME_CELL_CYCLE_CHECKPOINTS,1/65,292/21728,0.5855307955038043,0.5965672903757558,0.42262082781356175,CDKN1A,1
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,1/65,293/21728,0.5867875830710862,0.5975433636161774,0.4233122986459868,WIPF1,1
REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1/65,296/21728,0.5905354749802701,0.6010539185549824,0.425799249671056,SOD2,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,1/65,300/21728,0.5954806420314291,0.605778883043163,0.4291465139874197,SREBF1,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,1/65,303/21728,0.5991508817353983,0.6088931724953236,0.4313527421993187,NPC1,1
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,1/65,303/21728,0.5991508817353983,0.6088931724953236,0.4313527421993187,WIPF1,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1/65,307/21728,0.603993573776468,0.6135028682340965,0.4346183477068916,CDKN1A,1
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,1/65,323/21728,0.6227948959138133,0.6319582911352748,0.44769255782530526,CIITA,1
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,1/65,323/21728,0.6227948959138133,0.6319582911352748,0.44769255782530526,SLC39A8,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,1/65,325/21728,0.6250823685315385,0.6339577774153535,0.44910903600056107,APOBEC3C,1
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,1/65,327/21728,0.627356181441745,0.6359413902095743,0.4505142690642563,PPP1CB,1
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,1/65,329/21728,0.6296164149467385,0.6379092350017614,0.4519083317433531,CAV1,1
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,1/65,333/21728,0.6340964626298068,0.64212300013145,0.4548934516720693,CP,1
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,1/65,334/21728,0.6352081116098984,0.6429231898885611,0.45546032294210703,ABCC3,1
MIKKELSEN_NPC_HCP_WITH_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,1/65,345/21728,0.6472189085633258,0.6547485165031116,0.4638376332700991,TNFRSF11A,1
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,1/65,350/21728,0.652548820960607,0.6598066946012204,0.46742095312275933,TGFB1,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,1/65,357/21728,0.6598777261299811,0.6668799657705721,0.4724318073301001,SERPINB6,1
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,1/65,361/21728,0.6639971080574174,0.6707041495529469,0.47514093963066667,ACTA2,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1/65,366/21728,0.6690773094088733,0.6754945072275349,0.4785345298569801,CDKN1A,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1/65,374/21728,0.6770487496952968,0.6831975274422772,0.48399151154595027,DDO,1
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,1/65,378/21728,0.680963265109402,0.6868010742404458,0.4865443399619159,MXRA8,1
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,1/65,385/21728,0.6877015611342138,0.6932475414659413,0.4911111530595564,SOD2,1
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,1/65,399/21728,0.7007605025204431,0.7060559219349553,0.500184879433921,SERPINB6,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,1/65,403/21728,0.7043918382951407,0.7093573396728506,0.5025236732629774,NPC1,1
REACTOME_NEURONAL_SYSTEM,REACTOME_NEURONAL_SYSTEM,1/65,411/21728,0.7115248288734121,0.7161799988660413,0.507356988670364,KCNJ8,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,1/65,416/21728,0.715896602958944,0.7202179104214728,0.510217530224896,STAT5A,1
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,1/65,419/21728,0.7184882861288315,0.7224618261727819,0.511807167383455,PTPN1,1
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,1/65,425/21728,0.723602013224209,0.7272382042454362,0.5151908541654512,STAT5A,1
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,1/65,427/21728,0.7252861779613295,0.7285647191977194,0.5161305852842791,RIPK1,1
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,1/65,428/21728,0.7261244671699354,0.7290406296886902,0.5164677302952512,HSDL2,1
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,1/65,431/21728,0.7286242517558542,0.7311833936335717,0.5179857093846251,SOD2,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,1/65,433/21728,0.7302782798457967,0.7324757069666968,0.5189012113564074,CALD1,1
VECCHI_GASTRIC_CANCER_EARLY_UP,VECCHI_GASTRIC_CANCER_EARLY_UP,1/65,436/21728,0.7327407270244624,0.7345771699493356,0.5203899319746347,SOD2,1
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,1/65,440/21728,0.7359895863863914,0.7374645154172258,0.5224353882903086,SOD2,1
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,1/65,445/21728,0.739996020450749,0.7411076819737096,0.5250162841771648,HGSNAT,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,1/65,450/21728,0.7439425770937214,0.7446872643580795,0.5275521356978817,SOD2,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,1/65,454/21728,0.7470573032011731,0.7474310187105284,0.529495869044406,RHOB,1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,1/65,459/21728,0.7508982923009404,0.7508982923009404,0.5319521586510874,SOD2,1
